syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	57.052342195160755
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	1.3805416	51.79260606950534
DOORS SYNDROME	1.3486830539999997	50.59739607154133
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	1.2730769599999998	47.760946490452305
MYOCLONIC-ASTASTIC EPILEPSY	1.2209214940000002	45.804274192486446
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709462
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.15211626	43.22296669687592
LYMPHATIC MALFORMATION 1	1.0416667	39.07932441066724
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0333333	38.76668732430953
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	1.0081171789999999	37.820675540561766
RETT SYNDROME; RTT	1.007958999	37.8147412359178
GABRIELE-DE VRIES SYNDROME	1.0048951	37.699795540732836
COFFIN-SIRIS SYNDROME 2; CSS2	1.002048511	37.59300248015517
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.000541419	37.53646219026713
ANONYCHIA WITH FLEXURAL PIGMENTATION	1.0	37.51615023372374
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	1.0	37.51615023372374
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372374
CURVED NAIL OF FOURTH TOE	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.95944076	35.99452369251809
SEMANTIC DEMENTIA	0.920833	34.54610916817054
PROGRESSIVE NON-FLUENT APHASIA	0.9129429	34.250102991211435
LAFORA DISEASE	0.7732152999999999	29.00806135781377
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706170999999999	28.910586896276513
CRANIOSYNOSTOSIS 4; CRS4	0.75	28.13711267529281
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	28.083800875229276
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.58878041260787
POSTERIOR CORTICAL ATROPHY	0.6989939999999999	26.223563916471488
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.697436674	26.16513904029261
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.23737578730924
ROLANDIC EPILEPSY	0.5906213	22.157837422037222
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5849288	21.94427673683175
INHALATIONAL ANTHRAX	0.5833333	21.884419719133845
ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE; ECTD6	0.5357143	20.09793816115415
CITRULLINEMIA TYPE II	0.5344202730000001	20.04939124981566
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228724
SMITH-FINEMAN-MYERS SYNDROME	0.5213747190000001	19.559972286069506
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.5197757940000001	19.499986775557048
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.517808602	19.426185304946465
HYPODONTIA-DYSPLASIA OF NAILS SYNDROME	0.516129	19.363173103981598
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.510220798	19.141520110138412
TEMPLE-BARAITSER SYNDROME	0.5085708870000001	19.079621801190143
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.505803324	18.97579349190085
CORTICOBASAL SYNDROME	0.504167	18.9144049148858
TEMPLE-BARAITSER SYNDROME; TMBTS	0.502048511	18.834927363293307
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.501507092	18.814615406749915
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.500541419	18.778387073405263
CREST SYNDROME	0.5	18.75807511686187
%613938 PARASOMNIA, SLEEPWALKING TYPE; PSMNSWPARASOMNIA, SLEEP TERRORS TYPE, INCLUDED; PSMNST, INCLUDED	0.5	18.75807511686187
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.75807511686187
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.5	18.75807511686187
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5	18.75807511686187
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.5	18.75807511686187
49,XYYYY SYNDROME	0.5	18.75807511686187
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
PAROXYSMAL HEMICRANIA	0.5	18.75807511686187
SPINOCEREBELLAR ATAXIA TYPE 10	0.474039178	17.78412501851891
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.4350356	16.32086092661815
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.42617084	15.988289258672244
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42242719000000006	15.847841922849767
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.418977454	15.718421108807078
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.40998736	15.38114739168778
PERIORAL MYOCLONIA WITH ABSENCES	0.40159691	15.066370008959233
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.39648946	14.874758147448
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.392697919	14.732514125674678
CHILDHOOD APRAXIA OF SPEECH	0.3830966	14.372309599628771
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.381871992	14.32636702192335
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
HYPERTRICHOSIS CUBITI	0.350988754	13.167746825411506
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34853700400000004	13.075766604075975
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.346334392	12.993133081377369
OROFACIODIGITAL SYNDROME TYPE 3	0.3462259	12.989062879206212
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.345788838	12.972665995552763
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.34120729	12.800783952481746
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.34037525	12.769569014841279
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
COG4-CDG	0.337375054	12.657013210974661
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.33717915	12.649663647079274
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.335560759	12.588947847186367
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.33501934	12.568635890642973
OCULOPHARYNGODISTAL MYOPATHY	0.333333	12.505370905857834
BIFID UVULA	0.333333	12.505370905857834
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	12.505370905857834
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.32860944000000003	12.32816111925983
DYSTONIA 6, TORSION	0.31923024	11.976289642987686
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31566591	11.842569703225118
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.302242952	11.338991994316155
WRINKLY SKIN SYNDROME	0.30219475399999995	11.337183790907188
WEST SYNDROME	0.2822581	10.58923728428542
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.2819444	10.5774684679571
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.28021679699999996	10.512655454264868
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.27668634000000003	10.380206299059168
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.276393834	10.369232600018902
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.27255881	10.225357263484964
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.25916504	9.722874575969023
CONGENITAL ENTEROVIRUS INFECTION	0.25840336	9.694299274659002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.590251758503891
PALLISTER-HALL SYNDROME	0.254819054	9.559829912279362
HYPEREKPLEXIA 1; HKPX1	0.2542735	9.539362826454752
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.25150295699999997	9.435422719037762
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.250545554	9.399504644255545
SPEECH-LANGUAGE DISORDER 1	0.2500003	9.379048813276006
HYPERPARATHYROIDISM 2	0.25	9.379037558430936
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430936
OROFACIODIGITAL SYNDROME TYPE 10	0.25	9.379037558430936
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.24625873200000004	9.238679586078312
KUFOR-RAKEB SYNDROME	0.24527644	9.201827771832928
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	9.118118511042525
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.24149503800000002	9.059964126306825
UNILATERAL POLYMICROGYRIA	0.2346684	8.803854949507576
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.80184423391965
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013935
INFANTILE MYOFIBROMATOSIS	0.23225810000000002	8.713429772599234
BILATERAL POLYMICROGYRIA	0.231549564	8.686848229577231
LÉRI-WEILL DYSCHONDROSTEOSIS	0.2261903	8.485789276211044
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.475991933577506
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.22388017100000002	8.399122129587761
HAND-FOOT-GENITAL SYNDROME	0.21960780000000002	8.238839217297558
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21853340400000001	8.198532015551045
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21834761000000003	8.191561739934523
COFFIN-SIRIS SYNDROME	0.213135173	7.996011170358701
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	7.818491762972814
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.208271014	7.813526650553982
COFFIN-SIRIS SYNDROME 7; CSS7	0.206477122	7.746226728778906
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.2013986	7.555700134461635
6P22 MICRODELETION SYNDROME	0.2013986	7.555700134461635
HYPERTRYPTOPHANEMIA; HYPTRP	0.20054555400000001	7.5236971325693585
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.20054555400000001	7.5236971325693585
SPASTIC PARAPLEGIA 16, X-LINKED	0.2	7.50323004674475
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.50323004674475
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.2	7.50323004674475
BETA-THALASSEMIA	0.2	7.50323004674475
STUTTERING, FAMILIAL PERSISTENT, 1; STUT1	0.2	7.50323004674475
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.50323004674475
JUVENILE HYALINE FIBROMATOSIS	0.2	7.50323004674475
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.198837054	7.459600789895041
FILIPPI SYNDROME	0.196911673	7.387367907041884
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.194990354	7.315287414790976
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.19438934400000002	7.292739833339006
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.18962994	7.114185317852019
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.105249346027849
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.18913359999999999	7.095564551845013
9P13 MICRODELETION SYNDROME	0.1884681	7.07059755386447
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.18843271	7.069269857307699
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.18717955400000003	7.022256268545407
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.18481994999999998	6.933733010389311
DDOST-CDG	0.18413454699999998	6.908019328470664
JUVENILE MYOCLONIC EPILEPSY	0.1829753	6.864528843860672
MYOCLONIC EPILEPSY OF INFANCY	0.182972154	6.864410818052037
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.182972154	6.864410818052037
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.17835560899999997	6.691215822271289
8Q21.11 MICRODELETION SYNDROME	0.17749956	6.659100159379862
FREEMAN-SHELDON SYNDROME	0.17521401	6.573355122213174
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.17511509999999997	6.569644399793556
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.393860752130533
ADULT-ONSET DYSTONIA-PARKINSONISM	0.169440313	6.3567482381571745
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.169137192	6.345376305182178
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.16835334000000002	6.315969195789172
AGEL AMYLOIDOSIS	0.16835334000000002	6.315969195789172
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.16835334000000002	6.315969195789172
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16765261399999998	6.289680653900495
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.16742994	6.281326782663352
VERRUCOUS HEMANGIOMA	0.166667	6.252704211004036
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.166667	6.252704211004036
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.166667	6.252704211004036
CUTANEOUS NEUROENDOCRINE CARCINOMA	0.166667	6.252704211004036
PRESSURE-INDUCED LOCALIZED LIPOATROPHY	0.166667	6.252704211004036
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.166667	6.252704211004036
FETAL AKINESIA DEFORMATION SEQUENCE	0.166667	6.252704211004036
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.16042104	6.0183798372902055
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.15950570000000003	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.15950570000000003	5.98403980433527
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.1583333	5.940055869801252
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.15800176	5.927617765352763
FREE SIALIC ACID STORAGE DISEASE	0.15712461299999997	5.8947105867237015
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.157119852	5.89453197233244
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.155858392	5.847206849458607
DISTAL MONOSOMY 7Q36	0.15544661899999998	5.8317587117284155
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.72728354897679
FOCAL DERMAL HYPOPLASIA	0.15039125	5.642100728837506
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.145349148	5.452940472711747
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.144160752	5.408356429838591
COMBINED SAPOSIN DEFICIENCY	0.143818538	5.395517878002507
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.14339841899999997	5.379756630482464
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14339841899999997	5.379756630482464
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.143157951	5.370735196868062
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.14285699999999998	5.3594446739390715
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.14285699999999998	5.3594446739390715
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	5.3594446739390715
PACMAN DYSPLASIA	0.14285699999999998	5.3594446739390715
GLOMUVENOUS MALFORMATION	0.14285699999999998	5.3594446739390715
PIEBALDISM	0.14285699999999998	5.3594446739390715
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.14241023999999997	5.342683958660653
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.14215457099999998	5.333092242046548
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.141726	5.31701390802473
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.141239338	5.298756223319686
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.160973134422204
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.13067209999999999	4.902314134956172
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.13061906699999998	4.900324540960827
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.130128238	4.881910526457759
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.12965840299999998	4.864284126012696
CHARGE SYNDROME	0.12927349999999999	4.849844047239285
WILLIAMS SYNDROME	0.12915812	4.845515433825319
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.12857143	4.8235050836446955
MICROPHTHALMIA, SYNDROMIC 1	0.127901557	4.798374027539181
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.126944154	4.762455952756963
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.126944154	4.762455952756963
ACROOTOOCULAR SYNDROME	0.1263986	4.741988866932354
MONOSOMY 18Q	0.126086973	4.730297821583469
DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH	0.125	4.689518779215468
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.125	4.689518779215468
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.125	4.689518779215468
SPINOCEREBELLAR ATAXIA TYPE 40	0.12300984	4.61485563766632
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.121877352	4.57236904772043
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.12024401400000002	4.511092493929982
PITT-HOPKINS SYNDROME	0.12002001300000002	4.502688838761477
COOKS SYNDROME	0.11904760000000002	4.466207646564251
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.1166667	4.376885444472778
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.1166667	4.376885444472778
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.1166667	4.376885444472778
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.1166667	4.376885444472778
AUTOIMMUNE HYPOPARATHYROIDISM	0.1166667	4.376885444472778
AICARDI SYNDROME; AIC	0.115759338	4.342844715364405
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.11317881900000001	4.246033576879428
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11309530000000001	4.242900265528057
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.11263740000000001	4.225721620336035
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.111218054	4.172473222566399
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	4.005181580605681
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.106549919	3.997342768595096
VELOCARDIOFACIAL SYNDROME	0.105235	3.948012069845918
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.10521451400000001	3.9472435139922304
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.10428935000000002	3.9125349223773975
FAMILIAL DEVELOPMENTAL DYSPHASIA	0.10416660000000001	3.9079298149362085
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.10238735400000001	3.841179354697456
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.102184878	3.8335832346627323
17P11.2 MICRODUPLICATION SYNDROME	0.101911344	3.8233212920247004
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.101685164	3.814835889164837
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.10153017300000002	3.8090212235239624
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.10153017300000002	3.8090212235239624
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.10108985000000001	3.7925019997045983
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.10098875400000001	3.78870926698057
MIETENS SYNDROME	0.10098875400000001	3.78870926698057
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.1004902	3.7700054402169454
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.1004902	3.7700054402169454
MILROY DISEASE	0.1004902	3.7700054402169454
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.10044320000000001	3.768242181155961
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.10044320000000001	3.768242181155961
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.10044320000000001	3.768242181155961
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.09953571900000001	3.7341969876257113
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7123395157572903
DOMINANT DYSTROPHIC EPIDERMOLYSIS BULLOSA, NAILS ONLY	0.0982143	3.6846224339000138
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810906
DYSTONIA-APHONIA SYNDROME	0.09724031300000001	3.6480821912823203
ANONYCHIA-MICROCEPHALY SYNDROME	0.09538150000000001	3.5783466835179216
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.095178728	3.5707394587027284
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.094990054	3.563661136573531
RING CHROMOSOME 7 SYNDROME	0.09310205999999999	3.4928308700291613
ADAMS-OLIVER SYNDROME	0.09227807900000001	3.4619182750434283
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.09220811899999999	3.459293645173076
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.0921099	3.4556088464132704
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.091815454	3.4445623660415516
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.091516244	3.4333371587301187
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.090023292	3.377327347206381
LANDAU-KLEFFNER SYNDROME	0.088586973	3.3234421878188285
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.088045554	3.3031302312754365
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.087252231	3.2733678064235683
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.0870714	3.266583723460653
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.086004359	3.226552452999111
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.08558067899999999	3.2106576104680866
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08545307	3.2058702120529117
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.08527745400000002	3.1992817758134664
2Q32Q33 MICRODELETION SYNDROME	0.08527745400000002	3.1992817758134664
FRIEDREICH ATAXIA	0.08501964000000001	3.1896095870571086
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.08484045200000001	3.182887143129028
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.08473190000000001	3.178814689988857
DYSKERATOSIS CONGENITA	0.08387885400000002	3.1468116880965806
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.083858122	3.146033903269934
X-LINKED ADRENOLEUKODYSTROPHY	0.0838235	3.1447350191165424
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.083484633	3.132022033835291
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.08333330000000001	3.1263446022719714
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.08333330000000001	3.1263446022719714
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.08333330000000001	3.1263446022719714
KEIPERT SYNDROME	0.08333330000000001	3.1263446022719714
SALT-AND-PEPPER SYNDROME	0.082363642	3.089966767068639
CENANI-LENZ SYNDROME	0.08210780000000001	3.0803685601605424
PHELAN-MCDERMID SYNDROME	0.08084716100000001	3.0330742380460514
KUFOR-RAKEB SYNDROME	0.079150859	2.9694355173722853
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.078629	2.9498573767274645
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.07860944	2.949123560828893
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.07860944	2.949123560828893
DERMOODONTODYSPLASIA	0.07843130000000001	2.942440433826257
DUBOWITZ SYNDROME	0.07814024800000001	2.931521283268432
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07813836	2.93145045277679
TUBEROUS SCLEROSIS COMPLEX	0.07794046	2.924026006645536
ATYPICAL JUVENILE PARKINSONISM	0.07746451900000001	2.9061705325871476
SCHINZEL-GIEDION SYNDROME	0.07710070000000001	2.8925214443252645
LOCKED-IN SYNDROME	0.07692310000000001	2.885858576043755
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.885858576043755
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.885858576043755
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.076770071	2.880117517089638
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002488
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.07571525999999999	2.840545069145454
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.07568064	2.839246260024362
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07527475000000002	2.824018829805997
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.0749525	2.8119292503931788
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0749525	2.8119292503931788
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07427589999999999	2.786545823145041
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.07417580000000001	2.782790456506646
CHROMOSOME 16P13.2 DELETION SYNDROME	0.073610311	2.7615754862271276
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.0732084	2.7464973327705415
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.07309865700000001	2.742380197895442
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.073061059	2.740969665678954
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07293569200000001	2.736266378472603
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07293569200000001	2.736266378472603
JUVENILE PRIMARY LATERAL SCLEROSIS	0.0727513	2.7293487004987065
PRIMARY LATERAL SCLEROSIS	0.0727513	2.7293487004987065
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.072549929	2.721794035809991
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.07230196	2.7124911935526845
ACROMEGALY	0.0715198	2.683147561485875
SOMATOMAMMOTROPINOMA	0.0715198	2.683147561485875
TRICHOTHIODYSTROPHY	0.071481792	2.6817216476477923
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.67972608858456
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.071098494	2.667341782295506
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.070708754	2.6527202379034147
TONNE-KALSCHEUER SYNDROME; TOKAS	0.070417352	2.641787956693007
OROFACIODIGITAL SYNDROME TYPE 2	0.070087804	2.629424584415784
DYSTONIA 16; DYT16	0.06923024	2.5972520845567506
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.06879887900000001	2.581069080475782
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.068606719	2.573859977046869
LYNCH SYNDROME	0.068299189	2.562322635365492
FAMILIAL COLORECTAL CANCER TYPE X	0.068299189	2.562322635365492
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.068173792	2.5576182226746336
FOCAL DERMAL HYPOPLASIA; FDH	0.0681721	2.557554745348438
SMITH-MAGENIS SYNDROME; SMS	0.068119941	2.5555979404683975
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.067628238	2.537151136850025
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.067208119	2.5213898893299826
SECONDARY SYRINGOMYELIA	0.067208119	2.5213898893299826
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.067208119	2.5213898893299826
ISOLATED CLEFT LIP	0.0667735	2.5050846576315524
SPINOCEREBELLAR ATAXIA TYPE 35	0.0666667	2.5010779327865906
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0666667	2.5010779327865906
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865906
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.066537919	2.4962465654433417
PELIZAEUS-MERZBACHER DISEASE	0.066234851	2.4848766208243074
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.06607143	2.4787456940369617
RHEUMATIC FEVER	0.06607143	2.4787456940369617
WHITE-SUTTON SYNDROME; WHSUS	0.06587887199999999	2.4715216591802562
CHRISTIANSON SYNDROME	0.06565625	2.4631697387829243
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.065405692	2.4537697672126635
RING CHROMOSOME 12 SYNDROME	0.065396334	2.453418691078776
SPINOCEREBELLAR ATAXIA 1	0.06514787799999999	2.4440975784563057
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.064727759	2.428336330936264
CHOREOACANTHOCYTOSIS	0.064727759	2.428336330936264
ACERULOPLASMINEMIA	0.06418634	2.4080243743928715
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.06418634	2.4080243743928715
SPINOCEREBELLAR ATAXIA TYPE 21	0.06418634	2.4080243743928715
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.06418634	2.4080243743928715
SPINOCEREBELLAR ATAXIA 15	0.06418634	2.4080243743928715
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.06418634	2.4080243743928715
SPINOCEREBELLAR ATAXIA TYPE 27	0.06418634	2.4080243743928715
KEIPERT SYNDROME; KPTS	0.0638986	2.3972294773246197
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.06372334	2.3906543968346576
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.063586973	2.3855384319757356
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.06351011000000001	2.382654828120321
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.063484719	2.381702255549736
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.063461538	2.380832593671168
ADDUCTED THUMBS SYNDROME	0.063461538	2.380832593671168
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.063461538	2.380832593671168
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.063045554	2.365226475432343
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.063045554	2.365226475432343
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.063045554	2.365226475432343
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.062865554	2.3584735683902727
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.0625	2.344759389607734
%614927 ECTODERMAL DYSPLASIA 5, HAIR/NAIL TYPE; ECTD5	0.0625	2.344759389607734
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.0625	2.344759389607734
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 57	0.0625	2.344759389607734
BOUCHER-NEUHAUSER SYNDROME	0.0625	2.344759389607734
SPINOCEREBELLAR ATAXIA TYPE 37	0.0625	2.344759389607734
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.0625	2.344759389607734
SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE	0.0625	2.344759389607734
NEUROFIBROMATOSIS TYPE 2	0.0625	2.344759389607734
PALATOPHARYNGEAL INCOMPETENCE	0.0625	2.344759389607734
CLEFT VELUM	0.0625	2.344759389607734
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.0625	2.344759389607734
CLEFT LIP/PALATE	0.0625	2.344759389607734
MIYOSHI MYOPATHY	0.0625	2.344759389607734
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.0625	2.344759389607734
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.0625	2.344759389607734
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.0625	2.344759389607734
%614149 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9; NDNC9;;ANONYCHIA-ONYCHOLYSIS, ISOLATED;;ONYCHODYSTROPHY;;NAIL DYSPLASIA	0.0625	2.344759389607734
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.061615714	2.311584383182155
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.061051259000000004	2.2904082046019787
RING CHROMOSOME 22 SYNDROME	0.060872011000000004	2.2836835097048844
ADNP SYNDROME	0.06071181899999999	2.277673722566643
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0602221	2.259301350990335
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.0602221	2.259301350990335
POTOCKI-LUPSKI SYNDROME	0.060061261	2.2532672909028926
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.059464249999999996	2.230869736535707
NOCARDIOSIS	0.059364919	2.2271432198168415
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.059127030000000004	2.218218540353891
GITELMAN SYNDROME	0.059127030000000004	2.218218540353891
ADULT SYNDROME	0.0588235	2.2068312632734486
HUNTINGTON DISEASE-LIKE 2	0.0588235	2.2068312632734486
YELLOW NAIL SYNDROME	0.0588235	2.2068312632734486
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.0588235	2.2068312632734486
BUTYRYLCHOLINESTERASE	0.0588235	2.2068312632734486
MULTIFOCAL MOTOR NEUROPATHY	0.0588235	2.2068312632734486
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.0583136	2.1877017782692727
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.05753969999999999	2.1586680296033935
ZLOTOGORA-OGUR SYNDROME	0.05685092900000001	2.1328279932907623
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.0566448	2.1250948267592347
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.0566448	2.1250948267592347
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.056517138	2.120305439988097
COFFIN-SIRIS SYNDROME 5	0.056426773	2.1169152930722266
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.056387983999999995	2.1154600791208105
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.05593431299999999	2.098440089728127
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.055739252	2.0911221519473866
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.084232235924663
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.084232235924663
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.084232235924663
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.084232235924663
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.055125952000000006	2.068113497009044
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.054686993999999996	2.051645482734749
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0533507	2.0015128762743255
ERYTHERMALGIA, PRIMARY	0.05307093	1.9910169829234363
DISTAL MONOSOMY 10Q	0.052498252999999995	1.969532346556038
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.052456460999999996	1.96796447160547
CRONKHITE-CANADA SYNDROME	0.052384719	1.9652729879554027
DYSTONIA 28, CHILDHOOD-ONSET	0.052231894	1.9595395822959338
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.05218174099999999	1.9576580348132613
DISTAL MONOSOMY 12Q	0.05214815199999999	1.9563979048430609
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.05188749799999999	1.94661917022004
KID SYNDROME	0.0518433	1.94496103141201
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.05181181099999999	1.9437796853573002
SPINOCEREBELLAR ATAXIA TYPE 20	0.051686340000000004	1.9390724964713248
DYSTONIA 26, MYOCLONIC; DYT26	0.051686340000000004	1.9390724964713248
PRIMARY DYSTONIA, DYT6 TYPE	0.051686340000000004	1.9390724964713248
OROMANDIBULAR DYSTONIA	0.051686340000000004	1.9390724964713248
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.05110065999999999	1.9171000376024372
SARCOSINEMIA	0.051035064	1.9146391282117061
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.05088663	1.9090704559679137
AICARDI SYNDROME	0.05020198	1.8833850237103946
AICARDI-GOUTIÈRES SYNDROME	0.050048872999999994	1.8776410384965598
PRIMARY DYSTONIA, DYT21 TYPE	0.05	1.8758075116861874
AUTOSOMAL DOMINANT FOCAL DYSTONIA, DYT25 TYPE	0.05	1.8758075116861874
PRIMARY DYSTONIA, DYT27 TYPE	0.05	1.8758075116861874
PRIMARY DYSTONIA, DYT4 TYPE	0.05	1.8758075116861874
DYSTONIA 21; DYT21	0.05	1.8758075116861874
DYSTONIA 27; DYT27	0.05	1.8758075116861874
DYSTONIA 25	0.05	1.8758075116861874
BOHRING-OPITZ SYNDROME	0.049906140999999994	1.8722862833413998
WEAVER SYNDROME	0.049675051	1.8636166761838886
TRISOMY 18	0.049630754	1.8619548232769856
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.049076853999999996	1.8411746276625256
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.8411746276625256
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.048613804	1.8238027742968
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.8217696240510335
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.0485313	1.820707541837917
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.04796294	1.799384862691078
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.047777454	1.7924261420488252
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.0475633	1.7843919084116728
HALLERMANN-STREIFF SYNDROME; HSS	0.04690235	1.759595608914693
8Q24.3 MICRODELETION SYNDROME	0.046803721	1.7558954285332908
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.046580329999999996	1.747514658216429
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.046549349999999996	1.7463524078821882
RETT SYNDROME	0.046374719	1.739800925050723
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.046276898	1.73613105771871
CRI-DU-CHAT SYNDROME	0.04615381	1.7315132698187414
LYMPHEDEMA, HEREDITARY, III	0.04605840399999999	1.7279340039895421
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.046054268999999995	1.7277788747083258
TRISOMY 8P	0.045983447000000004	1.7251219059164733
AU-KLINE SYNDROME; AUKS	0.045971582	1.72467677679395
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.045687922000000006	1.7140349456186526
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.045238129999999994	1.697160481372725
HEREDITARY ACROKERATOTIC POIKILODERMA	0.04514826	1.6937889049512205
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.04514826	1.6937889049512205
CARDIOFACIOCUTANEOUS SYNDROME	0.045118054	1.6926556921172602
TARP SYNDROME; TARPS	0.044964251999999996	1.6868856331790132
FONTAINE PROGEROID SYNDROME; FPS	0.044962588	1.6868232063050241
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
COSTELLO SYNDROME; CSTLO	0.044830313999999996	1.6818607950490085
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.044775794	1.6798154145382664
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.0445451	1.6711606637762475
GALACTOSEMIA	0.044440012999999993	1.667218204096636
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.044228302	1.6592756224145042
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.044210292	1.6585999565487948
ALEXANDER DISEASE	0.044176389	1.6573280465074212
MENTAL RETARDATION, X-LINKED 98; MRX98	0.044108583	1.6547842264246733
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.043715211	1.6400264233749327
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.043715211	1.6400264233749327
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.04371521099999999	1.6400264233749322
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04336706	1.6269651381549115
CLASSIC GALACTOSEMIA	0.043353039999999995	1.6264391617286347
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.043211533	1.6211303638575112
CHROMOSOME 1P36 DELETION SYNDROME	0.043122790999999994	1.61780110565347
16P13.11 MICRODELETION SYNDROME	0.042827304	1.6067155709693577
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04279685	1.60557305413014
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.04275367299999999	1.603953219311498
MICROTRIPLICATION 11Q24.1	0.04262823799999999	1.599247381006931
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.04230765	1.5872201534358026
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.04221225399999999	1.5836412627681058
COG2-CDG	0.04221225399999999	1.5836412627681058
COWDEN SYNDROME 5; CWS5	0.042208118999999995	1.5834861334868895
COWDEN SYNDROME 6; CWS6	0.042208118999999995	1.5834861334868895
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042021954	1.5765019393786284
PERMANENT NEONATAL DIABETES MELLITUS	0.041847063999999996	1.5699407398642524
TRANSIENT NEONATAL DIABETES MELLITUS	0.041847063999999996	1.5699407398642524
THROMBOCYTOPENIA 1	0.041692059999999996	1.5641255865134243
PEROXISOME BIOGENESIS DISORDER 14B	0.041666699999999994	1.5631741769434968
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.041666699999999994	1.5631741769434968
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.041666699999999994	1.5631741769434968
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.041666699999999994	1.5631741769434968
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.041666699999999994	1.5631741769434968
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.041666699999999994	1.5631741769434968
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.041666699999999994	1.5631741769434968
INCONTINENTIA PIGMENTI	0.041074773	1.5409673546840998
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.040830533	1.531804410151015
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.04080511	1.530850637063623
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.040771851000000005	1.5296028874229999
NIEMANN-PICK DISEASE, TYPE C2	0.040771851	1.5296028874229994
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.040771851	1.5296028874229994
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.040771851	1.5296028874229994
ALLAN-HERNDON-DUDLEY SYNDROME	0.0405447	1.5210810563812591
ADAMS-OLIVER SYNDROME 5; AOS5	0.040529219000000005	1.5205002688594909
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.040505189999999996	1.5195987932855246
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.040284979000000005	1.5113373243264063
SMITH-KINGSMORE SYNDROME; SKS	0.040259257	1.5103723339100943
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.040226297	1.509135801598391
METACHROMATIC LEUKODYSTROPHY	0.040226297	1.509135801598391
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.040226297	1.509135801598391
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.040226297	1.509135801598391
WILSON DISEASE	0.040147840000000004	1.5061923969995035
EPISODIC ATAXIA, TYPE 1; EA1	0.040147840000000004	1.5061923969995035
NIEMANN-PICK DISEASE TYPE B	0.0399254	1.497847304541514
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0398601	1.4953974999312518
WIDOW'S PEAK SYNDROME	0.0398601	1.4953974999312518
PROGEROID SYNDROME, PETTY TYPE	0.0397543	1.4914282912365238
COSTELLO SYNDROME	0.03958295	1.4849998988939752
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.039560450000000004	1.4841557855137166
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.039301854	1.4744542591278764
FG SYNDROME TYPE 1	0.039283473	1.4737646747704303
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938224
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.039268894	1.4732177268161728
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.039085511	1.466337902637862
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.039085510999999996	1.4663379026378618
GM2-GANGLIOSIDOSIS, AB VARIANT	0.039085510999999996	1.4663379026378618
PIERPONT SYNDROME	0.039066273	1.4656161669396655
ALSTROM SYNDROME; ALMS	0.039007054	1.4633944980389746
FABRY DISEASE	0.039002919000000004	1.4632393687577583
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.038726194000000005	1.4528577120843311
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.03872334	1.452750640991564
MCLEOD SYNDROME; MCLDS	0.03872334	1.452750640991564
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.03872334	1.452750640991564
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.038625379	1.449075521398518
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0384615	1.4429274122143658
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0384615	1.4429274122143658
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0384615	1.4429274122143658
245800 LAURENCE-MOON SYNDROME	0.0384615	1.4429274122143658
DERMOCHONDROCORNEAL DYSTROPHY	0.0384615	1.4429274122143658
MUCOLIPIDOSIS III GAMMA	0.0384615	1.4429274122143658
3Q13 MICRODELETION SYNDROME	0.0384615	1.4429274122143658
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0384615	1.4429274122143658
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0384615	1.4429274122143658
MYCETOMA	0.0384615	1.4429274122143658
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4429274122143658
BLACKFAN-DIAMOND ANEMIA	0.0384615	1.4429274122143658
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.0384356	1.4419557439233124
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0383041	1.4370223701675777
ACROMELIC FRONTONASAL DYSPLASIA	0.038123973	1.4302646985744276
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037998538	1.4255588602698603
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.0379793	1.4248371245716642
SHASHI-PENA SYNDROME; SHAPNS	0.037929911	1.4229842394277707
AL KAISSI SYNDROME; ALKAS	0.037929911	1.4229842394277707
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.037844813	1.4197916900751812
LISSENCEPHALY 2; LIS2	0.037582554	1.4099527420310352
AICARDI-GOUTIERES SYNDROME 6	0.037582554	1.4099527420310352
HEREDITARY OROTIC ACIDURIA	0.037582554	1.4099527420310352
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.037578419	1.4097976127498186
ADRENOLEUKODYSTROPHY	0.037578419	1.4097976127498186
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.037578419	1.4097976127498186
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.037578419	1.4097976127498186
GM2 GANGLIOSIDOSIS, AB VARIANT	0.037578419	1.4097976127498186
CORNELIA DE LANGE SYNDROME 3	0.037575523	1.409688965978742
NOONAN SYNDROME 7; NS7	0.037384357	1.4025171536031618
MELAS	0.03730002	1.3993531540409003
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.037261692	1.3979152350347421
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.037257557	1.3977601057535256
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.037077154	1.3909920797029112
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.037037	1.3894856562064262
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.037037	1.3894856562064262
CANAVAN DISEASE	0.037037	1.3894856562064262
MARTSOLF SYNDROME	0.037037	1.3894856562064262
ACROCRANIOFACIAL DYSOSTOSIS	0.037037	1.3894856562064262
CRANIOECTODERMAL DYSPLASIA	0.037037	1.3894856562064262
KINDLER SYNDROME	0.037037	1.3894856562064262
KERATODERMA HEREDITARIUM MUTILANS	0.037037	1.3894856562064262
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.037037	1.3894856562064262
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.037037	1.3894856562064262
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.037037	1.3894856562064262
LEUKONYCHIA TOTALIS	0.037037	1.3894856562064262
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064262
CHARLIE M SYNDROME	0.037037	1.3894856562064262
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.037037	1.3894856562064262
AUTOSOMAL RECESSIVE HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.037037	1.3894856562064262
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3894856562064262
GENERALIZED DOMINANT DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.037037	1.3894856562064262
LELIS SYNDROME	0.037037	1.3894856562064262
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.037037	1.3894856562064262
19P13.12 MICRODELETION SYNDROME	0.036968373	1.3869110353643366
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.036904730000000004	1.3845233950150118
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.036675838	1.3759362483557143
SLC35A2-CDG	0.036649803999999994	1.3749595529005292
MOSAIC TRISOMY 9	0.036426954	1.366599078820944
MENINGIOMA	0.03632481	1.3627670291714706
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.036259854	1.3603301301168889
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.036259854	1.3603301301168889
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.036255719000000006	1.3601750008356726
INHERITED CREUTZFELDT-JAKOB DISEASE	0.036255719000000006	1.3601750008356726
CHROMOSOME 9P DELETION SYNDROME	0.036238992000000005	1.359547468190713
THUMBS, CONGENITAL CLASPED	0.0361093	1.3546819236346006
TETRASOMY 5P	0.035818873	1.343786220670671
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.0357368	1.3407071576725387
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.035714300000000004	1.33986304429228
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.035714300000000004	1.33986304429228
ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7	0.035714300000000004	1.33986304429228
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.035714300000000004	1.33986304429228
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.035714300000000004	1.33986304429228
CLEIDOCRANIAL DYSPLASIA	0.035714300000000004	1.33986304429228
SPINOCEREBELLAR ATAXIA TYPE 25	0.035714300000000004	1.33986304429228
PRIMARY LATERAL SCLEROSIS, ADULT	0.035714300000000004	1.33986304429228
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.035714300000000004	1.33986304429228
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.035714300000000004	1.33986304429228
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.035714300000000004	1.33986304429228
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.035714300000000004	1.33986304429228
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.035714300000000004	1.33986304429228
NAEGELI-FRANCESCHETTI-JADASSOHN SYNDROME	0.035714300000000004	1.33986304429228
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.035714300000000004	1.33986304429228
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.035714300000000004	1.33986304429228
EPIDERMOLYSIS BULLOSA SIMPLEX	0.035714300000000004	1.33986304429228
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.035714300000000004	1.33986304429228
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED, WITH SCARRING AND HAIR LOSS; EBSSH	0.035714300000000004	1.33986304429228
SPINOCEREBELLAR ATAXIA TYPE 8	0.035714300000000004	1.33986304429228
ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE	0.035714300000000004	1.33986304429228
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.035714300000000004	1.33986304429228
PRETIBIAL DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.035714300000000004	1.33986304429228
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.035714300000000004	1.33986304429228
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.035714300000000004	1.33986304429228
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3380603932735493
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.035576342	1.3346873912383357
20Q11.2 MICRODUPLICATION SYNDROME	0.035569773	1.3344409476474504
ALPERS-HUTTENLOCHER SYNDROME	0.035365604	1.3267813127703814
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.035277454	1.3234742641272785
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.035227493	1.3215999197454515
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.035145111	1.318509264256897
TRISOMY 8Q	0.035028354	1.314128991104058
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.035024219	1.3139738618228416
ZIMMERMANN-LABAND SYNDROME	0.035024219	1.3139738618228416
22Q11.2 DELETION SYNDROME	0.035009952999999996	1.3134386564236071
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.034944352	1.3109775594521247
DUPLICATION/INVERSION 15Q11	0.034836257	1.3069222511926104
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
NEONATAL MARFAN SYNDROME	0.0347319	1.3030071783026698
3P25.3 MICRODELETION SYNDROME	0.034723409999999996	1.3026886661871853
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.034618434	1.2987503708002497
MOSAIC TRISOMY 8	0.0344828	1.2936619052794491
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502925
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502925
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.03394444	1.2734647106396215
SPINOCEREBELLAR ATAXIA TYPE 34	0.03394444	1.2734647106396215
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.033934524	1.273092700493904
PULMONARY ARTERIOVENOUS MALFORMATION	0.033874719000000005	1.2708490471291765
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.033440257	1.254549705466332
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.033438182000000004	1.2544718594545972
DERMATOMYOSITIS	0.0334169	1.253673440745323
CORNELIA DE LANGE SYNDROME	0.033386139	1.2525194064479834
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.0333333	1.2505370905857838
AORTO-VENTRICULAR TUNNEL	0.0333333	1.2505370905857838
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.0333333	1.2505370905857838
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.0333333	1.2505370905857838
SECKEL SYNDROME 2; SCKL2	0.0333333	1.2505370905857838
PERIPARTUM CARDIOMYOPATHY	0.0333333	1.2505370905857838
CARCINOID SYNDROME	0.0333333	1.2505370905857838
PARTIAL ATRIOVENTRICULAR CANAL	0.0333333	1.2505370905857838
FAMILIAL ATRIAL MYXOMA	0.0333333	1.2505370905857838
CONGENITAL AORTIC VALVE STENOSIS	0.0333333	1.2505370905857838
DOUBLE OUTLET RIGHT VENTRICLE	0.0333333	1.2505370905857838
CONGENITAL TRICUSPID STENOSIS	0.0333333	1.2505370905857838
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0333333	1.2505370905857838
FAMILIAL BICUSPID AORTIC VALVE	0.0333333	1.2505370905857838
ANEURYSM OF SINUS OF VALSALVA	0.0333333	1.2505370905857838
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.0333333	1.2505370905857838
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.0333333	1.2505370905857838
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.0333333	1.2505370905857838
EISENMENGER SYNDROME	0.0333333	1.2505370905857838
ALG13-CDG	0.033219637999999996	1.246272929917918
OCULOCEREBRORENAL SYNDROME OF LOWE	0.033065799	1.2405014828821124
RETT SYNDROME, CONGENITAL VARIANT	0.032958999	1.2364947580371508
PEHO SYNDROME	0.032803653999999995	1.2306668116790926
NETHERTON SYNDROME; NETH	0.032803653999999995	1.2306668116790926
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	1.2306668116790926
HYDROXYKYNURENINURIA	0.032803653999999995	1.2306668116790926
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.03270182199999999	1.226846467068492
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2101997258544839
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0322581	1.2101997258544839
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.2101997258544839
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.2101997258544839
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2101997258544839
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0322581	1.2101997258544839
DESMOID TUMOR	0.0322581	1.2101997258544839
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2101997258544839
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2101997258544839
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2101997258544839
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2101997258544839
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0322581	1.2101997258544839
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.2101997258544839
ROWLEY-ROSENBERG SYNDROME	0.0322581	1.2101997258544839
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2101997258544839
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2101997258544839
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.0322222	1.2088528960610931
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.03204225	1.2021018648265347
PERIVENTRICULAR NODULAR HETEROTOPIA	0.031623950000000005	1.186408859183768
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.031421711000000005	1.1788216304766501
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.030662773	1.150349198450568
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.030582179	1.1473256218386314
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.030545011000000004	1.1459312215667445
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.030365029	1.1391789898153784
7Q11.23 MICRODUPLICATION SYNDROME	0.030355317000000003	1.1388146329643083
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.030216297	1.1335991377588162
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.03011502	1.1297996146115952
TOLUENE EMBRYOPATHY	0.030098964000000002	1.1291972553034426
CIRCUMVALLATE PLACENTA SYNDROME	0.029979	1.124696667856804
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.1146413266581099
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.029608403999999998	1.110793332644787
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.029553410000000002	1.1087301694788336
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.02948215	1.1060567686131784
POSTENCEPHALITIC PARKINSONISM	0.029471319000000003	1.105650431189997
EPILEPSY, PYRIDOXINE-DEPENDENT	0.029302902	1.0993320737160839
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.029193952000000002	1.09524468914812
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.029037919000000002	1.0893909316787012
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.028964210999999997	1.0866256912772738
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.028923464	1.0850970207037003
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.028792299	1.0801762148582938
TRISOMY 9P	0.028722754	1.0775671541902896
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.028700364000000003	1.0767271675865566
OTOFACIOCERVICAL SYNDROME	0.028700364000000003	1.0767271675865566
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.028556714	1.0713379726054821
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	1.0636766495016525
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341364	1.0632588696526497
DISTAL MONOSOMY 10P	0.0281772	1.0571000683656806
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.028168853999999997	1.0567869585758298
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.028156457000000003	1.0563218708613826
MULTIPLE SYNOSTOSES SYNDROME	0.0279212	1.0474959339058474
GAUCHER DISEASE	0.027795809999999997	1.0427917838280407
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623315
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623315
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623315
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.0421161179623315
BRAIN-LUNG-THYROID SYNDROME	0.027231894000000003	1.0216358264528402
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.027231894000000003	1.0216358264528402
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.027227759000000004	1.021480697171624
ALZHEIMER DISEASE 3; AD	0.027227759000000004	1.021480697171624
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.027227759000000004	1.021480697171624
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.027227759000000004	1.021480697171624
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.027196718999999998	1.0203161958683689
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.027189239000000004	1.0200355750646208
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.027103112999999998	1.0168044591095908
CHROMOSOME 17Q12 DELETION SYNDROME	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668517
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.02697786	1.0121054487443664
ROIFMAN SYNDROME; RFMN	0.026920172	1.0099412170696833
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.026906047	1.009411301447632
2Q37 MICRODELETION SYNDROME	0.026842633000000005	1.0070322522967108
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.026686340000000003	1.0011687406282312
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.026686340000000003	1.0011687406282312
MAST SYNDROME	0.026686340000000003	1.0011687406282312
19P13.3 MICRODUPLICATION SYNDROME	0.026556833999999998	0.9963101740760625
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.026391799	0.99011869622224
AYMÉ-GRIPP SYNDROME	0.026169053999999997	0.9817621613384292
DUBOWITZ SYNDROME	0.026104378999999997	0.979335804322063
15Q11Q13 MICRODUPLICATION SYNDROME	0.026086973000000003	0.9786827982110952
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.025961538000000003	0.9739769599065279
CADASIL	0.025541419000000003	0.9582157123864862
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.025541419000000003	0.9582157123864862
FLYNN-AIRD SYNDROME	0.025541419000000003	0.9582157123864862
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.025541419000000003	0.9582157123864862
SNEDDON SYNDROME	0.025541419000000003	0.9582157123864862
FLYNN-AIRD SYNDROME	0.025541419000000003	0.9582157123864862
PERLMAN SYNDROME	0.025486654	0.9561611404189362
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.025388259999999996	0.952469776332839
MONOSOMY 22Q13.3	0.025335622999999998	0.9504950387329866
CLASSIC MYCOSIS FUNGOIDES	0.025306959999999996	0.9494197133188373
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.025306959999999996	0.9494197133188373
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0252799	0.9484045262935128
KAPUR-TORIELLO SYNDROME	0.025135409	0.9429837802300919
ALZHEIMER DISEASE 4	0.025	0.9379037558430937
CARIBBEAN PARKINSONISM	0.025	0.9379037558430937
MOHR-TRANEBJAERG SYNDROME	0.025	0.9379037558430937
MASA SYNDROME	0.025	0.9379037558430937
PROGRESSIVE SUPRANUCLEAR PALSY	0.025	0.9379037558430937
RHEUMATOID FACTOR-NEGATIVE JUVENILE IDIOPATHIC ARTHRITIS	0.025	0.9379037558430937
CREUTZFELDT-JAKOB DISEASE; CJD	0.025	0.9379037558430937
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.025	0.9379037558430937
MASA SYNDROME	0.025	0.9379037558430937
POLYMYOSITIS	0.02496148	0.9364586337360906
TYROSINEMIA TYPE 2	0.024961429	0.9364567204124286
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.024895558999999998	0.9339855315965331
PITT-HOPKINS-LIKE SYNDROME	0.024820629	0.9311744464595203
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9277824237361383
SMITH-LEMLI-OPITZ SYNDROME	0.024540923000000003	0.9206809541422464
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.024532359999999996	0.9203597033477948
SAETHRE-CHOTZEN SYNDROME	0.024514519	0.919690377711475
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.024495692	0.9189840611510248
RAPID-ONSET DYSTONIA-PARKINSONISM	0.024465897	0.917866267454811
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.024424071	0.9162971169551353
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.02442001	0.9161447638690361
JOHANSON-BLIZZARD SYNDROME; JBS	0.024410298	0.9157804070179663
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.024228373	0.9089552813866961
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.024049913000000003	0.9022601492159857
COOPER-JABS SYNDROME	0.0238813	0.8959344385766269
SIALIDOSIS TYPE 2	0.023865911	0.89535710254068
MCDONOUGH SYNDROME	0.02370476	0.8893113374143651
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02365399	0.887406642466999
9Q33.3Q34.11 MICRODELETION SYNDROME	0.023613508999999998	0.8858879511893877
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.023567553999999998	0.8841638965053968
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.023542714	0.8832319953335912
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.023540142	0.8831355037951901
EARLY-ONSET LAFORA BODY DISEASE	0.023504359000000002	0.8817930633913769
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.023474742	0.8806819475699045
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.023474742	0.8806819475699045
TRISOMY 20P	0.02334681	0.8758824314382038
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.023330069000000002	0.8752543735671411
CONGENITAL MYASTHENIC SYNDROME	0.023330069000000002	0.8752543735671411
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.023203073	0.8704899725520592
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.022993969000000003	0.8626451954735865
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.02296294	0.8614811068479843
DYSTONIA 12; DYT12	0.02296294	0.8614811068479843
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.02296294	0.8614811068479843
CK SYNDROME	0.022881811000000002	0.8584374590956725
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.022801670000000003	0.8554308772997917
JUVENILE DERMATOMYOSITIS	0.022801670000000003	0.8554308772997917
TRISOMY 13	0.022535229000000004	0.8454350367153682
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064703
JACOBSEN SYNDROME	0.022495723000000002	0.8439529236842347
ROIFMAN SYNDROME	0.022443698	0.8420011459683251
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.022178826999999998	0.8320642057397684
CLASSICAL EHLERS-DANLOS SYNDROME	0.02211082	0.8295128449108236
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.022053014	0.827344186330413
AMISH INFANTILE EPILEPSY SYNDROME	0.02203305	0.8265952139071467
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.021920273	0.8223642550322383
CUTIS LAXA	0.021904413999999997	0.8217692864056815
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.021873781	0.8206200541755718
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.021869683	0.8204663129919142
RICHARDS-RUNDLE SYNDROME; RRNS	0.021822154	0.8186832078874554
HUNTINGTON DISEASE-LIKE 3	0.021818019	0.818528078606239
SCHWARTZ-JAMPEL SYNDROME	0.0218174	0.8185048561092444
FUMARASE DEFICIENCY; FMRD	0.021548402	0.8084130867286732
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.021528592	0.807669891792543
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.021520033	0.8073487910626927
CORNELIA DE LANGE SYNDROME 1	0.021492009	0.8062974384685428
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.02140106	0.8028853821209359
TREACHER-COLLINS SYNDROME	0.021378854	0.8020522984888457
BENIGN FAMILIAL INFANTILE EPILEPSY	0.021374719	0.8018971692076293
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.021374719	0.8018971692076293
L-2-HYDROXYGLUTARIC ACIDURIA	0.021374719	0.8018971692076293
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.02133566	0.8004318258956503
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299114	0.7990607606692087
PELGER-HUET ANOMALY; PHA	0.021295264	0.7989163234908089
NOONAN SYNDROME	0.021294140000000003	0.7988741553379463
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.798583930399738
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0212766	0.7982161220628465
NEUROLEPTIC MALIGNANT SYNDROME	0.0212766	0.7982161220628465
BECKWITH-WIEDEMANN SYNDROME	0.02122387	0.7962378954610223
NEUROFERRITINOPATHY	0.02111533	0.7921658925146541
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.021097992	0.7915154375019017
MONOSOMY 13Q14	0.0210064	0.7880792582696946
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.0210064	0.7880792582696946
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0210064	0.7880792582696946
ROBERTS SYNDROME	0.020997114	0.7877308832986241
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0208333	0.7815852126642369
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.0208333	0.7815852126642369
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.0208333	0.7815852126642369
CYSTINOSIS	0.0208333	0.7815852126642369
FAMILIAL CERVICAL ARTERY DISSECTION	0.0208333	0.7815852126642369
RING CHROMOSOME 14 SYNDROME	0.020810252	0.78072054043365
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.020744137000000003	0.7782401601609474
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7781168445751291
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.020715703999999998	0.7771734634613517
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.020595210000000003	0.7726529924550897
PYRIDOXINE-DEPENDENT EPILEPSY	0.020586864	0.7723398826652389
BETA-UREIDOPROPIONASE DEFICIENCY	0.020586864	0.7723398826652389
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.020586864	0.7723398826652389
NASU-HAKOLA DISEASE	0.020582729	0.7721847533840225
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.020569338000000003	0.7716823746162428
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.02054506	0.7707715575208683
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.020505813999999997	0.7692991986887955
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.02045156	0.7672637974740152
RENAL TUBULAR DYSGENESIS	0.02045156	0.7672637974740152
DISTAL MONOSOMY 17Q	0.02045156	0.7672637974740152
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.020443214	0.7669506876841645
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.020344042	0.7632301360331857
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.020317213000000004	0.7622236152385652
NIEMANN-PICK DISEASE TYPE C	0.020317213000000004	0.7622236152385652
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.020191778	0.7575177769339979
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.020169933999999997	0.7566982741482924
FETAL HYDANTOIN SYNDROME	0.020153354000000002	0.7560762563774174
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.020153354000000002	0.7560762563774174
FETAL ALCOHOL SYNDROME	0.020153354000000002	0.7560762563774174
48,XYYY SYNDROME	0.020153354000000002	0.7560762563774174
QAZI-MARKOUIZOS SYNDROME	0.020149219000000003	0.7559211270962011
CHIME SYNDROME	0.020149219000000003	0.7559211270962011
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.020149219000000003	0.7559211270962011
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.020149219000000003	0.7559211270962011
KABUKI SYNDROME	0.020149219000000003	0.7559211270962011
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.020146499999999998	0.7558191206837153
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.020146499999999998	0.7558191206837153
PITT-HOPKINS SYNDROME	0.019992797	0.7500527758443413
BAND HETEROTOPIA; BH	0.019954873	0.7486300133628777
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.019882139	0.7459013136917779
CURRY-JONES SYNDROME	0.019786734	0.7423220853787296
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.019785089999999998	0.7422604088277452
MARINESCO-SJÖGREN SYNDROME	0.019775794000000003	0.7419116586951726
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.019623960000000003	0.7362154315405856
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.019623960000000003	0.7362154315405856
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.019615653	0.7359037848805938
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0196078	0.7356091705528085
ACHALASIA-MICROCEPHALY SYNDROME	0.0196078	0.7356091705528085
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.0196078	0.7356091705528085
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.0196078	0.7356091705528085
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.0196078	0.7356091705528085
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.0196078	0.7356091705528085
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.0196078	0.7356091705528085
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.0196078	0.7356091705528085
ABSENCE OF FINGERPRINTS-CONGENITAL MILIA SYNDROME	0.0196078	0.7356091705528085
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.0196078	0.7356091705528085
IVIC SYNDROME	0.0196078	0.7356091705528085
CROSSED POLYSYNDACTYLY	0.0196078	0.7356091705528085
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.0196078	0.7356091705528085
RADIAL HYPOPLASIA-TRIPHALANGEAL THUMBS-HYPOSPADIAS-MAXILLARY DIASTEMA SYNDROME	0.0196078	0.7356091705528085
DERMATOGLYPHICS--PALMAR TRIRADIUS D, ABSENCE OF	0.0196078	0.7356091705528085
POLAND SYNDROME	0.0196078	0.7356091705528085
DERMAL RIDGES, NELSON SYNDROME	0.0196078	0.7356091705528085
DERMATOGLYPHICS--FINGERPRINT PATTERN	0.0196078	0.7356091705528085
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.019473463	0.7305693634788607
COFFIN-SIRIS SYNDROME 6; CSS6	0.019450972	0.729725587743954
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.019411652	0.728250452716764
HHHH SYNDROME	0.019409319	0.7281629275382687
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.7281629275382687
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7281629275382687
EMANUEL SYNDROME	0.019268051	0.722863096027051
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.019230240000000003	0.7214445728705637
KENNEDY DISEASE	0.019230240000000003	0.7214445728705637
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.019230240000000003	0.7214445728705637
PRIMARY DYSTONIA, DYT17 TYPE	0.019230240000000003	0.7214445728705637
SPINOCEREBELLAR ATAXIA 20	0.019230240000000003	0.7214445728705637
DYSTONIA 16	0.019230240000000003	0.7214445728705637
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.019103649	0.7166953658963263
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.019097186999999998	0.7164529365335159
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7158870804395407
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.019050992000000003	0.7147198779734693
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.018985071	0.7122467758339118
16P13.2 MICRODELETION SYNDROME	0.018955923	0.7111532550868992
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.018880714	0.7083317029439712
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7078509709948763
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.7078509709948763
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7078509709948763
THROMBOCYTOPENIA 3	0.0188679	0.7078509709948763
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.7078509709948763
MONOPHALANGY OF GREAT TOE	0.0188679	0.7078509709948763
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7078509709948763
VESICOURETERAL REFLUX 1	0.0188679	0.7078509709948763
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7078509709948763
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7078509709948763
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7078509709948763
TRACHEOBRONCHOMEGALY	0.0188679	0.7078509709948763
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.7078509709948763
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7078509709948763
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.7078509709948763
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7078509709948763
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7078509709948763
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.7078509709948763
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.7078509709948763
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7078509709948763
TOE, MISSHAPEN	0.0188679	0.7078509709948763
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.7078509709948763
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.7078509709948763
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7078509709948763
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7078509709948763
PUBIC BONE DYSPLASIA	0.0188679	0.7078509709948763
VAN DEN BOSCH SYNDROME	0.0188679	0.7078509709948763
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7078509709948763
RAYNAUD DISEASE	0.0188679	0.7078509709948763
CARPAL DISPLACEMENT	0.0188679	0.7078509709948763
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7078509709948763
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.7078509709948763
SPINAL ARACHNOIDITIS	0.0188679	0.7078509709948763
NEPHROSIALIDOSIS	0.0188679	0.7078509709948763
KNUCKLE PADS	0.0188679	0.7078509709948763
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.7078509709948763
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7078509709948763
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.7078509709948763
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7078509709948763
LETTERER-SIWE DISEASE	0.0188679	0.7078509709948763
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.7078509709948763
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.018830488	0.7064474167823321
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.01881384	0.705822847913241
XQ12-Q13.3 DUPLICATION SYNDROME	0.01869322	0.7012976498720493
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.018681203	0.7008468182946908
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.018661648	0.7001131899768702
2Q31.1 MICRODELETION SYNDROME	0.018614573	0.6983471172046176
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.018582394	0.6971398850062466
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01856223	0.6963834093529339
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.018505438000000003	0.6942527921488604
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.018450114	0.6921772486533296
1P36 DELETION SYNDROME	0.018411313000000002	0.690721584508111
TETRASOMY 9P	0.018370211000000004	0.6891795957012046
YUNIS-VARON SYNDROME	0.018339258	0.68801835830302
SAY-BARBER-MILLER SYNDROME	0.018109594	0.6794022491757421
OROFACIODIGITAL SYNDROME TYPE 4	0.018073153999999998	0.6780351606612252
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.018073153999999998	0.6780351606612252
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.018071979000000002	0.6779910791847007
TURNPENNY-FRY SYNDROME; TPFS	0.018002944	0.6754011517533154
IMMUNODEFICIENCY 49; IMD49	0.017948591	0.6733620364396619
KOOLEN-DE VRIES SYNDROME; KDVS	0.017892731000000002	0.6712663842876061
16P11.2P12.2 MICRODELETION SYNDROME	0.017838504	0.669231996008882
PROTEUS SYNDROME	0.017813019	0.6682758969201755
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01780627	0.6680227004222481
LATERAL MENINGOCELE SYNDROME	0.017744738	0.6657142566660665
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.017627371	0.6613110986615851
MOEBIUS SYNDROME; MBS	0.01755934	0.6587588374450347
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.017544841	0.6582148907827958
DYSTONIA 7, TORSION	0.0175439	0.658179588085426
GOOD SYNDROME	0.0175439	0.658179588085426
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.0175439	0.658179588085426
DYSTONIA 23; DYT23	0.0175439	0.658179588085426
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.0175439	0.658179588085426
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.0175439	0.658179588085426
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.0175439	0.658179588085426
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.0175439	0.658179588085426
MEDULLARY THYROID CARCINOMA	0.0175439	0.658179588085426
LARYNGEAL NEUROENDOCRINE TUMOR	0.0175439	0.658179588085426
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.0175439	0.658179588085426
ANAPLASTIC THYROID CARCINOMA	0.0175439	0.658179588085426
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.0175439	0.658179588085426
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.0175439	0.658179588085426
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.0175439	0.658179588085426
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.0175439	0.658179588085426
NON-FUNCTIONING PARAGANGLIOMA	0.0175439	0.658179588085426
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.0175439	0.658179588085426
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0175439	0.658179588085426
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.0175439	0.658179588085426
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.0175439	0.658179588085426
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.0175439	0.658179588085426
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.017527599999999997	0.6575680748366162
MOSAIC MONOSOMY X	0.017527599999999997	0.6575680748366162
TRISOMY 1Q	0.017527599999999997	0.6575680748366162
MONOSOMY X	0.017527599999999997	0.6575680748366162
FIBROCHONDROGENESIS 1; FBCG1	0.017527599999999997	0.6575680748366162
TURNER SYNDROME	0.017527599999999997	0.6575680748366162
PELIZAEUS-MERZBACHER DISEASE	0.017491789	0.6562245839805964
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.017469201	0.655377169179117
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.017437748	0.6541971737058158
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.017329093999999996	0.6501208939183206
SCALP-EAR-NIPPLE SYNDROME; SENS	0.017271599999999998	0.647963940376783
OTOONYCHOPERONEAL SYNDROME	0.017271599999999998	0.647963940376783
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
MOSAIC TRISOMY 15	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
SICKLE CELL ANEMIA	0.0172414	0.6468309526397246
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397246
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397246
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397246
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397246
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397246
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397246
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397246
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397246
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397246
BARDET-BIEDL SYNDROME 1; BBS1	0.017222644	0.6461272997259407
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.017195099999999998	0.6450939548839031
SMITH-MAGENIS SYNDROME	0.017051563000000002	0.6397089992278052
PONTINE TEGMENTAL CAP DYSPLASIA	0.017039310999999998	0.6392493513551415
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.017039310999999998	0.6392493513551415
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.017039310999999998	0.6392493513551415
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.017003828000000002	0.6379181657963984
FUCOSIDOSIS	0.016959973	0.6362728950278984
OLIVER SYNDROME	0.01694901	0.6358616054728861
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.016858023	0.6324481235115702
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.016847542	0.6320549167409706
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.016792813	0.6300016953548291
WEAVER SYNDROME	0.016674553999999998	0.625565072944339
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.016674553999999998	0.625565072944339
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.016674553999999998	0.625565072944339
2P15P16.1 MICRODELETION SYNDROME	0.016640232	0.6242774436360173
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.016559703	0.6212563055738457
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.016508373	0.6193306015823488
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.016497892	0.618937394811749
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.016497892	0.618937394811749
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.016497892	0.618937394811749
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.016497892	0.618937394811749
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.016432492	0.6164838385864635
HAREL-YOON SYNDROME; HAYOS	0.016432492	0.6164838385864635
MENTAL RETARDATION, X-LINKED 41	0.016432492	0.6164838385864635
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.016420960999999998	0.6160512398581184
HEREDITARY METHEMOGLOBINEMIA	0.016414419	0.6158058092032894
INTELLECTUAL DISABILITY, WOLFF TYPE	0.016414419	0.6158058092032894
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01639194	0.6149624836621856
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.0163217	0.6123273492697688
DOWN SYNDROME	0.0163217	0.6123273492697688
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0163217	0.6123273492697688
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.016313413	0.612016452932782
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
11Q22.2Q22.3 MICRODELETION SYNDROME	0.016220113	0.6085161961159755
C SYNDROME	0.016161049	0.6063003422185709
ADAMS-OLIVER SYNDROME 6; AOS6	0.016128999999999998	0.6050979871197302
NON-DISTAL TRISOMY 13Q	0.016128999999999998	0.6050979871197302
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.016128999999999998	0.6050979871197302
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.016128999999999998	0.6050979871197302
ODONTO-ONYCHO DYSPLASIA-ALOPECIA SYNDROME	0.016128999999999998	0.6050979871197302
BARTSOCAS-PAPAS SYNDROME	0.016128999999999998	0.6050979871197302
ELLIS VAN CREVELD SYNDROME	0.016128999999999998	0.6050979871197302
SCHNECKENBECKEN DYSPLASIA	0.016128999999999998	0.6050979871197302
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.016128999999999998	0.6050979871197302
AMELO-ONYCHO-HYPOHIDROTIC SYNDROME	0.016128999999999998	0.6050979871197302
NAIL-PATELLA SYNDROME	0.016128999999999998	0.6050979871197302
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.016128999999999998	0.6050979871197302
ISOTRETINOIN SYNDROME	0.016128999999999998	0.6050979871197302
CAMPTOBRACHYDACTYLY	0.016128999999999998	0.6050979871197302
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.016128999999999998	0.6050979871197302
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.016128999999999998	0.6050979871197302
ULNAR-MAMMARY SYNDROME	0.016128999999999998	0.6050979871197302
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.016123971	0.6049093184002049
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.016071310999999998	0.6029337179288969
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.015930493999999996	0.5976508062014345
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.015930174000000002	0.59763880103336
17Q23.1Q23.2 MICRODELETION SYNDROME	0.01589435	0.5962948224673871
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.015879542	0.595739283314726
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.015876351	0.5956195692793302
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.015872999999999998	0.595493852659897
LICHEN PLANUS PEMPHIGOIDES	0.015872999999999998	0.595493852659897
PILI TORTI	0.015872999999999998	0.595493852659897
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.015872999999999998	0.595493852659897
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.015872999999999998	0.595493852659897
CHILBLAIN LUPUS 1	0.015872999999999998	0.595493852659897
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.015872999999999998	0.595493852659897
ERYTHROKERATODERMIA VARIABILIS	0.015872999999999998	0.595493852659897
STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	0.015872999999999998	0.595493852659897
SILLENCE SYNDROME	0.015872999999999998	0.595493852659897
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.015872999999999998	0.595493852659897
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.015872999999999998	0.595493852659897
PSEUDOPELADE OF BROCQ	0.015872999999999998	0.595493852659897
ACROKERATOELASTOIDOSIS OF COSTA	0.015872999999999998	0.595493852659897
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.015872999999999998	0.595493852659897
ALKAPTONURIA	0.015872999999999998	0.595493852659897
LAMELLAR ICHTHYOSIS	0.015872999999999998	0.595493852659897
MONILETHRIX	0.015872999999999998	0.595493852659897
NASODIGITOACOUSTIC SYNDROME	0.015872999999999998	0.595493852659897
NAILBEDS, PIGMENTATION OF	0.015872999999999998	0.595493852659897
STRIATE PALMOPLANTAR KERATODERMA	0.015872999999999998	0.595493852659897
ACRODYSOSTOSIS	0.015872999999999998	0.595493852659897
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.015872999999999998	0.595493852659897
TOE, ROTATED FIFTH	0.015872999999999998	0.595493852659897
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.015872999999999998	0.595493852659897
NAIL LOW-SULFUR PROTEIN	0.015872999999999998	0.595493852659897
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.015872999999999998	0.595493852659897
FLOTCH SYNDROME	0.015872999999999998	0.595493852659897
NAIL HIGH-SULFUR PROTEIN	0.015872999999999998	0.595493852659897
ADACTYLIA, UNILATERAL	0.015872999999999998	0.595493852659897
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.015872999999999998	0.595493852659897
LUNULAE OF FINGERNAILS	0.015872999999999998	0.595493852659897
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.015872999999999998	0.595493852659897
ISOLATED PUNCTATE PALMOPLANTAR KERATODERMA	0.015872999999999998	0.595493852659897
OTOONYCHOPERONEAL SYNDROME	0.015872999999999998	0.595493852659897
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.015872999999999998	0.595493852659897
PUNCTATE PALMOPLANTAR KERATODERMA TYPE 1	0.015872999999999998	0.595493852659897
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.015872999999999998	0.595493852659897
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.015872999999999998	0.595493852659897
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.015872999999999998	0.595493852659897
GROWTH HORMONE INSENSITIVITY SYNDROME	0.015872999999999998	0.595493852659897
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.015832017	0.5939563282748683
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01582094	0.5935407618787293
SILVER-RUSSELL SYNDROME	0.01582094	0.5935407618787293
LICHTENSTEIN SYNDROME	0.01570584	0.5892226529868276
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.015642754	0.586855909133183
PEHO-LIKE SYNDROME; PEHOL	0.015536353999999999	0.5828641907483147
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.015536353999999999	0.5828641907483147
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.015536353999999999	0.5828641907483147
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230292
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5804106345230292
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.015384939999999998	0.5771837203768256
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.015260002000000002	0.5724965275989248
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.015229150999999998	0.571339116848064
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.015201556999999997	0.5703038961985147
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.015155202	0.5685648350544306
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.015097199999999998	0.5663888233085741
ALAZAMI-YUAN SYNDROME	0.015085893999999999	0.5659646657140316
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.015049564	0.5646017039760404
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.014990799999999999	0.5623971049237059
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.014990799999999999	0.5623971049237059
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.014990799999999999	0.5623971049237059
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.014959602	0.5612266760687142
WIEACKER-WOLFF SYNDROME	0.014941410999999998	0.5605442197798125
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984203
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.014799799999999998	0.5552315202290645
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.014754951999999998	0.5535489959233826
JOUBERT SYNDROME 32; JBTS32	0.014687731999999998	0.5510271603046717
SPINOCEREBELLAR ATAXIA TYPE 29	0.014687731999999998	0.5510271603046717
PEROXISOME BIOGENESIS DISORDER 5B	0.014687731999999998	0.5510271603046717
EPILEPSY, HOT WATER, 1	0.014660137999999998	0.5499919396551223
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01461801	0.548411459278076
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.014533773000000002	0.5452512113308379
RECOMBINANT 8 SYNDROME	0.014533773000000002	0.5452512113308379
MONOSOMY 9P	0.014533773000000002	0.5452512113308379
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.014460363	0.5424971507421802
JOUBERT SYNDROME 35; JBTS35	0.014399991999999999	0.5402322632364199
JOUBERT SYNDROME 2	0.014399991999999999	0.5402322632364199
OROFACIODIGITAL SYNDROME XVI; OFD16	0.014399991999999999	0.5402322632364199
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.014399991999999999	0.5402322632364199
JOUBERT SYNDROME 1	0.014399991999999999	0.5402322632364199
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.014372449999999998	0.5391989934266828
3C SYNDROME	0.014337314	0.5378808259720708
CATEL-MANZKE SYNDROME; CATMANS	0.014334832999999998	0.5377877484033408
COFFIN-SIRIS SYNDROME 1; CSS1	0.014334832999999998	0.5377877484033408
PETERS-PLUS SYNDROME; PTRPLS	0.014334832999999998	0.5377877484033408
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.014262852000000001	0.5350872983933672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.014262852000000001	0.5350872983933672
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.014262852000000001	0.5350872983933672
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.014253014	0.5347182145073678
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.534385821416297
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.534385821416297
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.01421911	0.5334462669498435
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.014176652999999999	0.5318534437593704
SPINOCEREBELLAR ATAXIA 2; SCA2	0.014142177999999998	0.5305600744800627
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.014142177999999998	0.5305600744800627
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.014092363	0.5286912074561698
PROPIONIC ACIDEMIA	0.014092363	0.5286912074561698
ROIFMAN-CHITAYAT SYNDROME	0.014078314	0.5281641430615363
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.014024740999999999	0.526154290345065
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.014012657000000001	0.5257009451856407
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.014012657	0.5257009451856407
FETAL TRIMETHADIONE SYNDROME	0.013992354000000002	0.5249392547874454
JOUBERT SYNDROME	0.013979872999999999	0.5244710157163781
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.013973410999999998	0.5242285863535678
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.013948371000000001	0.5232891819517156
SIMPSON-GOLABI-BEHMEL SYNDROME	0.013907483	0.521755221600959
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.013907482999999998	0.5217552216009589
ZIMMERMANN-LABAND SYNDROME 1	0.013906536999999998	0.5217197313228378
JOUBERT SYNDROME 3; JBTS3	0.013854437999999998	0.519765177411811
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.01375291	0.5159562377108816
DESANTO-SHINAWI SYNDROME	0.013750021	0.5158478535528563
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.013732182	0.515178602948837
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013726193999999999	0.5149539562412374
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.013726193999999999	0.5149539562412374
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.013722058999999998	0.514798826960021
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.513918735591688
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.513918735591688
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.513918735591688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.013570734000000001	0.5091216955259028
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.013542810999999998	0.5080741320629264
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.013542810999999998	0.5080741320629264
COACH SYNDROME	0.013542810999999998	0.5080741320629264
HYPERPROLINEMIA, TYPE I	0.013542810999999998	0.5080741320629264
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01353276	0.5076970572369273
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.013471238	0.5053889886422482
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.013434318999999998	0.5040039298917692
SCHAAF-YANG SYNDROME; SHFYNG	0.013399653000000001	0.5027033950277671
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.013374829999999999	0.5017721316305154
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.013366064	0.5014432650575665
BRANCHIOOCULOFACIAL SYNDROME	0.013361929	0.50128813577635
ASPARTYLGLUCOSAMINURIA	0.013361929	0.50128813577635
PALLISTER-KILLIAN SYNDROME	0.013352217	0.5009237789252801
CAMOS SYNDROME	0.013338859000000002	0.5004226381904582
VASCULAR EHLERS-DANLOS SYNDROME	0.013222414	0.4960540700764921
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.013180639999999999	0.4944868704166285
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.013180639999999999	0.4944868704166285
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.013180639999999999	0.4944868704166285
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.013180639999999999	0.4944868704166285
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.013180639999999999	0.4944868704166285
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.013180639999999999	0.4944868704166285
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.013180639999999999	0.4944868704166285
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.013180639999999999	0.4944868704166285
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.013135173000000002	0.4927811236139518
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.013135173000000002	0.4927811236139518
15Q24 MICRODELETION SYNDROME	0.013135173000000002	0.4927811236139518
MOSAIC TRISOMY 14	0.013135173000000002	0.4927811236139518
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.013120771	0.49224081601828573
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.013061763	0.4900270630252942
KAGAMI-OGATA SYNDROME	0.013061763	0.4900270630252942
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.013061763	0.4900270630252942
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.013016414	0.48832574312834504
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.013011872999999998	0.4881553822901336
JOUBERT SYNDROME 15	0.013001391999999999	0.487762175519534
JOUBERT SYNDROME 8	0.013001391999999999	0.487762175519534
JOUBERT SYNDROME 21	0.013001391999999999	0.487762175519534
JOUBERT SYNDROME 7	0.013001391999999999	0.487762175519534
JOUBERT SYNDROME 6	0.013001391999999999	0.487762175519534
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.013001391999999999	0.487762175519534
JOUBERT SYNDROME 31; JBTS31	0.013001391999999999	0.487762175519534
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.013001391999999999	0.487762175519534
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.013001391999999999	0.487762175519534
JOUBERT SYNDROME 27	0.013001391999999999	0.487762175519534
JOUBERT SYNDROME 28	0.013001391999999999	0.487762175519534
JOUBERT SYNDROME 25	0.013001391999999999	0.487762175519534
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.012962591	0.48630651137431535
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.012962591	0.48630651137431535
HURLER SYNDROME	0.012949134	0.4858016565406201
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.012944998999999999	0.4856465272594036
FRAGILE X SYNDROME	0.012934579	0.4852556089739682
KLEEFSTRA SYNDROME	0.012924867	0.4848912521228983
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.012854099	0.4822363092031582
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.01282051	0.4809761792329576
SPINOCEREBELLAR ATAXIA 34; SCA34	0.01279744	0.4801106816470656
FLOATING-HARBOR SYNDROME	0.012663994000000001	0.4751043014629761
WILLIAMS-BEUREN SYNDROME; WBS	0.012652618	0.4746775177379172
IMMUNODEFICIENCY 23; IMD23	0.012627392000000001	0.47373113533212136
14Q22Q23 MICRODELETION SYNDROME	0.012593754000000002	0.4724691670705594
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.012593754000000002	0.4724691670705594
DISTAL TRISOMY 18Q	0.012593754000000002	0.4724691670705594
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.012593754000000002	0.4724691670705594
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.012589619000000002	0.4723140377893429
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.012589619000000002	0.4723140377893429
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.012589619000000002	0.4723140377893429
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.012589619000000002	0.4723140377893429
NEONATAL ADRENOLEUKODYSTROPHY	0.012589619000000002	0.4723140377893429
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.012589619000000002	0.4723140377893429
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.012589619000000002	0.4723140377893429
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.012589619000000002	0.4723140377893429
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.012589619000000002	0.4723140377893429
GAUCHER DISEASE, TYPE II	0.012581272999999999	0.4720009279994922
JOUBERT SYNDROME WITH OCULAR DEFECT	0.012581272999999999	0.4720009279994922
JOUBERT SYNDROME WITH RENAL DEFECT	0.012581272999999999	0.4720009279994922
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.012574810999999998	0.47175849863668184
KLEEFSTRA SYNDROME 2; KLEFS2	0.012574810999999998	0.47175849863668184
SIMOSA CRANIOFACIAL SYNDROME	0.0125097	0.4693157845788139
POLYVALVULAR HEART DISEASE SYNDROME	0.0125097	0.4693157845788139
BRESEK SYNDROME	0.012470453999999999	0.46784342574674115
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.012470453999999999	0.46784342574674115
RAINE SYNDROME	0.012470453999999999	0.46784342574674115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.012455837999999999	0.46729508969492506
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.012455837999999999	0.46729508969492506
JOUBERT SYNDROME 4	0.012455837999999999	0.46729508969492506
JOUBERT SYNDROME 5	0.012455837999999999	0.46729508969492506
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.012455837999999999	0.46729508969492506
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.012421172000000001	0.46599455483092284
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.012421172000000001	0.46599455483092284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.012417037	0.4658394255497064
HURLER-SCHEIE SYNDROME	0.012403579999999999	0.46533457071601114
FLOATING-HARBOR SYNDROME	0.012403579999999999	0.46533457071601114
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.012403579999999999	0.46533457071601114
CRANIOFACIOFRONTODIGITAL SYNDROME	0.012403579999999999	0.46533457071601114
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.012403579999999999	0.46533457071601114
RIN2 SYNDROME	0.012403579999999999	0.46533457071601114
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.012403579999999999	0.46533457071601114
AARSKOG-SCOTT SYNDROME	0.012394814	0.46500570414306236
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.012304921	0.4616332648501022
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.012207273	0.4579698878120795
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.012167999	0.4564964785278003
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.012167998999999999	0.4564964785278002
PENOSCROTAL TRANSPOSITION	0.012048200000000002	0.4520020812459505
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.012048200000000002	0.4520020812459505
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.012048200000000002	0.4520020812459505
LETHAL FACIOCARDIOMELIC DYSPLASIA	0.012048200000000002	0.4520020812459505
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.012048200000000002	0.4520020812459505
MICROPHTHALMIA WITH LIMB ANOMALIES	0.012048200000000002	0.4520020812459505
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.012048200000000002	0.4520020812459505
CLEIDORHIZOMELIC SYNDROME	0.012048200000000002	0.4520020812459505
SHORT RIB-POLYDACTYLY SYNDROME	0.012048200000000002	0.4520020812459505
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.012048200000000002	0.4520020812459505
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.012048200000000002	0.4520020812459505
NON-DISTAL MONOSOMY 10Q	0.012048200000000002	0.4520020812459505
LAURENCE-MOON SYNDROME	0.012048200000000002	0.4520020812459505
FRONTONASAL DYSPLASIA	0.012048200000000002	0.4520020812459505
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.012048200000000002	0.4520020812459505
BÖÖK SYNDROME	0.012048200000000002	0.4520020812459505
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.012048200000000002	0.4520020812459505
SHELDON-HALL SYNDROME	0.012048200000000002	0.4520020812459505
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.012048200000000002	0.4520020812459505
MCDONOUGH SYNDROME	0.012048200000000002	0.4520020812459505
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.012048200000000002	0.4520020812459505
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.012048200000000002	0.4520020812459505
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.012048200000000002	0.4520020812459505
PROLIDASE DEFICIENCY	0.012048200000000002	0.4520020812459505
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.012048200000000002	0.4520020812459505
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.012039854	0.45168897145609965
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.45168897145609965
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45168897145609965
MECKEL SYNDROME 13; MKS13	0.012039854	0.45168897145609965
JOUBERT SYNDROME 17; JBTS17	0.012039854	0.45168897145609965
JOUBERT SYNDROME 33; JBTS33	0.012039854	0.45168897145609965
CRANIOSYNOSTOSIS 6; CRS6	0.012033391999999999	0.4514465420932894
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.012029256999999998	0.4512914128120729
ZUNICH NEUROECTODERMAL SYNDROME	0.012029256999999998	0.4512914128120729
XQ28 (MECP2) DUPLICATION	0.012001053000000001	0.45023330731088107
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01197479	0.4492480206572928
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.011963329	0.448818048059464
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.011963329	0.448818048059464
FIBROCHONDROGENESIS	0.011924899999999999	0.4473763399221322
ATELOSTEOGENESIS TYPE II	0.011924899999999999	0.4473763399221322
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.011924899999999999	0.4473763399221322
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.011924899999999999	0.4473763399221322
NEUROFACIODIGITORENAL SYNDROME	0.011924899999999999	0.4473763399221322
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.011864931	0.4451265339087661
MACS SYNDROME	0.01184926	0.4445386183184534
21Q22.11Q22.12 MICRODELETION SYNDROME	0.011846779000000002	0.44444554074972353
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.011794098	0.4424691524392607
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.01170151	0.43899560712142066
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01169108	0.438604313674483
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.011652519	0.43715765340532037
GM1 GANGLIOSIDOSIS	0.011652519	0.43715765340532037
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.011613272999999999	0.43568529457324756
6Q TERMINAL DELETION SYNDROME	0.011613272999999999	0.43568529457324756
DUANE RETRACTION SYNDROME	0.011613272999999999	0.43568529457324756
MUENKE SYNDROME	0.011613272999999999	0.43568529457324756
6Q25 MICRODELETION SYNDROME	0.011613272999999999	0.43568529457324756
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.011589493	0.43479316052068967
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.011494299999999999	0.4312218856314908
OCULAR MOTOR APRAXIA	0.011494299999999999	0.4312218856314908
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.011494299999999999	0.4312218856314908
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.011494299999999999	0.4312218856314908
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.011494299999999999	0.4312218856314908
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.011494299999999999	0.4312218856314908
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4312218856314908
DESMOSTEROLOSIS	0.011494299999999999	0.4312218856314908
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.011491154	0.4311038598228555
SULFOCYSTEINURIA	0.011482471	0.43077810709037606
INFANTILE DYSTONIA-PARKINSONISM	0.011459634	0.42992135076748855
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.011433954	0.4289579360294865
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.01142191	0.42850609151607155
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.011378114	0.42686303420043537
ECTODERMAL DYSPLASIA SYNDROME	0.011373979	0.42670790491921895
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.011373979	0.42670790491921895
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.011307771000000001	0.42422403564454464
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.0111111	0.41684569686192785
FUTCHER LINE	0.0111111	0.41684569686192785
GLOMUVENOUS MALFORMATIONS	0.0111111	0.41684569686192785
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	0.41684569686192785
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.41684569686192785
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.41684569686192785
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	0.41684569686192785
PIGMENTED PURPURIC ERUPTION	0.0111111	0.41684569686192785
CAROTENEMIA, FAMILIAL	0.0111111	0.41684569686192785
ACROMIAL DIMPLES	0.0111111	0.41684569686192785
PRENATAL BOWING	0.0111111	0.41684569686192785
SHORT SYNDROME	0.0111111	0.41684569686192785
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.0111111	0.41684569686192785
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	0.41684569686192785
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.41684569686192785
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.41684569686192785
HYPOPLASMINOGENEMIA	0.0111111	0.41684569686192785
PYCNODYSOSTOSIS	0.0111111	0.41684569686192785
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0111111	0.41684569686192785
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.41684569686192785
DERMAL RIDGES, PATTERNLESS	0.0111111	0.41684569686192785
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.41684569686192785
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	0.41684569686192785
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0111111	0.41684569686192785
FASCIAL DYSTROPHY, CONGENITAL	0.0111111	0.41684569686192785
131600 EPIDERMOID CYSTS	0.0111111	0.41684569686192785
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.41684569686192785
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0111111	0.41684569686192785
PARANA HARD-SKIN SYNDROME	0.0111111	0.41684569686192785
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0111111	0.41684569686192785
KYRLE DISEASE	0.0111111	0.41684569686192785
SCALP-EAR-NIPPLE SYNDROME	0.0111111	0.41684569686192785
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0111111	0.41684569686192785
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.41684569686192785
LENTIGINES	0.0111111	0.41684569686192785
PSEUDOATROPHODERMA COLLI	0.0111111	0.41684569686192785
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.41684569686192785
LICHEN PLANUS, FAMILIAL	0.0111111	0.41684569686192785
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	0.41684569686192785
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.0111111	0.41684569686192785
TRICHILEMMAL CYST 1	0.0111111	0.41684569686192785
SAY SYNDROME	0.0111111	0.41684569686192785
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	0.41684569686192785
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0111111	0.41684569686192785
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.41684569686192785
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.41684569686192785
SYRINGOMAS, MULTIPLE	0.0111111	0.41684569686192785
TRIOPIA	0.0111111	0.41684569686192785
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0111111	0.41684569686192785
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.41684569686192785
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.41684569686192785
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.41684569686192785
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.0111111	0.41684569686192785
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.41684569686192785
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.0111111	0.41684569686192785
PILONIDAL SINUS	0.0111111	0.41684569686192785
KERATOSIS, FAMILIAL ACTINIC	0.0111111	0.41684569686192785
MARFANOID HYPERMOBILITY SYNDROME	0.0111111	0.41684569686192785
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.41684569686192785
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	0.41684569686192785
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0111111	0.41684569686192785
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	0.41684569686192785
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.011084304	0.41584041410026495
PENTASOMY X	0.011071853999999999	0.4153733380298551
ISOLATED PLAGIOCEPHALY	0.011071853999999999	0.4153733380298551
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.011067718999999998	0.41521820874863863
MALAN OVERGROWTH SYNDROME	0.011067718999999998	0.41521820874863863
LINEAR NEVUS SEBACEUS SYNDROME	0.011067718999999998	0.41521820874863863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.011035772	0.41401968029712194
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.011032583	0.4139000412940266
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.011022871	0.4135356844429567
ADAMS-OLIVER SYNDROME 2; AOS2	0.011022871	0.4135356844429567
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.010993733000000002	0.41244253885744653
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.010993733000000002	0.41244253885744653
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.010993733000000002	0.41244253885744653
MENTAL RETARDATION, X-LINKED 101; MRX101	0.010993733	0.4124425388574464
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.0109456	0.41063677399824655
SHWACHMAN-DIAMOND SYNDROME	0.010941052	0.4104661505469836
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.010941052	0.4104661505469836
COFFIN-SIRIS SYNDROME 8; CSS8	0.010936916999999999	0.41031102126576713
EMANUEL SYNDROME	0.010864691000000001	0.40760137979898625
DISTAL TRISOMY 5Q	0.01083256	0.4063959483758265
2Q23.1 MICRODUPLICATION SYNDROME	0.010801964	0.40524810424327545
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.010766352	0.4039120791011521
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.010766352	0.4039120791011521
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.010615653	0.39825843277708006
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.010606877	0.397929191042629
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.010595521	0.3975031576405748
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01053875	0.395373328275656
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.01053875	0.395373328275656
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.010526299999999999	0.39490625220524617
ROBINOW-SORAUF SYNDROME	0.010526299999999999	0.39490625220524617
FACIOCARDIORENAL SYNDROME	0.010526299999999999	0.39490625220524617
SUMMITT SYNDROME	0.010526299999999999	0.39490625220524617
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.010526299999999999	0.39490625220524617
CRANIOFRONTONASAL DYSPLASIA	0.010526299999999999	0.39490625220524617
FAMILIAL LAMBDOID SYNOSTOSIS	0.010526299999999999	0.39490625220524617
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.010526299999999999	0.39490625220524617
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.010526299999999999	0.39490625220524617
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.010526299999999999	0.39490625220524617
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.010526299999999999	0.39490625220524617
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.010526299999999999	0.39490625220524617
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.010526299999999999	0.39490625220524617
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.010526299999999999	0.39490625220524617
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.010526299999999999	0.39490625220524617
FACIOCARDIORENAL SYNDROME	0.010526299999999999	0.39490625220524617
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.010520933	0.39470490302694183
CHROMOSOME 2Q37 DELETION SYNDROME	0.010520933	0.39470490302694183
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.010520933	0.39470490302694183
CLASSIC PHENYLKETONURIA	0.010520933	0.39470490302694183
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.010520933	0.39470490302694183
NETHERTON SYNDROME	0.010520933	0.39470490302694183
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.010520933	0.39470490302694183
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.010487029	0.3934329554694177
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.010481451999999999	0.39322372789956417
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.010477317	0.39306859861834775
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.010452314	0.392130582314054
KAGAMI-OGATA SYNDROME	0.010451871	0.3921139626595004
INFANTILE SIALIC ACID STORAGE DISEASE	0.010451871	0.3921139626595004
TYSHCHENKO SYNDROME	0.010347514	0.3881988897695597
GAUCHER DISEASE, PERINATAL LETHAL	0.010343379	0.38804376048834327
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.010323272	0.38728942325559373
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.010248342	0.38447833811858084
ATAXIA-PANCYTOPENIA SYNDROME	0.01023335	0.3839158959942769
48,XXYY SYNDROME	0.010190893	0.3823230728038036
COFFIN-SIRIS SYNDROME 4; CSS4	0.010178590999999999	0.38186154912362835
COFFIN-SIRIS SYNDROME 3; CSS3	0.010178590999999999	0.38186154912362835
KABUKI SYNDROME 1	0.010178590999999999	0.38186154912362835
LUSCAN-LUMISH SYNDROME; LLS	0.010178590999999999	0.38186154912362835
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.010178590999999999	0.38186154912362835
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.010178590999999999	0.38186154912362835
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.010145111	0.38060550841380336
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.010145111	0.38060550841380336
JOUBERT SYNDROME 10	0.010074234	0.37794647623368766
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.010074234	0.37794647623368766
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.010074234	0.37794647623368766
DISTAL MONOSOMY 15Q	0.010061332999999999	0.37746248037952235
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.010054102	0.3771912010971824
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.010049967	0.3770360718159659
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.009979514	0.37439294648354937
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.009975379	0.3742378172023329
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.009975379	0.3742378172023329
PHENYLKETONURIA	0.009975379	0.3742378172023329
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.009975379	0.3742378172023329
15Q26 OVERGROWTH SYNDROME	0.00994561	0.37312099892602524
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00994561	0.37312099892602524
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00994561	0.37312099892602524
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.009935898	0.3727566420749553
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.009935898	0.3727566420749553
STUVE-WIEDEMANN SYNDROME	0.009935898	0.3727566420749553
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.009935898	0.3727566420749553
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.009935898	0.3727566420749553
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.009910452	0.371802006116108
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.009910452	0.371802006116108
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.009910452	0.371802006116108
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.009903153	0.37152817573555197
611961 STEVENSON-CAREY SYNDROME	0.009903153	0.37152817573555197
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.009857371	0.36981061134555165
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36783887503771784
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.36783887503771784
BIOTINIDASE DEFICIENCY	0.009804814	0.36783887503771784
KRABBE DISEASE	0.009804814	0.36783887503771784
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.36783887503771784
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.009804814	0.36783887503771784
KNIEST-LIKE DYSPLASIA, LETHAL	0.00980196	0.3677318039449508
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00980196	0.3677318039449508
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00980196	0.3677318039449508
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00980196	0.3677318039449508
INTERMEDIATE NEMALINE MYOPATHY	0.00980196	0.3677318039449508
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00980196	0.3677318039449508
RESTRICTIVE DERMOPATHY, LETHAL	0.00980196	0.3677318039449508
GMS SYNDROME	0.00980196	0.3677318039449508
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650137
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36768374575650137
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.009637172	0.3615495925802359
COHEN SYNDROME	0.009633983	0.3614299535771406
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.009633983	0.3614299535771406
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.009633983	0.3614299535771406
CENTRAL BILATERAL MACROGYRIA	0.009633983	0.3614299535771406
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.009633983	0.3614299535771406
22Q11.2 MICRODUPLICATION SYNDROME	0.009633983	0.3614299535771406
ARGININEMIA	0.009633983	0.3614299535771406
ISOLATED GLYCEROL KINASE DEFICIENCY	0.009633983	0.3614299535771406
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.009633036999999999	0.3613944632990194
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.009633036999999999	0.3613944632990194
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.009626741999999999	0.3611582991332981
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.009626741999999999	0.3611582991332981
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.009624271	0.36106559672607064
WITTEVEEN-KOLK SYNDROME	0.009624271	0.36106559672607064
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.009624271	0.36106559672607064
TARP SYNDROME	0.009624271	0.36106559672607064
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.009624271	0.36106559672607064
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00952868	0.3574793904090787
FGFR2-RELATED BENT BONE DYSPLASIA	0.00952868	0.3574793904090787
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00952868	0.3574793904090787
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00952868	0.3574793904090787
YUNIS-VARON SYNDROME	0.009519914	0.35715052383612994
SHPRINTZEN-GOLDBERG SYNDROME	0.009518249999999999	0.357088096962141
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.009515779	0.35699539455491347
SECKEL SYNDROME 1; SCKL1	0.009515779	0.35699539455491347
FRYNS SYNDROME; FRNS	0.009515779	0.35699539455491347
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.009515779	0.35699539455491347
LOWRY-MACLEAN SYNDROME	0.009515779	0.35699539455491347
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.009508548	0.35672411527257347
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.35604075859606615
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.009490333	0.35604075859606615
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.009490333	0.35604075859606615
GALLOWAY-MOWAT SYNDROME	0.009490333	0.35604075859606615
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.35604075859606615
CONGENITAL TOXOPLASMOSIS	0.009490333	0.35604075859606615
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.009466091000000001	0.35513129208210026
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00943396	0.35392586065894044
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00943396	0.35392586065894044
IGE RESPONSIVENESS, ATOPIC	0.00943396	0.35392586065894044
WISKOTT-ALDRICH SYNDROME	0.00943396	0.35392586065894044
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00943396	0.35392586065894044
CASPASE 8 DEFICIENCY	0.00943396	0.35392586065894044
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00943396	0.35392586065894044
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00943396	0.35392586065894044
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.00943396	0.35392586065894044
PORPHYRIA CUTANEA TARDA, TYPE I	0.00943396	0.35392586065894044
BAZEX SYNDROME; BZX	0.00943396	0.35392586065894044
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.00943396	0.35392586065894044
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00943396	0.35392586065894044
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00943396	0.35392586065894044
DERMATITIS HERPETIFORMIS	0.00943396	0.35392586065894044
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00943396	0.35392586065894044
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.00943396	0.35392586065894044
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00943396	0.35392586065894044
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.00943396	0.35392586065894044
IMMUNODEFICIENCY 55; IMD55	0.00943396	0.35392586065894044
BULLOUS PEMPHIGOID	0.00943396	0.35392586065894044
ELASTODERMA	0.00943396	0.35392586065894044
CHRONIC GRANULOMATOUS DISEASE	0.00943396	0.35392586065894044
BLAU SYNDROME	0.00943396	0.35392586065894044
NEUTROPHIL CHEMOTACTIC RESPONSE	0.00943396	0.35392586065894044
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00943396	0.35392586065894044
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00943396	0.35392586065894044
EPIDERMOLYTIC PALMOPLANTAR KERATODERMA	0.00943396	0.35392586065894044
MYCOSIS FUNGOIDES	0.00943396	0.35392586065894044
PITYRIASIS RUBRA PILARIS	0.00943396	0.35392586065894044
DERMATITIS, ATOPIC	0.00943396	0.35392586065894044
ACRAL PEELING SKIN SYNDROME	0.00943396	0.35392586065894044
CRANIO-OSTEOARTHROPATHY	0.00943396	0.35392586065894044
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00943396	0.35392586065894044
PROTOPORPHYRIA, ERYTHROPOIETIC	0.00943396	0.35392586065894044
IMMUNODEFICIENCY 50; IMD50	0.00943396	0.35392586065894044
NEMALINE MYOPATHY 10	0.009364898	0.35133492029149904
TEMPLE SYNDROME	0.009364898	0.35133492029149904
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.009364898	0.35133492029149904
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.009364898	0.35133492029149904
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009364898	0.35133492029149904
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009364898	0.35133492029149904
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.009357599	0.35106108991094304
PERIPHERAL HYPOTHYROIDISM	0.009352022	0.35085186234108956
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.009352022	0.35085186234108956
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.009352022	0.35085186234108956
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.009352022	0.35085186234108956
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.009311817	0.3493435255209427
HOLMES-GANG SYNDROME	0.009286804000000001	0.3484051340551466
PAINE SYNDROME	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
GAUCHER DISEASE TYPE 3	0.00925926	0.3473717892131089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.3473717892131089
GLYCINE ENCEPHALOPATHY	0.00925926	0.3473717892131089
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.3473717892131089
GAUCHER DISEASE TYPE 2	0.00925926	0.3473717892131089
MERRF	0.00925926	0.3473717892131089
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.009217053	0.34578834506019407
WAISMAN SYNDROME; WSMN	0.009183573	0.3445323043503691
ANGELMAN SYNDROME	0.009116441000000001	0.34201377015287876
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.009116441000000001	0.34201377015287876
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.009092564000000001	0.3411179970337481
GERMAN SYNDROME	0.009092564000000001	0.3411179970337481
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.009092564000000001	0.3411179970337481
ISOLATED CEREBELLAR AGENESIS	0.009088429	0.34096286775253165
SIALIDOSIS TYPE 1	0.009088429	0.34096286775253165
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.009088429	0.34096286775253165
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.009088429	0.34096286775253165
NEUROFIBROMATOSIS TYPE 1	0.009088429	0.34096286775253165
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.009088429	0.34096286775253165
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.009088429	0.34096286775253165
NEURONAL CEROID LIPOFUSCINOSIS	0.009088429	0.34096286775253165
CONGENITAL RUBELLA SYNDROME	0.009088429	0.34096286775253165
MUSCLE-EYE-BRAIN DISEASE	0.009088429	0.34096286775253165
MICROPHTHALMIA, LENZ TYPE	0.009088429	0.34096286775253165
FOUNTAIN SYNDROME	0.009088429	0.34096286775253165
TAKAYASU ARTERITIS	0.009088429	0.34096286775253165
WHIM SYNDROME	0.009088429	0.34096286775253165
WORSTER-DROUGHT SYNDROME	0.009088429	0.34096286775253165
METACHROMATIC LEUKODYSTROPHY	0.009088429	0.34096286775253165
CEREBROTENDINOUS XANTHOMATOSIS	0.009088429	0.34096286775253165
COFFIN-LOWRY SYNDROME	0.009088429	0.34096286775253165
STURGE-WEBER SYNDROME	0.009088429	0.34096286775253165
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.009088429	0.34096286775253165
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.009088429	0.34096286775253165
WARSAW BREAKAGE SYNDROME; WABS	0.009082852	0.3407536401826782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.009082852	0.3407536401826782
DESBUQUOIS DYSPLASIA 2; DBQD2	0.009082852	0.3407536401826782
PEROXISOME BIOGENESIS DISORDER 3B	0.009082852	0.3407536401826782
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.009081187999999999	0.3406912133086892
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.009078717	0.3405985109014617
COHEN SYNDROME	0.009078717	0.3405985109014617
COFFIN-LOWRY SYNDROME; CLS	0.009078717	0.3405985109014617
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.009078717	0.3405985109014617
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.008979601	0.33688006015489597
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00897436	0.33668343801152106
OROFACIAL CLEFT 15	0.00897436	0.33668343801152106
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00897436	0.33668343801152106
MOSAIC TRISOMY 1	0.00897436	0.33668343801152106
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00897436	0.33668343801152106
TEEBI-SHALTOUT SYNDROME; TBSH	0.00897436	0.33668343801152106
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.00897436	0.33668343801152106
PEDIATRIC-ONSET GRAVES DISEASE	0.008948914	0.3357288020526737
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.008948914	0.3357288020526737
CINCA SYNDROME	0.008948914	0.3357288020526737
ZELLWEGER SYNDROME	0.008944779	0.3355736727714572
MICROFORM HOLOPROSENCEPHALY	0.008944779	0.3355736727714572
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3355736727714572
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.008924672	0.33481933553870774
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.008895833	0.3337374072821174
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.008895833	0.3337374072821174
8P23.1 MICRODELETION SYNDROME	0.008895833	0.3337374072821174
MAN1B1-CDG	0.008895833	0.3337374072821174
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.008849742	0.33200825040169485
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.008845607	0.3318531211204784
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.008806468	0.3303847765164806
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00872859	0.32746309376857874
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.008675634	0.32547638851680166
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.008675634	0.32547638851680166
RABSON-MENDENHALL SYNDROME	0.008675634	0.32547638851680166
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.008671499	0.32532125923558514
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.008671499	0.32532125923558514
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.008671499	0.32532125923558514
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.008671499	0.32532125923558514
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.008671499	0.32532125923558514
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.008671499	0.32532125923558514
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.008671499	0.32532125923558514
TOWNES-BROCKS SYNDROME 1; TBS1	0.008665204	0.3250850950698639
KBG SYNDROME	0.008662733	0.3249923926626364
KBG SYNDROME	0.008662733	0.3249923926626364
HEREDITARY HYPEREKPLEXIA	0.008661068999999999	0.3249299657886474
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.008642154	0.3242203478069766
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.008642154	0.3242203478069766
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.008642154	0.3242203478069766
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.008638019	0.32406521852576015
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.008638019	0.32406521852576015
MOWAT-WILSON SYNDROME; MOWS	0.008570887000000001	0.3215466843282698
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.008549342	0.3207383988714842
TRISOMY XQ28	0.00854701	0.3206509112091392
PENDRED SYNDROME	0.00854701	0.3206509112091392
NEURALGIC AMYOTROPHY	0.00854701	0.3206509112091392
PRIMARY PROGRESSIVE FREEZING GAIT	0.00854701	0.3206509112091392
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00854701	0.3206509112091392
SHORT SYNDROME	0.00854701	0.3206509112091392
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00854701	0.3206509112091392
DYSLEXIA, SUSCEPTIBILITY TO, 1	0.00854701	0.3206509112091392
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00854701	0.3206509112091392
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00854701	0.3206509112091392
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00854701	0.3206509112091392
VON HIPPEL-LINDAU DISEASE	0.00854701	0.3206509112091392
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00854701	0.3206509112091392
HISTIDINEMIA	0.00854701	0.3206509112091392
PSYCHOGENIC MOVEMENT DISORDERS	0.00854701	0.3206509112091392
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.00854701	0.3206509112091392
ALOPECIA ANTIBODY DEFICIENCY	0.00854701	0.3206509112091392
BARDET-BIEDL SYNDROME	0.00854701	0.3206509112091392
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00854701	0.3206509112091392
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.00854701	0.3206509112091392
ALBINISM-DEAFNESS SYNDROME	0.00854701	0.3206509112091392
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.00854701	0.3206509112091392
ALZHEIMER DISEASE 10	0.00854701	0.3206509112091392
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00854701	0.3206509112091392
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00854701	0.3206509112091392
CAMURATI-ENGELMANN DISEASE	0.00854701	0.3206509112091392
HISTIDINEMIA	0.00854701	0.3206509112091392
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00854701	0.3206509112091392
RECESSIVE X-LINKED ICHTHYOSIS	0.00854701	0.3206509112091392
GOLDENHAR SYNDROME	0.00854701	0.3206509112091392
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00854701	0.3206509112091392
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.00854701	0.3206509112091392
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00854701	0.3206509112091392
BRANCHIO-OCULO-FACIAL SYNDROME	0.00854701	0.3206509112091392
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.008537298	0.32028655435806924
HOLOPROSENCEPHALY	0.008504553	0.3190580880186659
KLEEFSTRA SYNDROME	0.008504553	0.3190580880186659
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.008504553	0.3190580880186659
48,XXXY SYNDROME	0.008504553	0.3190580880186659
49,XXXXY SYNDROME	0.008504553	0.3190580880186659
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.008458771	0.3173405236286656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.008458771	0.3173405236286656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.008458771	0.3173405236286656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.008458771	0.3173405236286656
MEHMO SYNDROME; MEHMO	0.008458771	0.3173405236286656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.008458771	0.3173405236286656
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008458771	0.3173405236286656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.008458771	0.3173405236286656
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00844085	0.3166681967003271
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.31526171622806476
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.31526171622806476
OMPHALOCELE	0.00840336	0.31526171622806476
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	0.31526171622806476
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.31526171622806476
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.31526171622806476
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.31526171622806476
VACTERL/VATER ASSOCIATION	0.00840336	0.31526171622806476
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.31526171622806476
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.31526171622806476
EBSTEIN MALFORMATION	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.31526171622806476
RETINOPATHY OF PREMATURITY	0.00840336	0.31526171622806476
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.31526171622806476
CONGENITAL ANALBUMINEMIA	0.00840336	0.31526171622806476
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.31526171622806476
SCHISIS ASSOCIATION	0.00840336	0.31526171622806476
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.31526171622806476
FATCO SYNDROME	0.00840336	0.31526171622806476
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.31526171622806476
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.31526171622806476
HYDROLETHALUS	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.31526171622806476
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.31526171622806476
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.31526171622806476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.31526171622806476
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.31526171622806476
HEC SYNDROME	0.00840336	0.31526171622806476
PEMPHIGOID GESTATIONIS	0.00840336	0.31526171622806476
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.31526171622806476
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.31526171622806476
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.31526171622806476
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.31526171622806476
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.31526171622806476
TEMPLE SYNDROME	0.00840336	0.31526171622806476
THYROID ECTOPIA	0.008390484	0.31477865827765533
CONGENITAL HYPOTHYROIDISM	0.008390484	0.31477865827765533
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.008390484	0.31477865827765533
FAMILIAL THYROID DYSHORMONOGENESIS	0.008390484	0.31477865827765533
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.008390484	0.31477865827765533
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.008390484	0.31477865827765533
THYROID HEMIAGENESIS	0.008390484	0.31477865827765533
PERMANENT CONGENITAL HYPOTHYROIDISM	0.008390484	0.31477865827765533
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.008379118	0.3143522497140988
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.008379118	0.3143522497140988
SLC39A8-CDG	0.008350279	0.3132703214575085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.008154903	0.3059405660894444
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.008154903	0.3059405660894444
GONADOBLASTOMA	0.00813008	0.30500930269219273
OVARIAN DYSGENESIS 2; ODG2	0.00813008	0.30500930269219273
CARNEY COMPLEX, TYPE 1; CNC1	0.00813008	0.30500930269219273
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00813008	0.30500930269219273
XYLT1-CDG	0.00813008	0.30500930269219273
OVARIAN HYPERSTIMULATION SYNDROME	0.00813008	0.30500930269219273
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00813008	0.30500930269219273
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00813008	0.30500930269219273
FOWLER URETHRAL SPHINCTER DYSFUNCTION SYNDROME	0.00813008	0.30500930269219273
CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	0.00813008	0.30500930269219273
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00813008	0.30500930269219273
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00813008	0.30500930269219273
HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL	0.00813008	0.30500930269219273
INSULIN-RESISTANCE SYNDROME TYPE B	0.00813008	0.30500930269219273
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00813008	0.30500930269219273
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00813008	0.30500930269219273
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00813008	0.30500930269219273
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00813008	0.30500930269219273
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00813008	0.30500930269219273
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00813008	0.30500930269219273
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00813008	0.30500930269219273
OVARIAN FIBROTHECOMA	0.00813008	0.30500930269219273
CRANIORHINY	0.00813008	0.30500930269219273
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00813008	0.30500930269219273
ACHALASIA-MICROCEPHALY SYNDROME	0.00813008	0.30500930269219273
CARNEY COMPLEX	0.00813008	0.30500930269219273
POLYCYSTIC OVARY SYNDROME 1	0.00813008	0.30500930269219273
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00813008	0.30500930269219273
46,XY SEX REVERSAL 6; SRXY6	0.00813008	0.30500930269219273
ACANTHOSIS NIGRICANS-INSULIN RESISTANCE-MUSCLE CRAMPS-ACRAL ENLARGEMENT SYNDROME	0.00813008	0.30500930269219273
FRONTOMETAPHYSEAL DYSPLASIA	0.00813008	0.30500930269219273
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.00813008	0.30500930269219273
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00813008	0.30500930269219273
PSEUDOAMINOPTERIN SYNDROME	0.008121314	0.3046804361192439
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.008121314	0.3046804361192439
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.008121314	0.3046804361192439
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.008121314	0.3046804361192439
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.008121314	0.3046804361192439
MEIER-GORLIN SYNDROME 6; MGORS6	0.008119649999999999	0.30461800924525495
X-LINKED EHLERS-DANLOS SYNDROME	0.008119649999999999	0.30461800924525495
FILIPPI SYNDROME; FLPIS	0.008117179	0.3045253068380275
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.008117179	0.3045253068380275
POTOCKI-SHAFFER SYNDROME	0.008117179	0.3045253068380275
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.007963134	0.2987461314752735
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.007963134	0.2987461314752735
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.007917352	0.2970285670852732
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.007917352	0.2970285670852732
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.007917352	0.2970285670852732
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.007917352	0.2970285670852732
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.007917352	0.2970285670852732
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.007917352	0.2970285670852732
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.007917352	0.2970285670852732
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.007913217	0.2968734378040567
MENTAL RETARDATION, X-LINKED 1	0.007913217	0.2968734378040567
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007884069	0.29577991705704415
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.007884069	0.29577991705704415
14Q12 MICRODELETION SYNDROME	0.007884069	0.29577991705704415
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00784493	0.2943115724530464
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00784493	0.2943115724530464
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00784493	0.2943115724530464
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00784493	0.2943115724530464
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00784493	0.2943115724530464
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.007720610999999999	0.28964760217214003
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.007720610999999999	0.28964760217214003
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.007609349000000001	0.28547348026483554
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28466519480804997
X SMALL RINGS	0.007587804	0.28466519480804997
1Q44 MICRODELETION SYNDROME	0.007587804	0.28466519480804997
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.28466519480804997
W SYNDROME	0.007587804	0.28466519480804997
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.28466519480804997
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.28466519480804997
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.007581001	0.2844099724380099
CZEIZEL-LOSONCI SYNDROME	0.00757576	0.28421335029463496
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00757576	0.28421335029463496
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00757576	0.28421335029463496
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00757576	0.28421335029463496
BASAN SYNDROME	0.00757576	0.28421335029463496
268650 RUDIGER SYNDROME	0.00757576	0.28421335029463496
MONOSOMY 22	0.00757576	0.28421335029463496
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.00757576	0.28421335029463496
POSTAXIAL OLIGODACTYLY, TETRAMELIC	0.00757576	0.28421335029463496
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00757576	0.28421335029463496
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00757576	0.28421335029463496
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00757576	0.28421335029463496
CRANIOECTODERMAL DYSPLASIA 1	0.00757576	0.28421335029463496
TETRAGAMETIC CHIMERISM	0.00757576	0.28421335029463496
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.00757576	0.28421335029463496
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.00757576	0.28421335029463496
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00757576	0.28421335029463496
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00757576	0.28421335029463496
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00757576	0.28421335029463496
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00757576	0.28421335029463496
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.007497233000000001	0.2812673195652314
WILSON-TURNER SYNDROME	0.007497233000000001	0.2812673195652314
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.007497233000000001	0.2812673195652314
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.007497233000000001	0.2812673195652314
KOOLEN-DE VRIES SYNDROME	0.007497233000000001	0.2812673195652314
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.007497233000000001	0.2812673195652314
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.007497233000000001	0.2812673195652314
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.007497233000000001	0.2812673195652314
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.007497233000000001	0.2812673195652314
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.007497233000000001	0.2812673195652314
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.007497233000000001	0.2812673195652314
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.007497233000000001	0.2812673195652314
NK-CELL ENTEROPATHY	0.00741758	0.2782790456506646
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.007371798000000001	0.27656148126066427
HEART AND BRAIN MALFORMATION SYNDROME	0.0072932610000000005	0.27361507536975826
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0072313510000000004	0.2712924505087885
COHEN-GIBSON SYNDROME; COGIS	0.007179191999999999	0.26933564562874757
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
AMISH LETHAL MICROCEPHALY	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26419810898344104
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26419810898344104
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26419810898344104
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.007039582000000001	0.2640980158946175
WIEDEMANN-STEINER SYNDROME; WDSTS	0.007018541	0.26330863857754966
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.006955814	0.2609553630218389
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.006955814	0.2609553630218389
FRIED SYNDROME	0.006955814	0.2609553630218389
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.006955814	0.2609553630218389
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.006955814	0.2609553630218389
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.006955814	0.2609553630218389
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.006955814	0.2609553630218389
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.006955814	0.2609553630218389
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.006955814	0.2609553630218389
COG8-CDG	0.0069516790000000005	0.26080023374062244
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.0069516790000000005	0.26080023374062244
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0069516790000000005	0.26080023374062244
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.0069516790000000005	0.26080023374062244
MENTAL RETARDATION, X-LINKED 100	0.0069516790000000005	0.26080023374062244
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.0069516790000000005	0.26080023374062244
MENTAL RETARDATION, X-LINKED 14	0.0069516790000000005	0.26080023374062244
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.006943611000000001	0.26049755344053677
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.006943611000000001	0.26049755344053677
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.006943611000000001	0.26049755344053677
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.006943611000000001	0.26049755344053677
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.006943611000000001	0.26049755344053677
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.006943611000000001	0.26049755344053677
MONOSOMY 9Q22.3	0.006759072999999999	0.2535743981087058
DIGEORGE SYNDROME; DGS	0.006759072999999999	0.2535743981087058
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.006759072999999999	0.2535743981087058
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.006747707	0.25314798954514933
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.006747707	0.25314798954514933
MARSHALL-SMITH SYNDROME; MRSHSS	0.006633637999999999	0.2488685598041387
OCULODENTODIGITAL DYSPLASIA	0.006501258999999999	0.24390220935234852
TRIGEMINAL NEURALGIA	0.00641026	0.24048827719722995
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.00641026	0.24048827719722995
SOTOS SYNDROME 3	0.00641026	0.24048827719722995
AL-RAQAD SYNDROME; ARS	0.006402192000000001	0.2401855968971443
HADZISELIMOVIC SYNDROME	0.006402192	0.24018559689714425
OROFACIODIGITAL SYNDROME XIV; OFD14	0.006402192	0.24018559689714425
ADENYLOSUCCINATE LYASE DEFICIENCY	0.006398057	0.24003046761592786
BOHRING-OPITZ SYNDROME	0.006331722999999999	0.23754187130632398
GENITOPATELLAR SYNDROME	0.006331722999999999	0.23754187130632398
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.006322010999999999	0.23717751445525406
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.006322010999999999	0.23717751445525406
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.006269813000000001	0.2352192464453542
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.006269813000000001	0.2352192464453542
CHROMOSOME 1P35 DELETION SYNDROME	0.006269813000000001	0.2352192464453542
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0062176539999999995	0.23326244156531337
DE BARSY SYNDROME	0.0062176539999999995	0.23326244156531337
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0062176539999999995	0.23326244156531337
LATERAL MENINGOCELE SYNDROME	0.0062176539999999995	0.23326244156531337
ICF SYNDROME	0.0062176539999999995	0.23326244156531337
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0062176539999999995	0.23326244156531337
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.006213518999999999	0.23310731228409687
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.006206288	0.23283603300175687
PGM3-CDG	0.006073909000000001	0.22786968254996676
RUBINSTEIN-TAYBI SYNDROME	0.006057003	0.22723543451411543
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.005982073000000001	0.22442434937710254
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.005982073	0.22442434937710248
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.005982073	0.22442434937710248
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.005982073	0.22442434937710248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.005894661000000001	0.22114498765287227
SSR4-CDG	0.005894661000000001	0.22114498765287227
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.005894661000000001	0.22114498765287227
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.005894661000000001	0.22114498765287227
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005894661000000001	0.22114498765287227
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.005894661000000001	0.22114498765287227
CODAS SYNDROME	0.005894661000000001	0.22114498765287227
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.005803324	0.21771837503897462
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.005803324	0.21771837503897462
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.005799189	0.21756324575775815
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.005799189	0.21756324575775815
WOLFRAM SYNDROME	0.005799189	0.21756324575775815
3Q29 MICRODELETION SYNDROME	0.005790304	0.2172299147629315
OKAMOTO SYNDROME	0.005790304	0.2172299147629315
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.005790304	0.2172299147629315
SWEENEY-COX SYNDROME; SWCOS	0.005790304	0.2172299147629315
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.005786169	0.21707478548171508
WIEDEMANN-STEINER SYNDROME	0.005786169	0.21707478548171508
CRANIOFRONTONASAL SYNDROME; CFNS	0.005780591999999999	0.21686555791186157
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.005780591999999999	0.21686555791186157
ACROCALLOSAL SYNDROME; ACLS	0.005776456999999999	0.21671042863064513
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.005776456999999999	0.21671042863064513
CHROMOSOME 18Q DELETION SYNDROME	0.005776456999999999	0.21671042863064513
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.005728394	0.2149072899019617
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.005724259000000001	0.21475216062074526
3MC SYNDROME	0.005672099999999999	0.21279535574070443
SCARF SYNDROME	0.005672099999999999	0.21279535574070443
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.005672099999999999	0.21279535574070443
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.005672099999999999	0.21279535574070443
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.005672099999999999	0.21279535574070443
GAPO SYNDROME	0.005672099999999999	0.21279535574070443
CRANIOFACIAL DYSSYNOSTOSIS	0.005672099999999999	0.21279535574070443
HYPERTELORISM, TEEBI TYPE	0.005672099999999999	0.21279535574070443
ACROOSTEOLYSIS DOMINANT TYPE	0.005672099999999999	0.21279535574070443
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.005672099999999999	0.21279535574070443
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.005672099999999999	0.21279535574070443
HOLOPROSENCEPHALY 2; HPE2	0.005619941	0.21083855086066364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.005619941	0.21083855086066364
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.005619941	0.21083855086066364
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.005619941	0.21083855086066364
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.005619941	0.21083855086066364
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.005619941	0.21083855086066364
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.005619941	0.21083855086066364
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.005619941	0.21083855086066364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.005545011000000001	0.20802746572365075
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.005545011000000001	0.20802746572365075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.005545011000000001	0.20802746572365075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.005545011000000001	0.20802746572365075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.005545011000000001	0.20802746572365075
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.005545011000000001	0.20802746572365075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.005545011000000001	0.20802746572365075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.005545011000000001	0.20802746572365075
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.005545011000000001	0.20802746572365075
RAYNAUD-CLAES SYNDROME; MRXSRC	0.005545011000000001	0.20802746572365075
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.005545011000000001	0.20802746572365075
AICARDI-GOUTIERES SYNDROME 7	0.005545011000000001	0.20802746572365075
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.005545011000000001	0.20802746572365075
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.005545011000000001	0.20802746572365075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.005545011000000001	0.20802746572365075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.005545011000000001	0.20802746572365075
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.005545011000000001	0.20802746572365075
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.005545011000000001	0.20802746572365075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.005545011000000001	0.20802746572365075
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.005545011000000001	0.20802746572365075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005545011000000001	0.20802746572365075
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.005545011000000001	0.20802746572365075
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.005545011000000001	0.20802746572365075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.005545011000000001	0.20802746572365075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.005545011000000001	0.20802746572365075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.005545011000000001	0.20802746572365075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.005545011000000001	0.20802746572365075
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.005545011000000001	0.20802746572365075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.005545011000000001	0.20802746572365075
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.005545011000000001	0.20802746572365075
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.005545011000000001	0.20802746572365075
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.005545011000000001	0.20802746572365075
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.005545011000000001	0.20802746572365075
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00553249	0.20755772600657427
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00553249	0.20755772600657427
NATIVE AMERICAN MYOPATHY	0.00553249	0.20755772600657427
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.005515584	0.20692347797072294
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.005436519000000001	0.2039572635524936
DONNAI-BARROW SYNDROME	0.005360472999999999	0.2011043103918198
DISTAL MONOSOMY 19P13.3	0.005360472999999999	0.2011043103918198
HYPEREKPLEXIA 4; HKPX4	0.005360472999999999	0.2011043103918198
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005360472999999999	0.2011043103918198
MUCOPOLYSACCHARIDOSIS TYPE 2	0.005360472999999999	0.2011043103918198
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.005353242	0.20083303110947975
TENORIO SYNDROME; TNORS	0.0053491070000000005	0.20067790182826334
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0053491070000000005	0.20067790182826334
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0053491070000000005	0.20067790182826334
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00525777	0.1972512892143657
PARKINSON DISEASE, LATE-ONSET; PD	0.00525777	0.1972512892143657
WOUND BOTULISM	0.00525777	0.1972512892143657
INFANT BOTULISM	0.00525777	0.1972512892143657
FOODBORNE BOTULISM	0.00525777	0.1972512892143657
BOTULISM	0.00525777	0.1972512892143657
MULTIPLE SYSTEM ATROPHY	0.00525777	0.1972512892143657
MEIER-GORLIN SYNDROME 3; MGORS3	0.005244749999999999	0.19676282893832256
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.005244749999999999	0.19676282893832256
MEIER-GORLIN SYNDROME 5; MGORS5	0.005244749999999999	0.19676282893832256
MEIER-GORLIN SYNDROME 1; MGORS1	0.005244749999999999	0.19676282893832256
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.005244749999999999	0.19676282893832256
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.005235037999999999	0.19639847208725264
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.005235037999999999	0.19639847208725264
ARTERIAL TORTUOSITY SYNDROME	0.005235037999999999	0.19639847208725264
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.005235037999999999	0.19639847208725264
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.005078522	0.19052659431727118
NIEMANN-PICK DISEASE, TYPE A	0.005078522	0.19052659431727118
HYPOPHOSPHATASIA, INFANTILE	0.005074387	0.1903714650360547
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.005003592000000001	0.1877155091802583
JOUBERT SYNDROME 24	0.005003592000000001	0.1877155091802583
YOU-HOOVER-FONG SYNDROME; YHFS	0.005003592000000001	0.1877155091802583
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.005003592000000001	0.1877155091802583
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.005003592000000001	0.1877155091802583
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.005003592	0.18771550918025826
OPTIC ATROPHY 11; OPA11	0.005003592	0.18771550918025826
MUCOLIPIDOSIS IV; ML4	0.005003592	0.18771550918025826
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.005003592	0.18771550918025826
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.0049994570000000006	0.18756037989904184
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0049994570000000006	0.18756037989904184
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0049994570000000006	0.18756037989904184
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0049994570000000006	0.18756037989904184
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0049994570000000006	0.18756037989904184
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0049994570000000006	0.18756037989904184
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00497003	0.18645639214611404
KAPUR-TORIELLO SYNDROME	0.00497003	0.18645639214611404
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.004933123	0.185071783589438
1Q21.1 MICRODUPLICATION SYNDROME	0.004933123	0.185071783589438
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.004933123	0.185071783589438
HEREDITARY FOLATE MALABSORPTION	0.004933123	0.185071783589438
SEVERE CANAVAN DISEASE	0.004933122999999999	0.18507178358943796
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.004933122999999999	0.18507178358943796
CANAVAN DISEASE	0.004933122999999999	0.18507178358943796
WEBB-DATTANI SYNDROME; WEDAS	0.004933122999999999	0.18507178358943796
MIRAGE SYNDROME; MIRAGE	0.004933122999999999	0.18507178358943796
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0048951	0.18364530700910112
ABLEPHARON MACROSTOMIA SYNDROME	0.004819054	0.18079235384842735
FANCONI ANEMIA	0.004819054	0.18079235384842735
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.004819054	0.18079235384842735
PETERS PLUS SYNDROME	0.004819054	0.18079235384842735
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.004819054	0.18079235384842735
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004819054	0.18079235384842735
XP22.13P22.2 DUPLICATION SYNDROME	0.004814918999999999	0.18063722456721087
MUCOPOLYSACCHARIDOSIS TYPE 3	0.004814918999999999	0.18063722456721087
BRANCHIOSKELETOGENITAL SYNDROME	0.004814918999999999	0.18063722456721087
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.004814918999999999	0.18063722456721087
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.004814918999999999	0.18063722456721087
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004814918999999999	0.18063722456721087
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.004814918999999999	0.18063722456721087
MUCOPOLYSACCHARIDOSIS, TYPE II	0.004814918999999999	0.18063722456721087
DISTAL MONOSOMY 3P	0.004814918999999999	0.18063722456721087
GAPO SYNDROME; GAPOS	0.004814918999999999	0.18063722456721087
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.004814918999999999	0.18063722456721087
MENKES DISEASE	0.004814918999999999	0.18063722456721087
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.004807688	0.18036594528487085
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.004807688	0.18036594528487085
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.004807688	0.18036594528487085
PRADER-WILLI-LIKE SYNDROME	0.004658403	0.1747653467972294
NEPHROGENIC DIABETES INSIPIDUS	0.004658403	0.1747653467972294
CHROMOSOME 19P13.13 DELETION SYNDROME	0.004658403	0.1747653467972294
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004658403	0.1747653467972294
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.004658403	0.1747653467972294
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004658403	0.1747653467972294
SPINOCEREBELLAR ATAXIA 47; SCA47	0.0045878970000000005	0.17212023310885047
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.004583473000000001	0.17195426166021652
FOIX-CHAVANY-MARIE SYNDROME	0.004583473000000001	0.17195426166021652
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.004583473000000001	0.17195426166021652
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.004583473000000001	0.17195426166021652
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.004583473000000001	0.17195426166021652
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, X-LINKED 103	0.004583473000000001	0.17195426166021652
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, X-LINKED 91; MRX91	0.004583473000000001	0.17195426166021652
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004583473000000001	0.17195426166021652
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.004583473000000001	0.17195426166021652
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.004583473000000001	0.17195426166021652
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.004583473000000001	0.17195426166021652
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.004583473	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.004583473	0.1719542616602165
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.004583473	0.1719542616602165
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.004583473	0.1719542616602165
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004583473	0.1719542616602165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.004583473	0.1719542616602165
MENTAL RETARDATION, X-LINKED 104; MRX104	0.004583473	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.004583473	0.1719542616602165
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.004583473	0.1719542616602165
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.004583473	0.1719542616602165
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.004583473	0.1719542616602165
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.004583473	0.1719542616602165
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.004583473	0.1719542616602165
LISSENCEPHALY 8; LIS8	0.004583473	0.1719542616602165
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.004532968	0.17005950849266224
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.004532968	0.17005950849266224
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.004458038000000001	0.16724842335564938
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.004458038000000001	0.16724842335564938
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.004458038000000001	0.16724842335564938
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.004458038000000001	0.16724842335564938
OCCIPITAL HORN SYNDROME	0.004391704	0.1647598270460455
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.004391704	0.1647598270460455
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.004391704	0.1647598270460455
CHOPS SYNDROME; CHOPS	0.004391704	0.1647598270460455
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.004391704	0.1647598270460455
8Q12 MICRODUPLICATION SYNDROME	0.004391704	0.1647598270460455
POPOV-CHANG SYNDROME; POPCHAS	0.004391704	0.1647598270460455
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.004391704	0.1647598270460455
BAKER-GORDON SYNDROME; BAGOS	0.004391704	0.1647598270460455
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.004391704	0.1647598270460455
CHARGE SYNDROME	0.004391704	0.1647598270460455
ARTERIAL TORTUOSITY SYNDROME	0.004391704	0.1647598270460455
ATYPICAL RETT SYNDROME	0.004387569	0.16460469776482906
CITRULLINEMIA TYPE I	0.004387569	0.16460469776482906
SCLERODERMA	0.004387569	0.16460469776482906
FAMILIAL DYSAUTONOMIA	0.004387569	0.16460469776482906
HADDAD SYNDROME	0.004387569	0.16460469776482906
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.004387569	0.16460469776482906
MIXED CONNECTIVE TISSUE DISEASE	0.004387569	0.16460469776482906
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.004387569	0.16460469776482906
FRYNS SYNDROME	0.004387569	0.16460469776482906
FRASER SYNDROME	0.0042734999999999995	0.1603252680238184
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.0042734999999999995	0.1603252680238184
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0042734999999999995	0.1603252680238184
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0042734999999999995	0.1603252680238184
FRANK-TER HAAR SYNDROME	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.0042734999999999995	0.1603252680238184
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.0042734999999999995	0.1603252680238184
MUSCULAR HYPERTONIA, LETHAL	0.0042734999999999995	0.1603252680238184
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.0042734999999999995	0.1603252680238184
BRITTLE CORNEA SYNDROME 2; BCS2	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.0042734999999999995	0.1603252680238184
AUTOSOMAL DOMINANT CUTIS LAXA	0.0042734999999999995	0.1603252680238184
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.0042734999999999995	0.1603252680238184
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0042734999999999995	0.1603252680238184
CARPENTER SYNDROME	0.0042734999999999995	0.1603252680238184
OSTEOGENESIS IMPERFECTA	0.0042734999999999995	0.1603252680238184
LOEYS-DIETZ SYNDROME 3; LDS3	0.0042734999999999995	0.1603252680238184
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, TYPE I	0.0042734999999999995	0.1603252680238184
MESOMELIA-SYNOSTOSES SYNDROME	0.0042734999999999995	0.1603252680238184
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.0042734999999999995	0.1603252680238184
OMODYSPLASIA 1; OMOD1	0.0042734999999999995	0.1603252680238184
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.0042734999999999995	0.1603252680238184
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.0042734999999999995	0.1603252680238184
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS TYPE 2	0.0042734999999999995	0.1603252680238184
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS TYPE 1B	0.0042734999999999995	0.1603252680238184
SCARF SYNDROME	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS TYPE 1A	0.0042734999999999995	0.1603252680238184
BLADDER EXSTROPHY	0.0042734999999999995	0.1603252680238184
HUNTER-MACDONALD SYNDROME	0.0042734999999999995	0.1603252680238184
FAMILIAL VISCERAL MYOPATHY	0.0042734999999999995	0.1603252680238184
FETAL MINOXIDIL SYNDROME	0.0042734999999999995	0.1603252680238184
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0042734999999999995	0.1603252680238184
GORLIN-CHAUDHRY-MOSS SYNDROME	0.0042734999999999995	0.1603252680238184
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.0042734999999999995	0.1603252680238184
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0042734999999999995	0.1603252680238184
LEPRECHAUNISM	0.0042734999999999995	0.1603252680238184
ATHYREOSIS	0.004116984	0.1544533902538369
THYROID HYPOPLASIA	0.004116984	0.1544533902538369
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.004116984	0.1544533902538369
300270 ADRENOMYODYSTROPHY	0.004116984	0.1544533902538369
PROPIONIC ACIDEMIA	0.004116984	0.1544533902538369
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.004116984	0.1544533902538369
2Q23.1 MICRODELETION SYNDROME	0.004112849	0.15429826097262048
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.004112849	0.15429826097262048
GITELMAN SYNDROME	0.004112849	0.15429826097262048
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.004112849	0.15429826097262048
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.15429826097262048
PORPHYRIA	0.004112849	0.15429826097262048
LOWE OCULOCEREBRORENAL SYNDROME	0.004112849	0.15429826097262048
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.15429826097262048
HEREDITARY FRUCTOSE INTOLERANCE	0.004112849	0.15429826097262048
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.004112849	0.15429826097262048
HEREDITARY COPROPORPHYRIA	0.004112849	0.15429826097262048
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.004112849	0.15429826097262048
ACUTE ADRENAL INSUFFICIENCY	0.004112849	0.15429826097262048
MOWAT-WILSON SYNDROME	0.004112849	0.15429826097262048
ADDISON DISEASE	0.004112849	0.15429826097262048
PORPHYRIA VARIEGATA	0.004112849	0.15429826097262048
ACUTE INTERMITTENT PORPHYRIA	0.004112849	0.15429826097262048
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.15429826097262048
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.15429826097262048
ADIPOSIS DOLOROSA	0.004112849	0.15429826097262048
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004042054000000001	0.15164230511682403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.004042054000000001	0.15164230511682403
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.004042054000000001	0.15164230511682403
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.004042054000000001	0.15164230511682403
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.004042054000000001	0.15164230511682403
TRANSKETOLASE DEFICIENCY	0.004042054000000001	0.15164230511682403
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.004042054000000001	0.15164230511682403
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.15164230511682403
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.004042054000000001	0.15164230511682403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.004042054000000001	0.15164230511682403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.004037919000000001	0.15148717583560758
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.004037919000000001	0.15148717583560758
HALL-RIGGS SYNDROME	0.004037919000000001	0.15148717583560758
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.004037919000000001	0.15148717583560758
CHILDHOOD DISINTEGRATIVE DISORDER	0.004037919000000001	0.15148717583560758
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.004037919000000001	0.15148717583560758
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.004037919000000001	0.15148717583560758
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004037919000000001	0.15148717583560758
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004037919000000001	0.15148717583560758
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.004037919000000001	0.15148717583560758
ANGELMAN SYNDROME	0.004037919000000001	0.15148717583560758
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.004037919000000001	0.15148717583560758
ISOTRETINOIN-LIKE SYNDROME	0.00384615	0.1442927412214366
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00384615	0.1442927412214366
CHRONIC GRAFT VERSUS HOST DISEASE	0.00384615	0.1442927412214366
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00384615	0.1442927412214366
ISOLATED POLYCYSTIC LIVER DISEASE	0.00384615	0.1442927412214366
MÉNÉTRIER DISEASE	0.00384615	0.1442927412214366
EOSINOPHILIC ESOPHAGITIS	0.00384615	0.1442927412214366
STICKLER SYNDROME	0.00384615	0.1442927412214366
SANDIFER SYNDROME	0.00384615	0.1442927412214366
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00384615	0.1442927412214366
ESOPHAGEAL ATRESIA	0.00384615	0.1442927412214366
CARCINOMA OF ESOPHAGUS	0.00384615	0.1442927412214366
REYNOLDS SYNDROME	0.00384615	0.1442927412214366
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.00384615	0.1442927412214366
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00384615	0.1442927412214366
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00384615	0.1442927412214366
IDIOPATHIC PULMONARY FIBROSIS	0.00384615	0.1442927412214366
ADENOCARCINOMA OF THE ESOPHAGUS	0.00384615	0.1442927412214366
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00384615	0.1442927412214366
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00384615	0.1442927412214366
MEIER-GORLIN SYNDROME 2; MGORS2	0.00384615	0.1442927412214366
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00384615	0.1442927412214366
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00384615	0.1442927412214366
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00384615	0.1442927412214366
GASTROESOPHAGEAL REFLUX	0.00384615	0.1442927412214366
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00384615	0.1442927412214366
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.0037348510000000004	0.14011723121657338
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0037348510000000004	0.14011723121657338
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0037348510000000004	0.14011723121657338
LEIGH SYNDROME; LS	0.0037348510000000004	0.14011723121657338
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.0037348510000000004	0.14011723121657338
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0037348510000000004	0.14011723121657338
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0037348510000000004	0.14011723121657338
SPINOCEREBELLAR ATAXIA TYPE 13	0.0037348510000000004	0.14011723121657338
SALLA DISEASE	0.003734851	0.14011723121657335
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.003734851	0.14011723121657335
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.003734851	0.14011723121657335
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.003734851	0.14011723121657335
ATTRV30M AMYLOIDOSIS	0.00357143	0.133986304429228
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.133986304429228
FG SYNDROME 2; FGS2	0.00357143	0.133986304429228
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.133986304429228
PRUNE BELLY SYNDROME	0.00357143	0.133986304429228
ANAL SPHINCTER DYSPLASIA; ASDP	0.00357143	0.133986304429228
PARATHYROID CARCINOMA	0.00357143	0.133986304429228
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.133986304429228
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00357143	0.133986304429228
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.133986304429228
TOWNES-BROCKS SYNDROME	0.00357143	0.133986304429228
WAARDENBURG-SHAH SYNDROME	0.00357143	0.133986304429228
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.133986304429228
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00357143	0.133986304429228
TURCOT SYNDROME WITH POLYPOSIS	0.00357143	0.133986304429228
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.133986304429228
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.133986304429228
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.133986304429228
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.133986304429228
TYPHOID	0.00357143	0.133986304429228
PANHYPOPITUITARISM	0.00357143	0.133986304429228
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.133986304429228
ADIPOSIS DOLOROSA	0.00357143	0.133986304429228
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.133986304429228
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.133986304429228
PURE AUTONOMIC FAILURE	0.00357143	0.133986304429228
SHEEHAN SYNDROME	0.00357143	0.133986304429228
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.133986304429228
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.133986304429228
PSEUDOMYXOMA PERITONEI	0.00357143	0.133986304429228
PORPHYRIA VARIEGATA	0.00357143	0.133986304429228
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00357143	0.133986304429228
CAP POLYPOSIS	0.00357143	0.133986304429228
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.133986304429228
UROFACIAL SYNDROME 2	0.00357143	0.133986304429228
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.133986304429228
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.133986304429228
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.133986304429228
GRFOMA	0.00357143	0.133986304429228
SOMATOSTATINOMA	0.00357143	0.133986304429228
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.133986304429228
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.133986304429228
PPOMA	0.00357143	0.133986304429228
GLUCAGONOMA	0.00357143	0.133986304429228
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.133986304429228
UROFACIAL SYNDROME	0.00357143	0.133986304429228
VISCERAL MYOPATHY; VSCM	0.00357143	0.133986304429228
INHALATIONAL BOTULISM	0.00357143	0.133986304429228
IATROGENIC BOTULISM	0.00357143	0.133986304429228
HINMAN SYNDROME	0.00357143	0.133986304429228
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00357143	0.133986304429228
PUDENDAL NEURALGIA	0.00357143	0.133986304429228
MYXEDEMA	0.00357143	0.133986304429228
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.133986304429228
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.133986304429228
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.133986304429228
LIDDLE SYNDROME	0.00357143	0.133986304429228
MALT LYMPHOMA	0.00357143	0.133986304429228
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.133986304429228
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.133986304429228
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.133986304429228
HIRSCHSPRUNG DISEASE	0.00357143	0.133986304429228
OCHOA SYNDROME	0.00357143	0.133986304429228
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.133986304429228
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0034965000000000005	0.1311752192922151
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.1311752192922151
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.0034965000000000005	0.1311752192922151
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.1311752192922151
WARBURG MICRO SYNDROME 2; WARBM2	0.0034965000000000005	0.1311752192922151
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0034965000000000005	0.1311752192922151
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0034965000000000005	0.1311752192922151
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.0034965000000000005	0.1311752192922151
MUCOLIPIDOSIS TYPE IV	0.0034965000000000005	0.1311752192922151
MENTAL RETARDATION, X-LINKED 105; MRX105	0.0034965000000000005	0.1311752192922151
OPTICOCOCHLEODENTATE DEGENERATION	0.0034965000000000005	0.1311752192922151
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.003447111	0.1293223341483217
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.003447111	0.1293223341483217
RECOMBINANT CHROMOSOME 8 SYNDROME	0.003447111	0.1293223341483217
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.003447111	0.1293223341483217
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.003447111	0.1293223341483217
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.003447111	0.1293223341483217
MEND SYNDROME; MEND	0.003447111	0.1293223341483217
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.003447111	0.1293223341483217
CHROMOSOME 10Q26 DELETION SYNDROME	0.003447111	0.1293223341483217
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.003447111	0.1293223341483217
ADENYLOSUCCINASE DEFICIENCY	0.003447111	0.1293223341483217
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.003447111	0.1293223341483217
SIALURIA	0.003447111	0.1293223341483217
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.003447111	0.1293223341483217
JABERI-ELAHI SYNDROME; JABELS	0.003447111	0.1293223341483217
VICI SYNDROME; VICIS	0.003447111	0.1293223341483217
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.003447111	0.1293223341483217
C SYNDROME	0.003447111	0.1293223341483217
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.003447111	0.1293223341483217
BARAITSER-WINTER SYNDROME 1; BRWS1	0.003447111	0.1293223341483217
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.003447111	0.1293223341483217
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.003447111	0.1293223341483217
MEND SYNDROME	0.003447111	0.1293223341483217
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.003447111	0.1293223341483217
TEMTAMY SYNDROME; TEMTYS	0.003447111	0.1293223341483217
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.003447111	0.1293223341483217
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.003447111	0.1293223341483217
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.003447111	0.1293223341483217
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.003447111	0.1293223341483217
ZTTK SYNDROME; ZTTKS	0.003447111	0.1293223341483217
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.003447111	0.1293223341483217
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.003447111	0.1293223341483217
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.0034471109999999997	0.12932233414832167
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0034471109999999997	0.12932233414832167
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0031934320000000004	0.1198052746731809
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0031934320000000004	0.1198052746731809
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0031934320000000004	0.1198052746731809
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0031934320000000004	0.1198052746731809
PEROXISOME BIOGENESIS DISORDER 6B	0.0031934320000000004	0.1198052746731809
MARINESCO-SJOGREN SYNDROME; MSS	0.0031934320000000004	0.1198052746731809
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0031934320000000004	0.1198052746731809
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.0031934320000000004	0.1198052746731809
SPINOCEREBELLAR ATAXIA 5; SCA5	0.0031934320000000004	0.1198052746731809
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.003193432	0.11980527467318088
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.003193432	0.11980527467318088
CEREBELLAR ATAXIA, CAYMAN TYPE	0.003193432	0.11980527467318088
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.003193432	0.11980527467318088
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.003193432	0.11980527467318088
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.003193432	0.11980527467318088
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.0031892970000000002	0.11965014539196445
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.0031892970000000002	0.11965014539196445
EPISODIC ATAXIA, TYPE 6	0.0031892970000000002	0.11965014539196445
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.0031892970000000002	0.11965014539196445
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0031892970000000002	0.11965014539196445
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0031892970000000002	0.11965014539196445
HUNTINGTON DISEASE-LIKE 1	0.0031892970000000002	0.11965014539196445
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0030849399999999996	0.11573507250202371
JOUBERT SYNDROME 14	0.0029056919999999997	0.1090103776049292
NOONAN SYNDROME 11; NS11	0.0029056919999999997	0.1090103776049292
OROFACIODIGITAL SYNDROME VI	0.0029056919999999997	0.1090103776049292
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0029056919999999997	0.1090103776049292
NOONAN SYNDROME 6; NS6	0.0029056919999999997	0.1090103776049292
OGDEN SYNDROME	0.0029056919999999997	0.1090103776049292
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0029056919999999997	0.1090103776049292
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0029056919999999997	0.1090103776049292
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0029056919999999997	0.1090103776049292
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0029056919999999997	0.1090103776049292
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0029056919999999997	0.1090103776049292
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0029056919999999997	0.1090103776049292
LAMB-SHAFFER SYNDROME	0.0029056919999999997	0.1090103776049292
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0029056919999999997	0.1090103776049292
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0029056919999999997	0.1090103776049292
CHROMOSOME 16Q22 DELETION SYNDROME	0.0029056919999999997	0.1090103776049292
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0029056919999999997	0.1090103776049292
GOLDBERG-SHPRINTZEN SYNDROME	0.0029056919999999997	0.1090103776049292
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0029056919999999997	0.1090103776049292
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0029056919999999997	0.1090103776049292
LARSEN-LIKE SYNDROME	0.0029056919999999997	0.1090103776049292
XIA-GIBBS SYNDROME	0.0029056919999999997	0.1090103776049292
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0029056919999999997	0.1090103776049292
DIAPHANOSPONDYLODYSOSTOSIS	0.0029056919999999997	0.1090103776049292
RITSCHER-SCHINZEL SYNDROME 1	0.0029056919999999997	0.1090103776049292
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0029056919999999997	0.1090103776049292
PEROXISOME BIOGENESIS DISORDER 10B	0.0029056919999999997	0.1090103776049292
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0029056919999999997	0.1090103776049292
MEVALONIC ACIDURIA; MEVA	0.0029056919999999997	0.1090103776049292
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0029056919999999997	0.1090103776049292
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.002901557	0.10885524832371277
MARDEN-WALKER SYNDROME	0.002901557	0.10885524832371277
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.002901557	0.10885524832371277
LISSENCEPHALY, X-LINKED, 2	0.002901557	0.10885524832371277
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.002901557	0.10885524832371277
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002901557	0.10885524832371277
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002901557	0.10885524832371277
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002901557	0.10885524832371277
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002901557	0.10885524832371277
GLUTAMINE DEFICIENCY, CONGENITAL	0.002901557	0.10885524832371277
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.002901557	0.10885524832371277
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.002901557	0.10885524832371277
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.002901557	0.10885524832371277
NON-DISTAL MONOSOMY 20Q	0.002901557	0.10885524832371277
PYRUVATE DEHYDROGENASE DEFICIENCY	0.002773313	0.1040440271531391
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.002773313	0.1040440271531391
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.002773313	0.1040440271531391
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.002773313	0.1040440271531391
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.002773313	0.1040440271531391
WYBURN-MASON SYNDROME	0.002773313	0.1040440271531391
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.002773313	0.1040440271531391
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.002773313	0.1040440271531391
HSD10 DISEASE	0.002773313	0.1040440271531391
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.002773313	0.1040440271531391
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.002773313	0.1040440271531391
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.002773313	0.1040440271531391
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.002647878	0.09933818884857197
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.002647878	0.09933818884857197
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.002647878	0.09933818884857197
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.002647878	0.09933818884857197
LESCH-NYHAN SYNDROME; LNS	0.002647878	0.09933818884857197
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.002647878	0.09933818884857197
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.002647878	0.09933818884857197
SPINOCEREBELLAR ATAXIA 13	0.002647878	0.09933818884857197
SYDENHAM CHOREA	0.002647878	0.09933818884857197
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.002647878	0.09933818884857197
SUSAC SYNDROME	0.002647878	0.09933818884857197
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.002647878	0.09933818884857197
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.002647878	0.09933818884857197
SPINOCEREBELLAR ATAXIA TYPE 1	0.002647878	0.09933818884857197
SPINOCEREBELLAR ATAXIA TYPE 2	0.002647878	0.09933818884857197
SPINOCEREBELLAR ATAXIA TYPE 14	0.002647878	0.09933818884857197
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0024855729999999996	0.0932491300848874
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0024855729999999996	0.0932491300848874
19P13.13 MICRODELETION SYNDROME	0.0024855729999999996	0.0932491300848874
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.0024855729999999996	0.0932491300848874
DISTAL MONOSOMY 1Q	0.0024855729999999996	0.0932491300848874
WALKER-WARBURG SYNDROME	0.0024855729999999996	0.0932491300848874
PFEIFFER SYNDROME TYPE 2	0.0024855729999999996	0.0932491300848874
GLYCEROL KINASE DEFICIENCY; GKD	0.0024855729999999996	0.0932491300848874
MYHRE SYNDROME	0.0024855729999999996	0.0932491300848874
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0024855729999999996	0.0932491300848874
GLASS SYNDROME	0.0024855729999999996	0.0932491300848874
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0024855729999999996	0.0932491300848874
10Q22.3Q23.3 MICRODELETION SYNDROME	0.0024855729999999996	0.0932491300848874
3Q29 MICRODUPLICATION SYNDROME	0.0024855729999999996	0.0932491300848874
15Q14 MICRODELETION SYNDROME	0.0024855729999999996	0.0932491300848874
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0024855729999999996	0.0932491300848874
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.002360138	0.08854329178032028
PSEUDOTRISOMY 13 SYNDROME	0.002360138	0.08854329178032028
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.002360138	0.08854329178032028
SIFRIM-HITZ-WEISS SYNDROME	0.002360138	0.08854329178032028
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.002360138	0.08854329178032028
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.002360138	0.08854329178032028
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.002360138	0.08854329178032028
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.002360138	0.08854329178032028
CAMPOMELIC DYSPLASIA	0.002360138	0.08854329178032028
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.002360138	0.08854329178032028
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.002360138	0.08854329178032028
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.002360138	0.08854329178032028
COFFIN-SIRIS SYNDROME 10; CSS10	0.002360138	0.08854329178032028
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.002360138	0.08854329178032028
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.002360138	0.08854329178032028
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.002360138	0.08854329178032028
JUVENILE POLYPOSIS OF INFANCY	0.002360138	0.08854329178032028
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.002360138	0.08854329178032028
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.002360138	0.08854329178032028
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.002360138	0.08854329178032028
JACOBSEN SYNDROME	0.002360138	0.08854329178032028
VERVERI-BRADY SYNDROME; VERBRAS	0.002360138	0.08854329178032028
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.002360138	0.08854329178032028
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.002360138	0.08854329178032028
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.002360138	0.08854329178032028
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.002360138	0.08854329178032028
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.002360138	0.08854329178032028
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.002231894	0.08373207060974662
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.002231894	0.08373207060974662
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.002231894	0.08373207060974662
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.002231894	0.08373207060974662
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.002231894	0.08373207060974662
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.002231894	0.08373207060974662
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.002231894	0.08373207060974662
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.002231894	0.08373207060974662
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.002231894	0.08373207060974662
SPINOCEREBELLAR ATAXIA TYPE 7	0.002231894	0.08373207060974662
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.002231894	0.08373207060974662
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.002231894	0.08373207060974662
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.002231894	0.08373207060974662
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.002231894	0.08373207060974662
PELLAGRA-LIKE SYNDROME	0.002231894	0.08373207060974662
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.002231894	0.08373207060974662
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.002231894	0.08373207060974662
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.002231894	0.08373207060974662
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.002231894	0.08373207060974662
COCKAYNE SYNDROME A; CSA	0.002227759	0.08357694132853018
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.002227759	0.08357694132853018
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.002227759	0.08357694132853018
GLUTATHIONE SYNTHETASE DEFICIENCY	0.002227759	0.08357694132853018
CEREBELLOPARENCHYMAL DISORDER II	0.002227759	0.08357694132853018
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.002227759	0.08357694132853018
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.002227759	0.08357694132853018
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.002227759	0.08357694132853018
PARTINGTON SYNDROME	0.002227759	0.08357694132853018
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.002227759	0.08357694132853018
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.002227759	0.08357694132853018
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002227759	0.08357694132853018
KALLMANN SYNDROME	0.002227759	0.08357694132853018
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.002227759	0.08357694132853018
LISSENCEPHALY, X-LINKED, 1; LISX1	0.002227759	0.08357694132853018
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.002227759	0.08357694132853018
ATAXIA-TELANGIECTASIA	0.002227759	0.08357694132853018
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.002227759	0.08357694132853018
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.002227759	0.08357694132853018
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002227759	0.08357694132853018
FAMILIAL THROMBOCYTOSIS	0.002227759	0.08357694132853018
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.002227759	0.08357694132853018
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.002227759	0.08357694132853018
SUPRABULBAR PARESIS, CONGENITAL	0.002227759	0.08357694132853018
SNEDDON SYNDROME	0.002227759	0.08357694132853018
SJÖGREN-LARSSON SYNDROME	0.002227759	0.08357694132853018
OCULODENTODIGITAL DYSPLASIA; ODDD	0.002227759	0.08357694132853018
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.002227759	0.08357694132853018
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.002227759	0.08357694132853018
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.002227759	0.08357694132853018
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.002227759	0.08357694132853018
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.002227759	0.08357694132853018
MYASTHENIA GRAVIS	0.002227759	0.08357694132853018
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.002227759	0.08357694132853018
OCULOCEREBROCUTANEOUS SYNDROME	0.002227759	0.08357694132853018
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.002227759	0.08357694132853018
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.002227759	0.08357694132853018
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.002227759	0.08357694132853018
INFANTILE LIVER FAILURE SYNDROME 1	0.0020485110000000003	0.07685224643143568
CHROMOSOME 5Q12 DELETION SYNDROME	0.0020485110000000003	0.07685224643143568
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0020485110000000003	0.07685224643143568
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0020485110000000003	0.07685224643143568
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
XQ25 MICRODUPLICATION SYNDROME	0.0020485110000000003	0.07685224643143568
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0020485110000000003	0.07685224643143568
JOUBERT SYNDROME 30; JBTS30	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0020485110000000003	0.07685224643143568
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0020485110000000003	0.07685224643143568
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0020485110000000003	0.07685224643143568
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0020485110000000003	0.07685224643143568
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0020485110000000003	0.07685224643143568
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0020485110000000003	0.07685224643143568
ELEJALDE DISEASE	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0020485110000000003	0.07685224643143568
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.0020485110000000003	0.07685224643143568
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0020485110000000003	0.07685224643143568
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0020485110000000003	0.07685224643143568
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0020485110000000003	0.07685224643143568
KETOADIPICACIDURIA	0.0020485110000000003	0.07685224643143568
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0020485110000000003	0.07685224643143568
ADAMS-OLIVER SYNDROME 1; AOS1	0.0020485110000000003	0.07685224643143568
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.0020485110000000003	0.07685224643143568
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0020485110000000003	0.07685224643143568
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0020485110000000003	0.07685224643143568
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.0020485110000000003	0.07685224643143568
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0020485110000000003	0.07685224643143568
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.0020485110000000003	0.07685224643143568
PYRUVATE CARBOXYLASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0020485110000000003	0.07685224643143568
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0020485110000000003	0.07685224643143568
GRISCELLI SYNDROME, TYPE 1	0.0020485110000000003	0.07685224643143568
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0020485110000000003	0.07685224643143568
METHYLMALONIC ACIDURIA, CBLA TYPE	0.0020485110000000003	0.07685224643143568
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.0020485110000000003	0.07685224643143568
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0020485110000000003	0.07685224643143568
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0020485110000000003	0.07685224643143568
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.0020485110000000003	0.07685224643143568
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0020485110000000003	0.07685224643143568
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.0020485110000000003	0.07685224643143568
PEHO SYNDROME; PEHO	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0020485110000000003	0.07685224643143568
SCHINDLER DISEASE, TYPE I	0.0020485110000000003	0.07685224643143568
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0020485110000000003	0.07685224643143568
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0020485110000000003	0.07685224643143568
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0020485110000000003	0.07685224643143568
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0020485110000000003	0.07685224643143568
HELSMOORTEL-VAN DER AA SYNDROME	0.0020485110000000003	0.07685224643143568
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0020485110000000003	0.07685224643143568
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0020485110000000003	0.07685224643143568
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0020485110000000003	0.07685224643143568
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0020485110000000003	0.07685224643143568
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0020485110000000003	0.07685224643143568
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.0020485110000000003	0.07685224643143568
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.0020485110000000003	0.07685224643143568
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0020485110000000003	0.07685224643143568
GRISCELLI SYNDROME TYPE 1	0.0020485110000000003	0.07685224643143568
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.0020485110000000003	0.07685224643143568
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0020485110000000003	0.07685224643143568
FOLATE MALABSORPTION, HEREDITARY	0.0020485110000000003	0.07685224643143568
SHUKLA-VERNON SYNDROME; SHUVER	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0020485110000000003	0.07685224643143568
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0020485110000000003	0.07685224643143568
XQ25 DUPLICATION SYNDROME	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0020485110000000003	0.07685224643143568
STT3A-CDG	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0020485110000000003	0.07685224643143568
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0020485110000000003	0.07685224643143568
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.0020485110000000003	0.07685224643143568
HOLOPROSENCEPHALY 1; HPE1	0.0020485110000000003	0.07685224643143568
TIMOTHY SYNDROME; TS	0.0020485110000000003	0.07685224643143568
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0020485110000000003	0.07685224643143568
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0020485110000000003	0.07685224643143568
PRADER-WILLI SYNDROME; PWS	0.0020485110000000003	0.07685224643143568
PETTIGREW SYNDROME	0.0020485110000000003	0.07685224643143568
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0020485110000000003	0.07685224643143568
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.0020485110000000003	0.07685224643143568
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0020485110000000003	0.07685224643143568
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0020485110000000003	0.07685224643143568
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0020485110000000003	0.07685224643143568
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0020485110000000003	0.07685224643143568
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0020485110000000003	0.07685224643143568
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.0020485110000000003	0.07685224643143568
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0020485110000000003	0.07685224643143568
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, X-LINKED 90	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0020485110000000003	0.07685224643143568
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.0020485110000000003	0.07685224643143568
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.0020485110000000003	0.07685224643143568
OROFACIODIGITAL SYNDROME TYPE 6	0.0020485110000000003	0.07685224643143568
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0020485110000000003	0.07685224643143568
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0020485110000000003	0.07685224643143568
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0020485110000000003	0.07685224643143568
STT3B-CDG	0.0020485110000000003	0.07685224643143568
MARDEN-WALKER SYNDROME	0.0019441539999999998	0.07293717354149494
ALAZAMI SYNDROME; ALAZS	0.0019441539999999998	0.07293717354149494
CREE MENTAL RETARDATION SYNDROME	0.0019441539999999998	0.07293717354149494
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.0019441539999999998	0.07293717354149494
CHAR SYNDROME	0.0019441539999999998	0.07293717354149494
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.0019441539999999998	0.07293717354149494
ELSAHY-WATERS SYNDROME; ESWS	0.0019441539999999998	0.07293717354149494
FRONTOOCULAR SYNDROME	0.0019441539999999998	0.07293717354149494
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.0019441539999999998	0.07293717354149494
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0019441539999999998	0.07293717354149494
HARTSFIELD SYNDROME; HRTFDS	0.0019441539999999998	0.07293717354149494
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0019441539999999998	0.07293717354149494
8Q22.1 MICRODELETION SYNDROME	0.0019441539999999998	0.07293717354149494
TEMTAMY SYNDROME	0.0019441539999999998	0.07293717354149494
DIAMOND-BLACKFAN ANEMIA 5	0.0019441539999999998	0.07293717354149494
6Q16 MICRODELETION SYNDROME	0.0019441539999999998	0.07293717354149494
DISTAL TRISOMY 6P	0.0019441539999999998	0.07293717354149494
NOONAN SYNDROME 5; NS5	0.0019441539999999998	0.07293717354149494
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0019441539999999998	0.07293717354149494
OPITZ G/BBB SYNDROME	0.0019441539999999998	0.07293717354149494
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.0019441539999999998	0.07293717354149494
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0019441539999999998	0.07293717354149494
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.0019441539999999998	0.07293717354149494
CEREBELLOFACIODENTAL SYNDROME	0.0019441539999999998	0.07293717354149494
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0019441539999999998	0.07293717354149494
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0019441539999999998	0.07293717354149494
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.0019441539999999998	0.07293717354149494
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0019441539999999998	0.07293717354149494
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.0019441539999999998	0.07293717354149494
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.0019441539999999998	0.07293717354149494
EAR-PATELLA-SHORT STATURE SYNDROME	0.0019441539999999998	0.07293717354149494
OTOPALATODIGITAL SYNDROME TYPE 2	0.0019441539999999998	0.07293717354149494
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0019441539999999998	0.07293717354149494
TRISOMY 12P	0.0019441539999999998	0.07293717354149494
OGDEN SYNDROME; OGDNS	0.0019441539999999998	0.07293717354149494
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.0019441539999999998	0.07293717354149494
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0019441539999999998	0.07293717354149494
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0019441539999999998	0.07293717354149494
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0019441539999999998	0.07293717354149494
TRISOMY 17P	0.0019441539999999998	0.07293717354149494
FORSYTHE-WAKELING SYNDROME; FWS	0.0019441539999999998	0.07293717354149494
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.0019441539999999998	0.07293717354149494
17P13.3 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.07293717354149494
ZECHI-CEIDE SYNDROME	0.0019441539999999998	0.07293717354149494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0019441539999999998	0.07293717354149494
CHROMOSOME 15Q14 DELETION SYNDROME	0.0019441539999999998	0.07293717354149494
NOONAN SYNDROME 3; NS3	0.0019441539999999998	0.07293717354149494
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0019441539999999998	0.07293717354149494
PHENOBARBITAL EMBRYOPATHY	0.0019441539999999998	0.07293717354149494
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0019441539999999998	0.07293717354149494
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0019441539999999998	0.07293717354149494
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0019441539999999998	0.07293717354149494
DISTAL MONOSOMY 6P	0.0019441539999999998	0.07293717354149494
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0019400189999999999	0.0727820442602785
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.0019400189999999999	0.0727820442602785
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0019400189999999999	0.0727820442602785
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.0019400189999999999	0.0727820442602785
COG5-CDG	0.0019400189999999999	0.0727820442602785
RING CHROMOSOME 10 SYNDROME	0.0019400189999999999	0.0727820442602785
4Q21 MICRODELETION SYNDROME	0.0019400189999999999	0.0727820442602785
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0019400189999999999	0.0727820442602785
THANATOPHORIC DYSPLASIA	0.0019400189999999999	0.0727820442602785
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.0019400189999999999	0.0727820442602785
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.0019400189999999999	0.0727820442602785
AICA-RIBOSIDURIA	0.0019400189999999999	0.0727820442602785
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0019400189999999999	0.0727820442602785
PFEIFFER SYNDROME TYPE 3	0.0019400189999999999	0.0727820442602785
AYME-GRIPP SYNDROME; AYGRP	0.0019400189999999999	0.0727820442602785
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0019400189999999999	0.0727820442602785
CONO-SPONDYLAR DYSPLASIA	0.0019400189999999999	0.0727820442602785
OROFACIODIGITAL SYNDROME I; OFD1	0.0019400189999999999	0.0727820442602785
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.0019400189999999999	0.0727820442602785
HENNEKAM SYNDROME	0.0019400189999999999	0.0727820442602785
20P13 MICRODELETION SYNDROME	0.0019400189999999999	0.0727820442602785
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.0019400189999999999	0.0727820442602785
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.0019400189999999999	0.0727820442602785
ACROCARDIOFACIAL SYNDROME	0.0019400189999999999	0.0727820442602785
47,XYY SYNDROME	0.0019400189999999999	0.0727820442602785
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0019400189999999999	0.0727820442602785
EDINBURGH MALFORMATION SYNDROME	0.0019400189999999999	0.0727820442602785
SPINOCEREBELLAR ATAXIA TYPE 6	0.00168634	0.0632649847851377
WOODHOUSE-SAKATI SYNDROME	0.00168634	0.0632649847851377
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00168634	0.0632649847851377
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.00168634	0.0632649847851377
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00168634	0.0632649847851377
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00168634	0.0632649847851377
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00168634	0.0632649847851377
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00168634	0.0632649847851377
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00168634	0.0632649847851377
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.00168634	0.0632649847851377
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00168634	0.0632649847851377
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 3	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 42	0.00168634	0.0632649847851377
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.00168634	0.0632649847851377
TREMOR, HEREDITARY ESSENTIAL, 1	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00168634	0.0632649847851377
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.00168634	0.0632649847851377
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.00168634	0.0632649847851377
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00168634	0.0632649847851377
EPISODIC ATAXIA, TYPE 5	0.00168634	0.0632649847851377
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00168634	0.0632649847851377
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 42	0.00168634	0.0632649847851377
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00168634	0.0632649847851377
WILSON DISEASE	0.00168634	0.0632649847851377
ERDHEIM-CHESTER DISEASE	0.00168634	0.0632649847851377
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00168634	0.0632649847851377
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00168634	0.0632649847851377
PURE MITOCHONDRIAL MYOPATHY	0.00168634	0.0632649847851377
EPISODIC ATAXIA TYPE 5	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 30	0.00168634	0.0632649847851377
UROCANIC ACIDURIA	0.00168634	0.0632649847851377
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00168634	0.0632649847851377
EPISODIC ATAXIA TYPE 7	0.00168634	0.0632649847851377
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00168634	0.0632649847851377
DISTAL MYOTILINOPATHY	0.00168634	0.0632649847851377
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00168634	0.0632649847851377
SYRINGOMYELIA, ISOLATED	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00168634	0.0632649847851377
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00168634	0.0632649847851377
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00168634	0.0632649847851377
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 12	0.00168634	0.0632649847851377
MYOPATHY AND DIABETES MELLITUS	0.00168634	0.0632649847851377
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00168634	0.0632649847851377
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00168634	0.0632649847851377
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00168634	0.0632649847851377
MACHADO-JOSEPH DISEASE; MJD	0.00168634	0.0632649847851377
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00168634	0.0632649847851377
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00168634	0.0632649847851377
ALLAN-HERNDON-DUDLEY SYNDROME	0.00168634	0.0632649847851377
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00168634	0.0632649847851377
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 4	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 14	0.00168634	0.0632649847851377
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.00168634	0.0632649847851377
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00168634	0.0632649847851377
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00168634	0.0632649847851377
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00168634	0.0632649847851377
HUNTINGTON DISEASE-LIKE 2	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA-PRECOCIOUS PUBERTY SYNDROME	0.00168634	0.0632649847851377
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00168634	0.0632649847851377
OPTIC ATROPHY 2	0.00168634	0.0632649847851377
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.00168634	0.0632649847851377
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.00168634	0.0632649847851377
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00168634	0.0632649847851377
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00168634	0.0632649847851377
INTESTINAL BOTULISM	0.00168634	0.0632649847851377
CHIARI MALFORMATION TYPE I	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 31	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00168634	0.0632649847851377
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.00168634	0.0632649847851377
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00168634	0.0632649847851377
LEBER OPTIC ATROPHY AND DYSTONIA	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA TYPE 2	0.00168634	0.0632649847851377
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00168634	0.0632649847851377
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00168634	0.0632649847851377
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION	0.00168634	0.0632649847851377
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.00168634	0.0632649847851377
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00168634	0.0632649847851377
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00168634	0.0632649847851377
EPISODIC ATAXIA, TYPE 7; EA7	0.00168634	0.0632649847851377
EPISODIC ATAXIA TYPE 1	0.00168634	0.0632649847851377
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00168634	0.0632649847851377
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00168634	0.0632649847851377
PRIMARY DYSTONIA, DYT2 TYPE	0.00168634	0.0632649847851377
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00168634	0.0632649847851377
ACHONDROPLASIA	0.00168634	0.0632649847851377
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00168634	0.0632649847851377
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 11	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 38	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 36	0.00168634	0.0632649847851377
MACHADO-JOSEPH DISEASE TYPE 1	0.00168634	0.0632649847851377
MACHADO-JOSEPH DISEASE TYPE 2	0.00168634	0.0632649847851377
MACHADO-JOSEPH DISEASE TYPE 3	0.00168634	0.0632649847851377
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 30; SCA30	0.00168634	0.0632649847851377
POSTPOLIOMYELITIS SYNDROME	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00168634	0.0632649847851377
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00168634	0.0632649847851377
PERRY SYNDROME	0.00168634	0.0632649847851377
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 18	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00168634	0.0632649847851377
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00168634	0.0632649847851377
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00168634	0.0632649847851377
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA TYPE 7	0.00168634	0.0632649847851377
POSTORGASMIC ILLNESS SYNDROME	0.00168634	0.0632649847851377
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00168634	0.0632649847851377
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.00168634	0.0632649847851377
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00168634	0.0632649847851377
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00168634	0.0632649847851377
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00168634	0.0632649847851377
UNVERRICHT-LUNDBORG DISEASE	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00168634	0.0632649847851377
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00168634	0.0632649847851377
SANDHOFF DISEASE	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00168634	0.0632649847851377
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00168634	0.0632649847851377
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00168634	0.0632649847851377
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 43	0.00168634	0.0632649847851377
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 31	0.00168634	0.0632649847851377
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00168634	0.0632649847851377
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00168634	0.0632649847851377
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00168634	0.0632649847851377
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00168634	0.0632649847851377
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00168634	0.0632649847851377
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00168634	0.0632649847851377
HUNTINGTON DISEASE-LIKE 1	0.00168634	0.0632649847851377
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.00168634	0.0632649847851377
FAMILIAL PAROXYSMAL ATAXIA	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 28	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 23	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 40; SCA40	0.00168634	0.0632649847851377
EPISODIC ATAXIA, TYPE 8	0.00168634	0.0632649847851377
FACIAL ONSET SENSORY AND MOTOR NEURONOPATHY	0.00168634	0.0632649847851377
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00168634	0.0632649847851377
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00168634	0.0632649847851377
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.00168634	0.0632649847851377
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00168634	0.0632649847851377
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00168634	0.0632649847851377
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.00168634	0.0632649847851377
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00168634	0.0632649847851377
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.00168634	0.0632649847851377
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00168634	0.0632649847851377
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.00168634	0.0632649847851377
MYASTHENIA GRAVIS; MG	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.00168634	0.0632649847851377
EPISODIC ATAXIA, TYPE 2	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA TYPE 26	0.00168634	0.0632649847851377
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00168634	0.0632649847851377
ATAXIA WITH VITAMIN E DEFICIENCY	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00168634	0.0632649847851377
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE	0.00168634	0.0632649847851377
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00168634	0.0632649847851377
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00168634	0.0632649847851377
ACERULOPLASMINEMIA	0.00168634	0.0632649847851377
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 26	0.00168634	0.0632649847851377
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00168634	0.0632649847851377
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.00168634	0.0632649847851377
WOODHOUSE-SAKATI SYNDROME	0.00168634	0.0632649847851377
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00168634	0.0632649847851377
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00168634	0.0632649847851377
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.001507092	0.05654028988804318
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001507092	0.05654028988804318
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.001507092	0.05654028988804318
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001507092	0.05654028988804318
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001507092	0.05654028988804318
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.001507092	0.05654028988804318
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001507092	0.05654028988804318
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.001507092	0.05654028988804318
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001507092	0.05654028988804318
JOUBERT SYNDROME 26	0.001507092	0.05654028988804318
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001507092	0.05654028988804318
MICROPHTHALMIA, SYNDROMIC 3	0.001507092	0.05654028988804318
NAVAJO NEUROHEPATOPATHY	0.001507092	0.05654028988804318
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.001507092	0.05654028988804318
HYPOTONIA-CYSTINURIA SYNDROME	0.001507092	0.05654028988804318
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.001507092	0.05654028988804318
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001507092	0.05654028988804318
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.001507092	0.05654028988804318
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001507092	0.05654028988804318
GALACTOSE EPIMERASE DEFICIENCY	0.001507092	0.05654028988804318
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001507092	0.05654028988804318
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.001507092	0.05654028988804318
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001507092	0.05654028988804318
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.001507092	0.05654028988804318
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001507092	0.05654028988804318
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.001507092	0.05654028988804318
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001507092	0.05654028988804318
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.001507092	0.05654028988804318
CHROMOSOME 4Q21 DELETION SYNDROME	0.001507092	0.05654028988804318
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001507092	0.05654028988804318
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001507092	0.05654028988804318
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.001507092	0.05654028988804318
ARIMA SYNDROME	0.001507092	0.05654028988804318
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001507092	0.05654028988804318
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.001507092	0.05654028988804318
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001507092	0.05654028988804318
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.001507092	0.05654028988804318
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.001507092	0.05654028988804318
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.001507092	0.05654028988804318
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.001507092	0.05654028988804318
RIGID SPINE SYNDROME	0.001507092	0.05654028988804318
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001507092	0.05654028988804318
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.001507092	0.05654028988804318
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001507092	0.05654028988804318
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.001507092	0.05654028988804318
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001507092	0.05654028988804318
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001507092	0.05654028988804318
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001507092	0.05654028988804318
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.001507092	0.05654028988804318
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.001507092	0.05654028988804318
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.001507092	0.05654028988804318
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.001507092	0.05654028988804318
AURICULOCONDYLAR SYNDROME	0.001507092	0.05654028988804318
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001507092	0.05654028988804318
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001507092	0.05654028988804318
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.001507092	0.05654028988804318
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001507092	0.05654028988804318
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001507092	0.05654028988804318
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.001507092	0.05654028988804318
GENITOPATELLAR SYNDROME; GTPTS	0.001507092	0.05654028988804318
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001507092	0.05654028988804318
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.001507092	0.05654028988804318
MENTAL RETARDATION, X-LINKED 99	0.001507092	0.05654028988804318
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001507092	0.05654028988804318
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.001502957	0.05638516060682674
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.001502957	0.05638516060682674
NEURAMINIDASE DEFICIENCY	0.001502957	0.05638516060682674
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.001502957	0.05638516060682674
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.001502957	0.05638516060682674
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.001502957	0.05638516060682674
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.001502957	0.05638516060682674
CYCLIC VOMITING SYNDROME	0.001502957	0.05638516060682674
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001502957	0.05638516060682674
XYLOSIDASE DEFICIENCY	0.001502957	0.05638516060682674
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.001502957	0.05638516060682674
MENKES DISEASE	0.001502957	0.05638516060682674
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.001502957	0.05638516060682674
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001502957	0.05638516060682674
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.001502957	0.05638516060682674
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.001502957	0.05638516060682674
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.001502957	0.05638516060682674
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.001502957	0.05638516060682674
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.001502957	0.05638516060682674
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.001502957	0.05638516060682674
SUDDEN CARDIAC FAILURE, INFANTILE	0.001502957	0.05638516060682674
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.001502957	0.05638516060682674
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.001502957	0.05638516060682674
PSEUDO-TORCH SYNDROME 2	0.001502957	0.05638516060682674
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001502957	0.05638516060682674
MAPLE SYRUP URINE DISEASE; MSUD	0.001502957	0.05638516060682674
GLYCINE ENCEPHALOPATHY; GCE	0.001502957	0.05638516060682674
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001502957	0.05638516060682674
TAY-SACHS DISEASE; TSD	0.001502957	0.05638516060682674
ASPARTYLGLUCOSAMINURIA; AGU	0.001502957	0.05638516060682674
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.001502957	0.05638516060682674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.001502957	0.05638516060682674
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.001502957	0.05638516060682674
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.001502957	0.05638516060682674
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.001502957	0.05638516060682674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.001502957	0.05638516060682674
LISSENCEPHALY 3; LIS3	0.001502957	0.05638516060682674
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.001502957	0.05638516060682674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.001502957	0.05638516060682674
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.001502957	0.05638516060682674
ETHYLMALONIC ENCEPHALOPATHY	0.001502957	0.05638516060682674
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.001502957	0.05638516060682674
LISSENCEPHALY 5; LIS5	0.001502957	0.05638516060682674
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001502957	0.05638516060682674
OHDO SYNDROME	0.001502957	0.05638516060682674
LATHOSTEROLOSIS	0.001502957	0.05638516060682674
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.001502957	0.05638516060682674
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.001502957	0.05638516060682674
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.001502957	0.05638516060682674
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.001502957	0.05638516060682674
MENTAL RETARDATION, X-LINKED 102	0.001502957	0.05638516060682674
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.001502957	0.05638516060682674
GLUTARIC ACIDEMIA I; GA1	0.001502957	0.05638516060682674
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001502957	0.05638516060682674
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.001502957	0.05638516060682674
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.001502957	0.05638516060682674
VISCERAL STEATOSIS, CONGENITAL	0.001502957	0.05638516060682674
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.001502957	0.05638516060682674
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001502957	0.05638516060682674
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.001502957	0.05638516060682674
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.001502957	0.05638516060682674
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.0013985999999999998	0.05247008771688602
PELVISCAPULAR DYSPLASIA	0.0013985999999999998	0.05247008771688602
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0013985999999999998	0.05247008771688602
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.0013985999999999998	0.05247008771688602
TRISOMY 18-LIKE SYNDROME	0.0013985999999999998	0.05247008771688602
OROFACIODIGITAL SYNDROME XVII	0.0013985999999999998	0.05247008771688602
CEREBROOCULONASAL SYNDROME	0.0013985999999999998	0.05247008771688602
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0013985999999999998	0.05247008771688602
CAMPOMELIC DYSPLASIA	0.0013985999999999998	0.05247008771688602
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.0013985999999999998	0.05247008771688602
TETRAAMELIA SYNDROME 2; TETAMS2	0.0013985999999999998	0.05247008771688602
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.0013985999999999998	0.05247008771688602
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0013985999999999998	0.05247008771688602
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.0013985999999999998	0.05247008771688602
ACRORENAL-MANDIBULAR SYNDROME	0.0013985999999999998	0.05247008771688602
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.0013985999999999998	0.05247008771688602
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.0013985999999999998	0.05247008771688602
TRANSALDOLASE DEFICIENCY	0.0013985999999999998	0.05247008771688602
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0013985999999999998	0.05247008771688602
PFEIFFER SYNDROME TYPE 1	0.0013985999999999998	0.05247008771688602
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.0013985999999999998	0.05247008771688602
JUVENILE POLYPOSIS SYNDROME	0.0013985999999999998	0.05247008771688602
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.0013985999999999998	0.05247008771688602
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.0013985999999999998	0.05247008771688602
SPONDYLOOCULAR SYNDROME; SOS	0.0013985999999999998	0.05247008771688602
PYKNOACHONDROGENESIS	0.0013985999999999998	0.05247008771688602
HAMAMY SYNDROME; HMMS	0.0013985999999999998	0.05247008771688602
ULBRIGHT-HODES SYNDROME	0.0013985999999999998	0.05247008771688602
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.0013985999999999998	0.05247008771688602
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.0013985999999999998	0.05247008771688602
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.0013985999999999998	0.05247008771688602
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.0013985999999999998	0.05247008771688602
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.0013985999999999998	0.05247008771688602
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0013985999999999998	0.05247008771688602
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.0013985999999999998	0.05247008771688602
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0013985999999999998	0.05247008771688602
OROFACIODIGITAL SYNDROME III	0.0013985999999999998	0.05247008771688602
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.0013985999999999998	0.05247008771688602
LETHAL KNIEST-LIKE DYSPLASIA	0.0013985999999999998	0.05247008771688602
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.0013985999999999998	0.05247008771688602
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.0013985999999999998	0.05247008771688602
STROMME SYNDROME; STROMS	0.0013985999999999998	0.05247008771688602
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0013985999999999998	0.05247008771688602
NOONAN SYNDROME 8; NS8	0.0013985999999999998	0.05247008771688602
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0013985999999999998	0.05247008771688602
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.0013985999999999998	0.05247008771688602
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.0013985999999999998	0.05247008771688602
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.0013985999999999998	0.05247008771688602
BARTSOCAS-PAPAS SYNDROME; BPS	0.0013985999999999998	0.05247008771688602
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0013985999999999998	0.05247008771688602
MATTHEW-WOOD SYNDROME	0.0013985999999999998	0.05247008771688602
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.0013985999999999998	0.05247008771688602
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0013985999999999998	0.05247008771688602
ROBERTS SYNDROME; RBS	0.0013985999999999998	0.05247008771688602
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.0013985999999999998	0.05247008771688602
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0013985999999999998	0.05247008771688602
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.0013985999999999998	0.05247008771688602
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.0013985999999999998	0.05247008771688602
MEIER-GORLIN SYNDROME 8; MGORS8	0.0013985999999999998	0.05247008771688602
RESTRICTIVE DERMOPATHY	0.0013985999999999998	0.05247008771688602
TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	0.0013985999999999998	0.05247008771688602
16P12.1P12.3 TRIPLICATION SYNDROME	0.0013985999999999998	0.05247008771688602
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0013985999999999998	0.05247008771688602
OTOFACIOCERVICAL SYNDROME 2	0.0013985999999999998	0.05247008771688602
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.0013985999999999998	0.05247008771688602
GENITOPALATOCARDIAC SYNDROME	0.0013985999999999998	0.05247008771688602
IMAGE SYNDROME	0.0013985999999999998	0.05247008771688602
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.0013985999999999998	0.05247008771688602
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.0013985999999999998	0.05247008771688602
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0013985999999999998	0.05247008771688602
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.0013985999999999998	0.05247008771688602
MECKEL SYNDROME 12; MKS12	0.0013985999999999998	0.05247008771688602
FRANK-TER HAAR SYNDROME; FTHS	0.0013985999999999998	0.05247008771688602
NEU-LAXOVA SYNDROME 2; NLS2	0.0013985999999999998	0.05247008771688602
FRONTONASAL DYSPLASIA 1; FND1	0.0013985999999999998	0.05247008771688602
INIENCEPHALY	0.0013985999999999998	0.05247008771688602
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.0013985999999999998	0.05247008771688602
MECKEL SYNDROME, TYPE 1; MKS1	0.0013985999999999998	0.05247008771688602
PRIMARY PULMONARY HYPOPLASIA	0.0013985999999999998	0.05247008771688602
OROFACIODIGITAL SYNDROME IV; OFD4	0.0013985999999999998	0.05247008771688602
SPONDYLO-OCULAR SYNDROME	0.0013985999999999998	0.05247008771688602
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.0013985999999999998	0.05247008771688602
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0013985999999999998	0.05247008771688602
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.0013985999999999998	0.05247008771688602
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.0013985999999999998	0.05247008771688602
NEMALINE MYOPATHY 2; NEM2	0.0013985999999999998	0.05247008771688602
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.0013985999999999998	0.05247008771688602
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.0013985999999999998	0.05247008771688602
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0013985999999999998	0.05247008771688602
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0013985999999999998	0.05247008771688602
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.0013985999999999998	0.05247008771688602
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.0013985999999999998	0.05247008771688602
TRICHOHEPATOENTERIC SYNDROME 1	0.0013985999999999998	0.05247008771688602
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0013985999999999998	0.05247008771688602
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0013985999999999998	0.05247008771688602
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0013985999999999998	0.05247008771688602
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.0013985999999999998	0.05247008771688602
SECKEL SYNDROME 4	0.0013985999999999998	0.05247008771688602
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.0013985999999999998	0.05247008771688602
3Q27.3 MICRODELETION SYNDROME	0.0013985999999999998	0.05247008771688602
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0013985999999999998	0.05247008771688602
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.0013985999999999998	0.05247008771688602
HYPOGLOSSIA WITH SITUS INVERSUS	0.0013985999999999998	0.05247008771688602
RENAL AGENESIS, BILATERAL	0.0013985999999999998	0.05247008771688602
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.0013985999999999998	0.05247008771688602
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0013985999999999998	0.05247008771688602
BARBER-SAY SYNDROME; BBRSAY	0.0013985999999999998	0.05247008771688602
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.0013985999999999998	0.05247008771688602
DIAMOND-BLACKFAN ANEMIA 10	0.0013985999999999998	0.05247008771688602
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.0013985999999999998	0.05247008771688602
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0013985999999999998	0.05247008771688602
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.0013985999999999998	0.05247008771688602
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.0013985999999999998	0.05247008771688602
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0013985999999999998	0.05247008771688602
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0013985999999999998	0.05247008771688602
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0013985999999999998	0.05247008771688602
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.0013985999999999998	0.05247008771688602
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.0013985999999999998	0.05247008771688602
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.0013985999999999998	0.05247008771688602
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0013985999999999998	0.05247008771688602
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.0013985999999999998	0.05247008771688602
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.0013985999999999998	0.05247008771688602
GENITOPALATOCARDIAC SYNDROME	0.0013985999999999998	0.05247008771688602
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.0013985999999999998	0.05247008771688602
FEMORAL-FACIAL SYNDROME	0.0013985999999999998	0.05247008771688602
HYDROLETHALUS SYNDROME 1	0.0013985999999999998	0.05247008771688602
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.0013985999999999998	0.05247008771688602
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0013985999999999998	0.05247008771688602
FEINGOLD SYNDROME 1; FGLDS1	0.0013985999999999998	0.05247008771688602
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0013985999999999998	0.05247008771688602
KYPHOMELIC DYSPLASIA	0.0013985999999999998	0.05247008771688602
ATELOSTEOGENESIS TYPE I	0.0013985999999999998	0.05247008771688602
PHAVER SYNDROME	0.0013985999999999998	0.05247008771688602
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0013985999999999998	0.05247008771688602
MACDERMOT-WINTER SYNDROME	0.001086973	0.040779042368001395
DISTAL TRISOMY 17Q	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.040779042368001395
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001086973	0.040779042368001395
ALG1-CDG	0.001086973	0.040779042368001395
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.040779042368001395
ALG3-CDG	0.001086973	0.040779042368001395
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001086973	0.040779042368001395
SCHIZENCEPHALY	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.040779042368001395
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.040779042368001395
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.040779042368001395
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001086973	0.040779042368001395
INFANTILE REFSUM DISEASE	0.001086973	0.040779042368001395
TRISOMY X	0.001086973	0.040779042368001395
PMM2-CDG	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001086973	0.040779042368001395
CEDNIK SYNDROME	0.001086973	0.040779042368001395
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.040779042368001395
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.040779042368001395
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.040779042368001395
LATHOSTEROLOSIS	0.001086973	0.040779042368001395
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040779042368001395
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.040779042368001395
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.040779042368001395
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.040779042368001395
DPAGT1-CDG	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001086973	0.040779042368001395
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.040779042368001395
15Q13.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
PHACE SYNDROME	0.001086973	0.040779042368001395
TAY-SACHS DISEASE	0.001086973	0.040779042368001395
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.040779042368001395
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.040779042368001395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.040779042368001395
OCULOECTODERMAL SYNDROME; OES	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040779042368001395
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
ARGININOSUCCINIC ACIDURIA	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040779042368001395
GRISCELLI SYNDROME	0.001086973	0.040779042368001395
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.040779042368001395
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.040779042368001395
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.040779042368001395
LEBER CONGENITAL AMAUROSIS	0.001086973	0.040779042368001395
NARP SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
ALSTRÖM SYNDROME	0.001086973	0.040779042368001395
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.040779042368001395
POTOCKI-SHAFFER SYNDROME	0.001086973	0.040779042368001395
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.040779042368001395
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
CRANIOPHARYNGIOMA	0.001086973	0.040779042368001395
KEUTEL SYNDROME	0.001086973	0.040779042368001395
CITRULLINEMIA, CLASSIC	0.001086973	0.040779042368001395
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.040779042368001395
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.040779042368001395
MAPLE SYRUP URINE DISEASE	0.001086973	0.040779042368001395
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001086973	0.040779042368001395
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.040779042368001395
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.040779042368001395
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.040779042368001395
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.040779042368001395
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.040779042368001395
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
17Q12 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
20P12.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.040779042368001395
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.040779042368001395
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040779042368001395
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.040779042368001395
XP21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MATERNAL PHENYLKETONURIA	0.001086973	0.040779042368001395
HYDRANENCEPHALY	0.001086973	0.040779042368001395
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.040779042368001395
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.040779042368001395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.040779042368001395
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.040779042368001395
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.040779042368001395
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.040779042368001395
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.040779042368001395
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.040779042368001395
MICRO SYNDROME	0.001086973	0.040779042368001395
8P11.2 DELETION SYNDROME	0.001086973	0.040779042368001395
1Q21.1 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.040779042368001395
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.040779042368001395
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.040779042368001395
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001086973	0.040779042368001395
PALLISTER-HALL SYNDROME	0.001086973	0.040779042368001395
2P21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 7	0.001086973	0.040779042368001395
RFT1-CDG	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.040779042368001395
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040779042368001395
XQ21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.040779042368001395
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.040779042368001395
SRD5A3-CDG	0.001086973	0.040779042368001395
MEVALONIC ACIDURIA	0.001086973	0.040779042368001395
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
RUVALCABA SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.040779042368001395
PHACE ASSOCIATION	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.040779042368001395
LISSENCEPHALY 1; LIS1	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
COWDEN SYNDROME	0.001086973	0.040779042368001395
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
EAST SYNDROME	0.001086973	0.040779042368001395
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.040779042368001395
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
ALG11-CDG	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.001086973	0.040779042368001395
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001086973	0.040779042368001395
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040779042368001395
VICI SYNDROME	0.001086973	0.040779042368001395
SOTOS SYNDROME	0.001086973	0.040779042368001395
LISSENCEPHALY 4	0.001086973	0.040779042368001395
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001086973	0.040779042368001395
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.040779042368001395
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.040779042368001395
CHÉDIAK-HIGASHI SYNDROME	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.040779042368001395
HARTNUP DISEASE	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.040779042368001395
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.040779042368001395
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.040779042368001395
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040779042368001395
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.040779042368001395
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
OPTIC PATHWAY GLIOMA	0.001086973	0.040779042368001395
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001086973	0.040779042368001395
WOLF-HIRSCHHORN SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0009615380000000001	0.03607320406343426
SOTOS SYNDROME 2	0.0009615380000000001	0.03607320406343426
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0009615380000000001	0.03607320406343426
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.03607320406343426
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0009615380000000001	0.03607320406343426
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0009615380000000001	0.03607320406343426
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
NEUTRAL LIPID STORAGE MYOPATHY	0.0009615380000000001	0.03607320406343426
MENTAL RETARDATION, X-LINKED 19	0.0009615380000000001	0.03607320406343426
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.03607320406343426
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0009615380000000001	0.03607320406343426
COG1-CDG	0.0009615380000000001	0.03607320406343426
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0009615380000000001	0.03607320406343426
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.03607320406343426
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0009615380000000001	0.03607320406343426
MENTAL RETARDATION, X-LINKED 93	0.0009615380000000001	0.03607320406343426
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0009615380000000001	0.03607320406343426
OSTEOGENESIS IMPERFECTA, TYPE X	0.0009615380000000001	0.03607320406343426
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.0009615380000000001	0.03607320406343426
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0009615380000000001	0.03607320406343426
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.03607320406343426
SCHOLTE SYNDROME; SHLTS	0.0009615380000000001	0.03607320406343426
MYOTONIC DYSTROPHY 1	0.0009615380000000001	0.03607320406343426
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.03607320406343426
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0009615380000000001	0.03607320406343426
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0009615380000000001	0.03607320406343426
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0009615380000000001	0.03607320406343426
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0009615380000000001	0.03607320406343426
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0009615380000000001	0.03607320406343426
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0009615380000000001	0.03607320406343426
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0009615380000000001	0.03607320406343426
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0009615380000000001	0.03607320406343426
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0009615380000000001	0.03607320406343426
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.03607320406343426
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0009615380000000001	0.03607320406343426
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.0009615380000000001	0.03607320406343426
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	0.03607320406343426
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0009615380000000001	0.03607320406343426
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0009615380000000001	0.03607320406343426
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0009615380000000001	0.03607320406343426
BETHLEM MYOPATHY 2; BTHLM2	0.0009615380000000001	0.03607320406343426
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.03607320406343426
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0009615380000000001	0.03607320406343426
DESBUQUOIS DYSPLASIA 1	0.0009615380000000001	0.03607320406343426
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0009615380000000001	0.03607320406343426
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0009615380000000001	0.03607320406343426
EHLERS-DANLOS SYNDROME, TYPE VI	0.0009615380000000001	0.03607320406343426
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0009615380000000001	0.03607320406343426
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0009615380000000001	0.03607320406343426
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0009615380000000001	0.03607320406343426
GLYCOGEN STORAGE DISEASE IV	0.0009615380000000001	0.03607320406343426
GLYCOGEN STORAGE DISEASE II	0.0009615380000000001	0.03607320406343426
ETHANOLAMINOSIS	0.0009615380000000001	0.03607320406343426
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0009615380000000001	0.03607320406343426
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0009615380000000001	0.03607320406343426
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0009615380000000001	0.03607320406343426
CAP MYOPATHY	0.0009615380000000001	0.03607320406343426
CHITAYAT SYNDROME	0.0009615380000000001	0.03607320406343426
GIANT AXONAL NEUROPATHY	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0009615380000000001	0.03607320406343426
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.0009615380000000001	0.03607320406343426
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0009615380000000001	0.03607320406343426
SENGERS SYNDROME	0.0009615380000000001	0.03607320406343426
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0009615380000000001	0.03607320406343426
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.03607320406343426
CEREBELLAR HYPOPLASIA	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0009615380000000001	0.03607320406343426
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0009615380000000001	0.03607320406343426
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.03607320406343426
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0009615380000000001	0.03607320406343426
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.03607320406343426
RING CHROMOSOME 13 SYNDROME	0.0009615380000000001	0.03607320406343426
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.0009615380000000001	0.03607320406343426
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0009615380000000001	0.03607320406343426
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	0.03607320406343426
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0009615380000000001	0.03607320406343426
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0009615380000000001	0.03607320406343426
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
OSTEOPENIA AND SPARSE HAIR	0.0009615380000000001	0.03607320406343426
PRIMROSE SYNDROME; PRIMS	0.0009615380000000001	0.03607320406343426
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0009615380000000001	0.03607320406343426
HYPERCALCEMIA, INFANTILE, 1	0.0009615380000000001	0.03607320406343426
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0009615380000000001	0.03607320406343426
OPSISMODYSPLASIA; OPSMD	0.0009615380000000001	0.03607320406343426
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0009615380000000001	0.03607320406343426
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0009615380000000001	0.03607320406343426
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0009615380000000001	0.03607320406343426
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0009615380000000001	0.03607320406343426
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
MULTIMINICORE MYOPATHY	0.0009615380000000001	0.03607320406343426
MYOPATHY, CENTRONUCLEAR, 5	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.03607320406343426
PORPHYRIA, ACUTE HEPATIC	0.0009615380000000001	0.03607320406343426
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0009615380000000001	0.03607320406343426
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0009615380000000001	0.03607320406343426
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0009615380000000001	0.03607320406343426
GLYCOGEN STORAGE DISEASE IXC	0.0009615380000000001	0.03607320406343426
SHPRINTZEN OMPHALOCELE SYNDROME	0.0009615380000000001	0.03607320406343426
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.0009615380000000001	0.03607320406343426
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0009615380000000001	0.03607320406343426
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.0009615380000000001	0.03607320406343426
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.0009615380000000001	0.03607320406343426
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0009615380000000001	0.03607320406343426
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.03607320406343426
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.0009615380000000001	0.03607320406343426
ACID PHOSPHATASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0009615380000000001	0.03607320406343426
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0009615380000000001	0.03607320406343426
CHIARI MALFORMATION TYPE II	0.0009615380000000001	0.03607320406343426
LEGIUS SYNDROME	0.0009615380000000001	0.03607320406343426
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0009615380000000001	0.03607320406343426
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.03607320406343426
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.0009615380000000001	0.03607320406343426
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.03607320406343426
NEMALINE MYOPATHY 4	0.0009615380000000001	0.03607320406343426
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0009615380000000001	0.03607320406343426
PIERSON SYNDROME	0.0009615380000000001	0.03607320406343426
RIGID SPINE MUSCULAR DYSTROPHY 1	0.0009615380000000001	0.03607320406343426
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0009615380000000001	0.03607320406343426
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0009615380000000001	0.03607320406343426
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0009615380000000001	0.03607320406343426
WARBURG MICRO SYNDROME 1	0.0009615380000000001	0.03607320406343426
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0009615380000000001	0.03607320406343426
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.03607320406343426
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0009615380000000001	0.03607320406343426
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0009615380000000001	0.03607320406343426
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.0009615380000000001	0.03607320406343426
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0009615380000000001	0.03607320406343426
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0009615380000000001	0.03607320406343426
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.0009615380000000001	0.03607320406343426
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0009615380000000001	0.03607320406343426
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0009615380000000001	0.03607320406343426
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.0009615380000000001	0.03607320406343426
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.0009615380000000001	0.03607320406343426
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0009615380000000001	0.03607320406343426
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
CLASSIC MULTIMINICORE MYOPATHY	0.0009615380000000001	0.03607320406343426
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0009615380000000001	0.03607320406343426
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.03607320406343426
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	0.03607320406343426
NEMALINE MYOPATHY 7; NEM7	0.0009615380000000001	0.03607320406343426
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020467085824608922
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020467085824608922
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020467085824608922
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020467085824608922
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020467085824608922
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020467085824608922
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608922
HURLER SYNDROME	0.000545554	0.020467085824608922
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 2	0.000545554	0.020467085824608922
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020467085824608922
OXOGLUTARIC ACIDURIA	0.000545554	0.020467085824608922
JAWAD SYNDROME	0.000545554	0.020467085824608922
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.020467085824608922
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020467085824608922
EPIDERMAL NEVUS SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020467085824608922
TRANSALDOLASE DEFICIENCY	0.000545554	0.020467085824608922
MEDULLOBLASTOMA	0.000545554	0.020467085824608922
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020467085824608922
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020467085824608922
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020467085824608922
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.020467085824608922
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020467085824608922
ATELOSTEOGENESIS TYPE III	0.000545554	0.020467085824608922
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.020467085824608922
DISTAL MONOSOMY 9P	0.000545554	0.020467085824608922
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.020467085824608922
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020467085824608922
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.020467085824608922
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020467085824608922
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020467085824608922
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.020467085824608922
USHER SYNDROME TYPE 1	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020467085824608922
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020467085824608922
CULLER-JONES SYNDROME; CJS	0.000545554	0.020467085824608922
OROTIC ACIDURIA	0.000545554	0.020467085824608922
FRIAS SYNDROME	0.000545554	0.020467085824608922
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020467085824608922
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020467085824608922
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020467085824608922
ALPHA-MANNOSIDOSIS	0.000545554	0.020467085824608922
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020467085824608922
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020467085824608922
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.020467085824608922
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020467085824608922
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020467085824608922
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020467085824608922
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.020467085824608922
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.020467085824608922
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020467085824608922
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020467085824608922
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020467085824608922
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.020467085824608922
FARBER DISEASE	0.000545554	0.020467085824608922
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608922
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020467085824608922
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.020467085824608922
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020467085824608922
SECKEL SYNDROME 9; SCKL9	0.000545554	0.020467085824608922
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
NOONAN SYNDROME 9; NS9	0.000545554	0.020467085824608922
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020467085824608922
ABETAL34V AMYLOIDOSIS	0.000545554	0.020467085824608922
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.020467085824608922
ALG6-CDG	0.000545554	0.020467085824608922
MEIER-GORLIN SYNDROME 7	0.000545554	0.020467085824608922
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.020467085824608922
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.020467085824608922
LIG4 SYNDROME	0.000545554	0.020467085824608922
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020467085824608922
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020467085824608922
NOONAN SYNDROME 2; NS2	0.000545554	0.020467085824608922
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.020467085824608922
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
EVEN-PLUS SYNDROME	0.000545554	0.020467085824608922
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020467085824608922
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020467085824608922
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020467085824608922
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
DEXTROCARDIA	0.000545554	0.020467085824608922
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020467085824608922
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020467085824608922
SENIOR-LOKEN SYNDROME	0.000545554	0.020467085824608922
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.020467085824608922
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.020467085824608922
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020467085824608922
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020467085824608922
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.020467085824608922
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
CDAGS SYNDROME	0.000545554	0.020467085824608922
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608922
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020467085824608922
SYNDROMIC DIARRHEA	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.020467085824608922
ZEBRA BODY MYOPATHY	0.000545554	0.020467085824608922
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020467085824608922
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.020467085824608922
WOLMAN DISEASE	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020467085824608922
COLE-CARPENTER SYNDROME	0.000545554	0.020467085824608922
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.020467085824608922
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020467085824608922
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020467085824608922
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020467085824608922
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.020467085824608922
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020467085824608922
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.020467085824608922
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020467085824608922
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.020467085824608922
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020467085824608922
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.020467085824608922
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.020467085824608922
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020467085824608922
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.020467085824608922
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.020467085824608922
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.020467085824608922
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.020467085824608922
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.020467085824608922
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.020467085824608922
CHAR SYNDROME	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020467085824608922
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.020467085824608922
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.020467085824608922
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.020467085824608922
N SYNDROME	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020467085824608922
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020467085824608922
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.020467085824608922
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.020467085824608922
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020467085824608922
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.020467085824608922
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.020467085824608922
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020467085824608922
BARATELA-SCOTT SYNDROME	0.000545554	0.020467085824608922
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.020467085824608922
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.020467085824608922
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.020467085824608922
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020467085824608922
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.020467085824608922
WAARDENBURG-SHAH SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020467085824608922
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020467085824608922
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.020467085824608922
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020467085824608922
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020467085824608922
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 11	0.000545554	0.020467085824608922
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.020467085824608922
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020467085824608922
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.020467085824608922
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.020467085824608922
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020467085824608922
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020467085824608922
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.020467085824608922
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020467085824608922
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.020467085824608922
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.020467085824608922
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.020467085824608922
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020467085824608922
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020467085824608922
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020467085824608922
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.020467085824608922
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.020467085824608922
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.020467085824608922
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.020467085824608922
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.020467085824608922
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020467085824608922
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.020467085824608922
CODAS SYNDROME	0.000545554	0.020467085824608922
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.020467085824608922
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.020467085824608922
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020467085824608922
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.020467085824608922
TETRASOMY X	0.000545554	0.020467085824608922
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
REVESZ SYNDROME	0.000545554	0.020467085824608922
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.020467085824608922
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.020467085824608922
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
ROTHMUND-THOMSON SYNDROME	0.000545554	0.020467085824608922
RAHMAN SYNDROME	0.000545554	0.020467085824608922
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.020467085824608922
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.020467085824608922
12Q14 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020467085824608922
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.020467085824608922
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020467085824608922
MONOSOMY 13Q34	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.020467085824608922
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.020467085824608922
STEEL SYNDROME; STLS	0.000545554	0.020467085824608922
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.020467085824608922
3MC SYNDROME 2	0.000545554	0.020467085824608922
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.020467085824608922
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.020467085824608922
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020467085824608922
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020467085824608922
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.020467085824608922
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.000545554	0.020467085824608922
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.020467085824608922
SEPTOOPTIC DYSPLASIA	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020467085824608922
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020467085824608922
AUSTRALIA ANTIGEN	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020467085824608922
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.020467085824608922
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020467085824608922
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020467085824608922
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020467085824608922
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.020467085824608922
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
CURRARINO SYNDROME	0.000545554	0.020467085824608922
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.020467085824608922
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020467085824608922
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020467085824608922
RIDDLE SYNDROME	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.020467085824608922
LOWRY-MACLEAN SYNDROME	0.000545554	0.020467085824608922
LIG4 SYNDROME	0.000545554	0.020467085824608922
MONOSOMY 18P	0.000545554	0.020467085824608922
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020467085824608922
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.020467085824608922
TRIPLE A SYNDROME	0.000541419	0.020311956543392476
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392476
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020311956543392476
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.020311956543392476
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392476
SANDHOFF DISEASE	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
XERODERMA PIGMENTOSUM	0.000541419	0.020311956543392476
PARIETAL FORAMINA	0.000541419	0.020311956543392476
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392476
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392476
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.020311956543392476
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392476
LASSA FEVER	0.000541419	0.020311956543392476
CROUZON SYNDROME	0.000541419	0.020311956543392476
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
BANGSTAD SYNDROME	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000541419	0.020311956543392476
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392476
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392476
ALEXANDER DISEASE	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392476
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020311956543392476
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392476
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392476
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392476
SYSTEMIC SCLEROSIS	0.000541419	0.020311956543392476
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020311956543392476
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020311956543392476
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392476
MEHMO SYNDROME	0.000541419	0.020311956543392476
AUTISM	0.000541419	0.020311956543392476
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.020311956543392476
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392476
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392476
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020311956543392476
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392476
DIAMINOPENTANURIA	0.000541419	0.020311956543392476
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392476
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392476
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392476
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.000541419	0.020311956543392476
SCRUB TYPHUS	0.000541419	0.020311956543392476
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392476
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392476
INSULINOMA	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392476
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392476
CROME SYNDROME	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020311956543392476
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020311956543392476
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392476
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392476
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392476
EPENDYMOMA	0.000541419	0.020311956543392476
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392476
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392476
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020311956543392476
SECKEL SYNDROME 7; SCKL7	0.000541419	0.020311956543392476
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020311956543392476
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392476
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020311956543392476
SUBEPENDYMOMA	0.000541419	0.020311956543392476
MOYAMOYA DISEASE	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
PINEOBLASTOMA	0.000541419	0.020311956543392476
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392476
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392476
MICROSPORIDIOSIS	0.000541419	0.020311956543392476
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392476
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392476
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392476
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392476
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020311956543392476
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.020311956543392476
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392476
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392476
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.020311956543392476
SANJAD-SAKATI SYNDROME	0.000541419	0.020311956543392476
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020311956543392476
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000541419	0.020311956543392476
MOMO SYNDROME	0.000541419	0.020311956543392476
MOYNAHAN SYNDROME	0.000541419	0.020311956543392476
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392476
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392476
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392476
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392476
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
PROLACTINOMA	0.000541419	0.020311956543392476
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392476
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392476
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.020311956543392476
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392476
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020311956543392476
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020311956543392476
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392476
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392476
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392476
PERRAULT SYNDROME 3	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392476
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392476
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.020311956543392476
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020311956543392476
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020311956543392476
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392476
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.020311956543392476
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392476
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392476
KNOBLOCH SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
COFS SYNDROME	0.000541419	0.020311956543392476
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392476
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392476
CRISPONI SYNDROME	0.000541419	0.020311956543392476
CRYPTOCOCCOSIS	0.000541419	0.020311956543392476
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392476
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020311956543392476
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392476
BOWEN-CONRADI SYNDROME	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392476
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392476
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392476
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392476
BEHÇET DISEASE	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392476
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020311956543392476
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.020311956543392476
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392476
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392476
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392476
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392476
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 6	0.000541419	0.020311956543392476
HARROD SYNDROME	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
HENNEKAM-BEEMER SYNDROME	0.000541419	0.020311956543392476
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392476
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392476
2Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392476
WOLCOTT-RALLISON SYNDROME	0.000541419	0.020311956543392476
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
DISTAL TRISOMY 15Q	0.000541419	0.020311956543392476
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.020311956543392476
DYSEQUILIBRIUM SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392476
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392476
COCKAYNE SYNDROME	0.000541419	0.020311956543392476
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020311956543392476
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020311956543392476
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392476
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392476
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS	0.000541419	0.020311956543392476
MILLER-DIEKER SYNDROME	0.000541419	0.020311956543392476
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392476
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.020311956543392476
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
ONDINE SYNDROME	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020311956543392476
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020311956543392476
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392476
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392476
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392476
NORRIE DISEASE	0.000541419	0.020311956543392476
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392476
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020311956543392476
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392476
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020311956543392476
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392476
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
LEIGH SYNDROME	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392476
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392476
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392476
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392476
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020311956543392476
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392476
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
DEND SYNDROME	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392476
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392476
DPM1-CDG	0.000541419	0.020311956543392476
MPDU1-CDG	0.000541419	0.020311956543392476
ALG2-CDG	0.000541419	0.020311956543392476
ALG9-CDG	0.000541419	0.020311956543392476
MOGS-CDG	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392476
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.020311956543392476
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392476
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020311956543392476
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392476
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392476
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
KRABBE DISEASE	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392476
PRADER-WILLI SYNDROME	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392476
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392476
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392476
RABIES	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020311956543392476
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392476
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392476
MERCURY POISONING	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
TETRASOMY 18P	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
VIRAL HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392476
WHIPPLE DISEASE	0.000541419	0.020311956543392476
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392476
GALACTOSIALIDOSIS	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
RENPENNING SYNDROME	0.000541419	0.020311956543392476
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392476
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392476
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392476
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392476
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020311956543392476
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
15Q OVERGROWTH SYNDROME	0.000541419	0.020311956543392476
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392476
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
RIFT VALLEY FEVER	0.000541419	0.020311956543392476
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392476
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020311956543392476
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392476
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392476
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020311956543392476
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392476
RENPENNING SYNDROME 1; RENS1	0.000541419	0.020311956543392476
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020311956543392476
GLIOBLASTOMA	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392476
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020311956543392476
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392476
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020311956543392476
CLASSIC HOMOCYSTINURIA	0.000541419	0.020311956543392476
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392476
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392476
